Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3043747	s-beta-2	g/l (g/l)	9990	22371	0.00%
3043747	s-beta-2	— (—)	1803	2372	100.00%	Distribution not available
3043747	s-beta2	g/l (—)	896	1431	100.00%	Distribution not available
3043747	beta2-glob	g/l (—)	682	2714	100.00%	Distribution not available
3043747	s-b2glob	g/l (—)	410	876	100.00%	Distribution not available
3043747	s-beta-2-fraktio	g/l (—)	285	347	100.00%	Distribution not available
3043747	s-beeta-2	g/l (—)	224	258	100.00%	Distribution not available
3043747	beeta-2	g/l (—)	113	347	100.00%	Distribution not available
3043747	beeta-2-gl	g/l (—)	86	98	100.00%	Distribution not available
3043747	s-beta2-globuliini(valetietues-prot-fr)	g/l (—)	60	82	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Finngen Rheumatological endpoints

2881

7284

2.31

321.94

2.0

2.3

3.82

3.81

g/l

0.21

2119

5176

Glomerular diseases

923

2392

4.25

319.90

2.6

2.2

3.93

3.83

g/l

0.94

730

1706

Dialysis, with operation codes

701

1477

5.34

318.55

3.9

2.1

3.70

3.83

g/l

1.24

565

1051

Anaemias

1037

711

10.37

307.65

2.5

1.2

3.88

3.69

g/l

1.90

770

505

Primary_lymphoid and hematopoietic malignant neoplasms

1644

3309

5.72

307.65

8.3

1.4

3.70

3.85

g/l

1.03

1140

2333

Implicit Sepsis

2669

8466

2.55

307.65

2.5

2.1

3.81

3.83

g/l

0.28

1929

5958

Renal failure

2590

5920

4.43

307.65

2.5

2.2

3.86

3.83

g/l

0.32

1948

4076

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

1354

1064

22.09

307.65

10.6

1.3

3.99

3.83

g/l

0.71

875

747

Oral corticosteroids

3850

8971

2.69

307.65

2.0

2.3

3.84

3.82

g/l

0.15

2809

6319

Pain in limb

2560

7765

2.46

307.65

2.1

2.3

3.79

3.86

g/l

1.14

1910

5529

General symptoms and signs

3442

7228

2.45

307.65

2.4

2.0

3.80

3.87

g/l

0.95

2498

5075

Metabolic disorders

3136

8479

2.37

307.65

2.5

2.1

3.85

3.83

g/l

0.31

2264

6030

Condition for Implicit Sepsis (Organ dysfunction codes)

2838

9020

2.36

307.65

2.4

2.1

3.79

3.84

g/l

0.96

2076

6358

Chronic kidney disease

1905

4128

5.20

307.65

2.3

2.1

3.85

3.81

g/l

0.44

1428

2809

Other systemic involvement of connective tissue

1233

3757

3.53

307.65

1.8

2.3

3.79

3.77

g/l

0.15

895

2616

Pneumonias (Asthma/COPD co-morbidities)

3172

9869

2.29

307.65

3.1

1.9

3.86

3.81

g/l

0.61

2316

7023

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2949

8024

2.37

307.65

3.1

1.9

3.84

3.80

g/l

0.58

2148

5714

ILD medications: immunosuppressive drugs

2592

6740

3.90

307.65

4.4

1.7

3.78

3.83

g/l

0.67

1918

4731

Heart failure, not strict

2889

7815

2.67

307.65

2.4

2.3

3.84

3.86

g/l

0.26

2117

5505

Second line medication for Crohn's disease

2111

7493

2.96

307.65

5.0

1.7

3.79

3.82

g/l

0.31

1538

5372

Multiple myeloma

398

327

21.88

307.65

20.5

1.6

4.08

3.82

g/l

0.37

260

230

Multiple myeloma and malignant plasma cell neoplasms

672

617

17.72

307.65

16.4

1.5

4.05

3.83

g/l

0.46

413

447

Other and unspecified polyneuropathies, also in other diseases

1287

2709

5.50

307.65

2.0

2.2

3.77

3.82

g/l

0.40

913

1911

Bacterial Sepsis

1838

5986

2.89

307.65

2.9

2.1

3.93

3.82

g/l

1.43

1307

4154

L04AX Other immunosuppressants

2086

7351

2.98

307.65

5.0

1.7

3.79

3.82

g/l

0.33

1517

5271

Aplastic and other anaemias

2554

6158

4.33

307.65

2.5

2.1

3.90

3.81

g/l

1.05

1780

4305

Persons encountering health services for specific procedures and health care

3302

9581

2.19

307.65

2.6

2.1

3.78

3.84

g/l

1.10

2341

6883

Malaise and fatigue

1814

5235

3.02

307.65

2.1

3.80

3.84

g/l

0.62

1309

3614

Multiple myeloma and malignant plasma cell neoplasms

672

586

18.69

307.65

16.4

1.4

4.05

3.90

g/l

0.28

413

416

Pneumonia, organism unspecified

2912

9369

2.32

307.65

3.0

1.9

3.87

3.82

g/l

0.64

2128

6660

Other soft tissue disorders, not elsewhere classified

2897

7913

2.33

307.65

2.3

2.2

3.79

3.86

g/l

1.36

2130

5638

Renal tubulo-interstitial diseases

3522

9165

3.10

307.65

2.4

2.2

3.83

3.82

g/l

0.19

2604

6436

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

4679

8798

4.06

307.65

2.5

2.1

3.84

3.83

g/l

0.13

3384

6222

Inflammatory bowel disease treatment related agents

3955

9036

2.57

307.65

2.0

2.3

3.85

3.82

g/l

0.34

2887

6370

Autoimmune diseases excluding thyroid diseases, strict definition

3301

8066

2.35

307.65

1.9

2.4

3.88

3.83

g/l

0.67

2424

5691

Bacterial infection, other or unspecified

2320

6812

3.27

307.65

3.3

2.0

3.99

3.78

g/l

4.01

1625

4776

Other bacterial diseases

3579

9289

2.78

307.65

2.9

2.0

3.97

3.78

g/l

5.95

2579

6598

Systemic connective tissue disorders

1638

4868

3.62

307.65

1.8

2.3

3.77

3.79

g/l

0.16

1202

3395

ILD medications: prednisolone, methylprednisolone, prednisone

3988

7957

2.94

307.65

2.1

1.7

3.82

3.83

g/l

0.24

2962

5554

Examination and observation for other reasons

2012

4495

2.82

307.65

2.3

2.1

3.77

3.95

g/l

5.00

1615

3339

ILD medications

4186

7989

2.99

307.65

2.9

1.7

3.80

3.83

g/l

0.46

3082

5577

Multiple myeloma, excluding all cancers (controls excluding all cancers)

684

587

19.11

307.65

16.3

1.4

4.03

3.88

g/l

0.29

422

417

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

598

1075

6.65

307.65

3.4

2.2

4.36

3.78

g/l

6.45

371

759

Polyneuropathies and other disorders of the peripheral nervous system

1393

3093

5.14

307.65

2.3

2.2

3.77

3.82

g/l

0.42

990

2189

Other systemic involvement of connective tissue (FG)

1206

2977

4.35

307.65

1.7

2.4

3.78

3.76

g/l

0.23

875

2063

2949

8024

2.37

307.65

3.1

1.9

3.84

3.80

g/l

0.58

2148

5714

Fever of other and unknown origin

1995

6084

3.18

307.65

3.7

2.1

3.82

3.86

g/l

0.26

1505

4227

Other anaemias

2427

5804

4.46

307.65

2.5

2.1

3.90

3.81

g/l

1.09

1695

4059

Other and unspecified anaemias

2411

5756

4.48

307.65

2.5

2.1

3.90

3.81

g/l

1.07

1687

4027

Influenza and pneumonia

3265

9782

2.26

307.65

3.0

1.9

3.85

3.81

g/l

0.56

2365

6986

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3095

9941

2.25

307.65

3.0

2.0

3.87

3.81

g/l

0.84

2257

7072

Polyarthropathies

2677

6047

3.08

307.65

2.4

2.3

3.95

3.81

g/l

3.39

1999

4288

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

398

327

21.88

307.65

20.5

1.6

4.08

3.82

g/l

0.37

260

230

First line medication for Crohn's disease

3850

7862

2.76

307.65

3.0

1.6

3.80

3.84

g/l

0.52

2828

5515

Primary_lymphoid and hematopoietic malignant neoplasms

1644

3346

5.65

307.65

8.3

1.4

3.70

3.86

g/l

1.04

1140

2373

All pneumoniae

3183

9889

2.29

307.65

3.0

1.9

3.86

3.81

g/l

0.65

2325

7046

Tramadol

2596

6922

2.49

307.65

2.3

1.9

3.82

3.83

g/l

0.10

1980

4774

Autoimmune diseases excluding thyroid diseases

3410

8322

2.34

307.65

1.9

2.4

3.87

3.83

g/l

0.68

2501

5875

Acute renal failure

1022

2734

4.11

307.65

2.9

2.1

3.84

3.80

g/l

0.37

775

1892

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

830

579

27.25

307.65

7.4

1.3

3.93

3.90

g/l

0.09

563

410

Implicit bacterial Sepsis

1614

5445

2.88

305.98

2.8

2.1

3.89

3.81

g/l

0.84

1147

3787

Infections, IBD-co-morbidities

601

729

6.35

304.65

4.1

2.1

3.68

3.84

g/l

1.01

407

532

Heart failure and antihypertensive medication

1035

1806

4.03

302.62

2.0

2.5

3.92

3.84

g/l

0.53

761

1242

Hypertension, essential

2270

5572

2.39

272.27

2.1

2.2

3.90

3.77

g/l

3.01

1644

3983

Gout

1186

3583

3.22

272.19

3.2

2.3

3.98

3.84

g/l

1.59

898

2500

Disorders of lipoprotein metabolism and other lipidaemias

2685

7913

2.20

271.66

2.2

2.1

3.87

3.85

g/l

0.32

1918

5611

Osteopathies and chondropathies

1898

7592

2.47

271.37

3.0

2.1

3.76

3.82

g/l

0.73

1290

5394

Heart failure,strict

1952

5930

2.49

265.07

2.1

2.3

3.90

3.85

g/l

0.63

1433

4127

Abnormal findings on examination of blood, without diagnosis

1738

6732

2.54

259.63

2.7

2.3

4.01

3.85

g/l

2.66

1202

4799

Other heart diseases

1284

2864

3.05

255.97

2.3

2.0

3.82

3.76

g/l

0.58

953

2046

Codeine

2713

7103

2.15

252.58

2.1

1.9

3.78

3.82

g/l

0.61

2024

4916

Autoimmune diseases related-to ILD

2540

10934

2.10

246.36

2.0

2.2

3.90

3.81

g/l

1.46

1844

7758

Glomerular disorders in diseases classified elsewhere

616

1461

4.71

241.73

2.7

2.2

3.95

3.83

g/l

0.99

483

1060

Nephropathy related operations

635

1548

4.57

240.23

3.9

2.3

3.69

3.83

g/l

1.33

503

1116

Certain infectious and parasitic diseases

2836

6953

2.09

239.69

2.5

1.8

3.85

3.78

g/l

0.88

2062

4914

Reimbursement for rheumatic diseases

1889

8404

2.32

239.21

1.7

2.3

3.89

3.78

g/l

2.54

1406

5934

Unspecified kidney failure

551

1209

5.14

239.02

2.6

2.1

3.84

3.79

g/l

0.35

418

831

Nutritional anaemias

1697

7127

2.42

231.73

2.0

2.2

3.83

3.80

g/l

0.25

1195

5001

Hypertensive diseases (excluding secondary)

1370

2892

2.83

230.93

2.2

2.0

3.92

3.76

g/l

2.29

1022

2058

Oedema, not elsewhere classified

1085

3760

3.01

230.75

2.2

2.1

3.86

3.84

g/l

0.17

793

2598

Pure hypercholesterolaemia

2341

7525

2.15

228.07

2.3

2.2

3.83

3.85

g/l

0.24

1671

5321

Hypertensive diseases

2177

5622

2.25

227.36

2.1

2.2

3.92

3.77

g/l

3.75

1610

4018

Gout, FINNGEN

1186

4402

2.87

226.40

3.2

2.2

3.98

3.84

g/l

1.57

898

3055

Hypertension

2173

5620

2.24

226.01

2.1

2.2

3.92

3.77

g/l

3.77

1606

4016

Iron deficiency anaemia

1458

5927

2.55

223.85

1.9

2.3

3.84

3.77

g/l

0.86

1023

4121

Other and unspecified iron deficiency

1194

4465

2.82

223.02

1.9

2.3

3.87

3.76

g/l

1.57

849

3111

Opioids

2729

7144

2.05

222.63

2.5

1.9

3.81

3.82

g/l

0.05

2028

4945

Asthma, unspecified (mode), excluding more controls

1481

4700

2.55

221.03

2.1

1.9

3.85

3.80

g/l

0.40

1087

3334

Diseases of oesophagus, stomach and duodenum

3080

9904

1.93

220.85

2.1

2.2

3.79

3.84

g/l

0.87

2125

7142

Medical observation and evaluation for suspected diseases and conditions

2009

4553

2.31

218.82

2.3

2.1

3.74

3.95

g/l

6.66

1454

3374

Septicaemia

1415

5569

2.55

217.17

3.0

2.0

3.93

3.77

g/l

2.48

996

3889

Diverticular disease of intestine

2332

7572

2.11

215.13

2.5

2.2

3.83

3.87

g/l

0.33

1669

5389

Cardiovascular diseases (excluding rheumatic etc)

1440

3216

2.64

214.67

2.2

2.0

3.83

3.73

g/l

1.11

1086

2307

Abnormalities of breathing

2473

7250

2.07

214.58

2.3

2.1

3.79

3.86

g/l

0.99

1802

5143

Codeine or tramadol medication

3287

9892

1.88

212.70

2.1

2.2

3.80

3.83

g/l

0.48

2456

6923

Pain in joint

1703

4875

2.38

210.32

2.0

2.2

3.83

3.89

g/l

0.68

1274

3479

Heart failure, strict

2074

7119

2.18

209.71

2.1

2.3

3.88

3.83

g/l

0.63

1519

4957

Explicit Sepsis

1448

5848

2.47

208.31

3.0

2.1

3.92

3.81

g/l

1.54

1025

4050

Autoimmune diseases

3070

8347

1.92

206.53

2.0

2.4

3.79

3.83

g/l

0.51

2237

5893

Care involving dialysis

441

913

5.47

205.27

2.5

2.0

3.72

3.82

g/l

0.57

348

687

Other arthritis (FG)

992

3509

2.95

204.92

2.2

2.5

3.98

3.81

g/l

2.32

731

2477

Benign neoplasm of colon, rectum, anus and anal canal

1769

5689

2.30

204.59

2.2

1.4

3.85

3.87

g/l

0.13

1212

4050

Diseases of arteries, arterioles and capillaries (FINNGEN)

835

1767

3.46

203.92

2.2

3.88

3.80

g/l

0.55

645

1261

Used for control exclusion in common control thyroid runs

2902

7713

1.94

203.81

2.0

2.4

3.77

3.84

g/l

1.62

2115

5448

Asthma, excluding more controls

2029

5001

2.21

201.54

2.0

1.8

3.87

3.81

g/l

0.60

1488

3560

All-cause Heart Failure

2020

7020

2.16

198.43

2.1

2.3

3.88

3.84

g/l

0.51

1473

4878

Dental caries

887

2980

3.09

197.64

3.7

2.1

3.80

3.86

g/l

0.49

645

2120

Osteoporosis

1031

3627

2.89

197.43

2.2

2.1

3.66

3.75

g/l

1.02

674

2526

Dyspnoea

2615

10614

1.93

197.03

2.4

2.2

3.82

3.83

g/l

0.07

1914

7487

Other diseases of blood and blood-forming organs, wide

876

2989

3.13

195.54

3.1

2.2

3.69

3.82

g/l

0.94

664

2115

Asthma, unspecified (mode)

1518

5222

2.37

194.40

2.1

1.9

3.85

3.80

g/l

0.37

1108

3701

Persons encountering health services for other counselling and medical advice, not elsewhere classified

3130

9891

1.84

191.55

2.1

2.3

3.77

3.85

g/l

1.27

2316

6959

Other diseases of intestines

2827

8837

1.90

190.73

2.3

2.1

3.79

3.85

g/l

0.91

1994

6351

Asthma

2134

5567

2.10

187.28

2.0

1.8

3.85

3.81

g/l

0.43

1561

3964

Polymyalgia rheumatica

650

1918

3.73

187.07

1.7

2.3

3.83

3.78

g/l

0.28

446

1321

Any gastric operation

2068

4958

2.13

185.71

2.2

1.8

3.77

3.85

g/l

1.25

1519

3439

GASTRO-related operations

2068

4958

2.13

185.71

2.2

1.8

3.77

3.85

g/l

1.25

1519

3439

Other heart diseases, wide

2403

7718

1.97

184.43

2.4

2.2

3.83

g/l

0.02

1752

5511

Other specific joint derangements/joint disorders

1901

6097

2.14

184.43

1.9

2.3

3.79

3.80

g/l

0.04

1402

4378

Dentinal caries

800

2671

3.13

182.19

3.8

2.1

3.82

3.89

g/l

0.49

571

1902

Benign neoplasm: Colon

1572

5464

2.29

181.82

2.2

1.4

3.85

3.87

g/l

0.10

1069

3892

Transplanted organ and tissue status

462

1091

4.67

181.68

5.5

2.1

3.48

3.89

g/l

7.06

342

812

Pain in throat and chest

2289

7152

2.00

181.58

2.2

2.1

3.74

3.87

g/l

3.35

1670

5068

Other septicaemia

1228

5053

2.49

179.57

2.8

2.0

3.90

3.76

g/l

1.87

865

3532

Persons encountering health services in other circumstances, wide

3340

9961

1.77

176.94

2.1

2.2

3.81

3.85

g/l

0.49

2455

6998

Asthma (mode)

2070

5608

2.07

176.17

2.0

1.8

3.82

3.81

g/l

0.21

1508

3994

Type 2 diabetes, wide definition

2454

8548

1.92

174.82

2.0

2.4

4.00

3.78

g/l

8.49

1711

6084

Spondylopathies

2363

7541

1.95

173.74

2.5

2.1

3.76

3.87

g/l

2.66

1662

5404

Other specified/unspecified arthritis

881

3207

2.87

172.76

2.1

2.4

3.97

3.76

g/l

3.28

644

2265

Erysipelas

1673

7336

2.15

172.57

2.2

2.0

4.09

3.80

g/l

5.82

1230

5182

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

391

557

5.49

172.12

2.4

2.1

3.85

3.81

g/l

0.14

302

399

Cardiovascular diseases

1224

2636

2.57

171.47

2.2

1.9

3.82

3.75

g/l

0.75

928

1891

Acute tubulo-interstitial nephritis

1734

7502

2.11

170.42

2.2

2.1

3.84

3.80

g/l

0.48

1248

5227

Codes for special purposes

1282

5602

2.36

170.13

2.7

2.1

3.72

3.80

g/l

1.02

877

4025

Provisional assignment of new diseases of uncertain etiology

1280

5592

2.36

169.96

2.6

2.1

3.72

3.80

g/l

0.99

876

4018

Asthma (only as main-diagnosis), excluding more controls

1768

5001

2.15

169.57

2.0

1.8

3.82

3.81

g/l

0.09

1292

3560

Pain, not elsewhere classified

803

2812

2.97

168.75

2.4

2.1

3.67

3.81

g/l

1.91

610

1979

Exposure to unspecified factor

2615

11298

1.83

168.43

2.1

2.2

3.86

3.82

g/l

0.68

1969

7959

Enlarged lymph nodes

560

1594

3.72

167.22

2.1

3.80

3.86

g/l

0.35

403

1128

Low back pain

1986

7816

2.00

166.33

2.6

2.1

3.70

3.85

g/l

4.05

1424

5628

Ulcer of lower limb, not elsewhere classified

635

1985

3.49

166.15

2.2

3.98

3.84

g/l

1.29

524

1378

Diabetic nephropathy, excluding more controls

589

1420

3.75

165.50

1.7

2.0

3.94

3.95

g/l

0.01

452

973

Cerebrovascular diseases (FINNGEN)

886

2273

2.88

163.57

2.3

2.1

3.87

3.79

g/l

0.57

663

1608

Neurological diseases, wide definition

648

876

3.79

163.13

2.2

2.0

3.81

g/l

0.00

469

635

Rheumatoid arthritis

1064

3957

2.54

161.34

1.8

2.4

3.93

3.75

g/l

3.10

778

2769

Care involving use of rehabilitation procedures

1799

8666

2.02

160.44

2.3

2.1

3.78

3.84

g/l

0.80

1201

6192

Complications of surgical and medical care, not elsewhere classified

2698

11013

1.79

159.27

2.2

3.83

3.82

g/l

0.09

1941

7816

Headache

1561

6250

2.13

158.17

2.0

3.65

3.84

g/l

4.54

1097

4392

Symptoms and signs involving cognition, perception, emotional state and behaviour

2654

10550

1.80

157.78

2.0

2.3

3.77

3.85

g/l

1.43

1877

7516

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

587

1803

3.53

157.69

2.9

1.4

3.74

3.85

g/l

0.46

447

1259

Continuous positive airway pressure

675

1894

3.23

156.62

2.2

2.3

4.04

3.74

g/l

1.79

475

1397

Diseases of the skin and subcutaneous tissue

2735

7679

1.82

156.57

2.3

2.1

3.81

3.79

g/l

0.23

2004

5382

L04AA Selective immunosuppressants

738

2636

2.95

150.80

1.8

2.3

3.73

3.80

g/l

0.68

589

1883

Disorders resulting from impaired renal tubular function

239

377

7.61

150.27

2.3

2.5

3.92

3.86

g/l

0.26

191

285

Dorsalgia

2610

7961

1.81

149.51

2.4

2.1

3.78

3.85

g/l

1.08

1877

5718

Fall on same level

2990

9810

1.73

149.37

2.2

3.84

3.82

g/l

0.26

2138

7050

Other disorders of skin and subcutaneous tissue

2007

9902

1.91

149.35

2.3

2.2

3.86

3.82

g/l

0.48

1485

6944

Asthma (only as main-diagnosis)

1826

5567

2.02

149.13

2.0

1.8

3.82

3.81

g/l

0.12

1330

3964

Symptoms and signs involving the skin and subcutaneous tissue

1913

10154

1.92

148.34

2.2

3.69

3.83

g/l

2.39

1414

7172

Gout, idiopatic and unspecified

945

3867

2.59

148.28

2.1

2.4

4.02

3.84

g/l

2.48

736

2710

Covid-19 confirmed case

916

3684

2.60

147.35

2.7

2.2

3.70

3.82

g/l

1.65

657

2624

COPD/asthma/ILD related infections

2789

8027

1.77

146.40

2.9

1.9

3.82

3.80

g/l

0.24

2027

5716

COPD/asthma related infections

2789

8027

1.77

146.40

2.9

1.9

3.82

3.80

g/l

0.24

2027

5716

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

119

28.56

146.26

10.8

1.1

4.23

3.79

g/l

0.44

Other disorders of fluid, electrolyte and acid-base balance

998

4031

2.49

146.17

2.6

2.1

3.77

3.80

g/l

0.29

696

2807

Malignant immunoproliferative diseases

130

101

21.04

144.85

10.0

1.2

3.90

3.86

g/l

0.05

Speech therapy

943

3898

2.54

143.70

2.1

2.2

3.77

3.79

g/l

0.14

636

2763

Coagulation defects, purpura and other haemorrhagic conditions

682

2400

3.00

143.56

2.4

2.2

3.72

3.81

g/l

0.97

509

1708

Glomerulonephritis

443

1204

4.01

143.49

2.8

2.3

3.92

3.84

g/l

0.52

348

879

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2516

9821

1.77

142.25

2.8

2.1

3.77

3.85

g/l

1.28

1711

7170

Disorders of thyroid, IBD co-morbidities

424

749

4.25

142.06

2.0

2.1

3.76

3.83

g/l

0.26

314

546

Benign neoplasm of colon, rectum, anus and anal canal

1916

9347

1.91

141.31

2.2

2.3

3.84

g/l

0.06

1320

6614

Parasetamol

1976

5268

1.95

140.39

2.3

2.0

3.88

3.81

g/l

1.06

1405

3835

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

850

1531

2.84

138.70

2.2

1.9

3.78

3.90

g/l

1.00

635

1078

Atrial fibrillation and flutter

868

2171

2.69

137.90

2.6

2.1

3.97

3.82

g/l

1.46

651

1532

Small fibre neuropathy

206

309

8.29

136.80

2.4

2.5

3.72

3.85

g/l

0.53

138

224

Diseases of arteries, arterioles and capillaries

2051

8444

1.86

136.64

2.0

2.4

3.84

g/l

0.01

1512

5892

Heart failure and bmi 25plus

1132

3455

2.36

135.99

2.0

2.4

3.98

3.94

g/l

0.40

821

2299

Other necrotizing vasculopathies (FG)

300

636

5.27

135.48

1.4

2.8

3.85

3.70

g/l

0.88

220

448

Other pulmonary diagnosis

2086

5622

1.89

135.33

2.5

1.8

3.80

3.81

g/l

0.08

1531

4003

L04AD Calcineurin inhibitors

415

1121

3.99

135.09

2.6

2.5

3.60

3.87

g/l

3.34

351

818

Disturbances of skin sensation

795

3111

2.66

135.03

1.9

2.2

3.65

3.79

g/l

2.22

617

2238

Syncope and collapse

1239

5158

2.19

134.53

2.2

2.1

3.72

3.86

g/l

2.40

889

3556

Viral Sepsis

676

2453

2.91

134.34

3.2

2.1

3.67

3.79

g/l

1.36

470

1725

Implicit viral Sepsis

673

2447

2.90

133.24

3.2

2.1

3.67

3.79

g/l

1.41

468

1721

Hypertensive heart and/or renal disease

882

2762

2.59

133.17

1.9

2.4

3.84

3.76

g/l

0.75

650

1930

Oxycodone

1104

4861

2.28

132.76

4.9

2.0

3.79

3.83

g/l

0.22

763

3319

Other dorsopathies, not elsewhere classified

2595

7968

1.75

132.06

2.2

2.1

3.77

3.85

g/l

1.65

1824

5724

Gout, unspecified

775

3058

2.70

131.52

2.1

2.3

3.99

3.85

g/l

1.84

611

2134

Seropositive rheumatoid arthritis

795

3153

2.62

130.84

1.8

2.5

3.95

3.78

g/l

2.10

578

2192

Excluding asthma or asthma-COPD overlap

2067

5622

1.87

130.40

2.5

1.8

3.80

3.81

g/l

0.05

1510

4003

Symptoms and signs involving the circulatory and respiratory systems

2500

7264

1.75

127.28

2.3

2.1

3.78

3.86

g/l

1.58

1827

5155

Gout, strict definition

700

2681

2.79

126.53

2.0

2.3

4.08

3.86

g/l

2.76

550

1873

COPD differential diagnosis

2048

5608

1.86

126.52

2.5

1.8

3.81

g/l

0.03

1499

3994

ILD differential diagnosis

2048

5608

1.86

126.50

2.5

1.8

3.81

g/l

0.03

1499

3994

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

1020

2777

2.38

126.38

2.3

2.1

3.96

3.76

g/l

2.19

743

1982

Lower back pain or/and sciatica

2671

11191

1.68

126.27

2.5

2.2

3.72

3.85

g/l

3.73

1929

7962

Pain (limb, back, neck, head abdominally)

1941

5230

1.89

126.11

2.2

2.1

3.79

3.89

g/l

1.83

1379

3698

Symptoms and signs involving the urinary system

2160

9592

1.78

125.84

2.0

2.3

3.84

3.83

g/l

0.11

1529

6800

Endocrine, nutritional and metabolic diseases

1879

5099

1.90

125.42

2.1

2.2

3.88

3.78

g/l

1.68

1362

3685

Malignant immunoproliferative diseases

130

128

16.45

125.09

10.0

1.8

3.90

3.69

g/l

0.27

Any reimbursement code in KELA

1182

2643

2.28

124.91

2.4

1.5

3.86

3.77

g/l

0.99

888

1877

Asthma (diagnoses ohter than nonallergic)

2243

11215

1.74

124.34

2.0

2.2

3.84

3.81

g/l

0.31

1630

7944

Chronic periodontitis

562

1929

3.10

124.27

3.3

2.1

3.76

3.89

g/l

1.02

412

1385

Symptoms and signs involving the nervous and musculoskeletal systems

1613

8637

1.92

123.87

2.0

2.3

3.64

3.85

g/l

6.95

1204

6072

Other special examinations and investigations of persons without complaint or reported diagnosis

1722

4553

1.95

122.26

2.3

2.1

3.79

3.95

g/l

2.58

1134

3374

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1868

9728

1.83

121.58

2.4

2.3

3.81

3.84

g/l

0.29

1346

6821

Symptoms and signs concerning food and fluid intake

375

1013

3.95

121.38

2.0

2.2

3.60

3.86

g/l

2.73

274

717

Other necrotizing vasculopathies

346

894

4.30

121.35

1.6

2.6

3.83

3.80

g/l

0.11

252

643

Non-follicular lymphoma, hilmo, excluding all cancers

421

1241

3.71

121.24

2.6

1.4

3.74

3.85

g/l

0.33

324

876

Preparatory care for dialysis

254

522

5.66

120.44

2.0

2.8

3.70

3.86

g/l

0.80

223

381

Antihypertensive medication - note that there are other indications

1176

2945

2.22

120.21

2.0

2.2

3.82

3.77

g/l

0.40

876

2078

Diseases of pulp and periapical tissues

994

4525

2.27

119.90

3.6

2.0

3.77

3.84

g/l

0.61

685

3207

Cardiac arrhythmias

1425

4748

2.02

119.81

2.3

3.84

3.76

g/l

1.09

1053

3435

Non-ischemic cardiomyopathy

1037

3904

2.28

119.56

2.2

2.3

3.88

3.84

g/l

0.34

751

2714

Nephrotic syndrome

191

301

7.40

119.51

2.7

2.6

3.81

3.80

g/l

0.05

155

223

Disorders of mineral metabolism

349

914

4.16

119.29

3.7

2.2

3.90

3.76

g/l

0.63

239

660

Constipation

2379

10169

1.71

118.85

2.7

2.2

3.71

3.85

g/l

4.00

1615

7280

Lymphoid leukaemia

283

641

4.96

118.29

2.7

1.4

3.10

3.85

g/l

8.51

220

464

Soft tissue disorders

2564

7975

1.69

117.27

2.2

3.73

3.86

g/l

3.76

1859

5679

Diseases of the musculoskeletal system and connective tissue

1204

2797

2.19

116.86

2.3

2.1

3.84

3.82

g/l

0.14

889

2004

Disorders of calcium metabolism

297

704

4.68

116.75

4.1

2.2

3.87

3.79

g/l

0.28

201

516

Other and unspecified dermatitis

1387

7214

1.97

116.54

2.1

2.2

3.82

3.81

g/l

0.04

1018

5056

Hyperlipidaemia, other/unspecified

1203

5632

2.09

116.46

2.3

2.1

3.95

3.84

g/l

1.08

806

3969

Abnormalities of gait and mobility

494

1652

3.23

115.32

1.8

2.4

3.73

3.83

g/l

0.76

404

1156

Atrial fibrillation and flutter with reimbursement

746

1857

2.66

115.32

2.6

2.2

3.94

3.80

g/l

1.03

545

1329

Osteoporosis with pathological fracture (FG)

305

746

4.52

114.96

1.9

2.4

3.63

3.62

g/l

0.04

205

496

Depression medications

517

773

3.42

113.95

1.8

1.2

3.77

3.71

g/l

0.43

396

551

Neoplasms

1657

4715

1.91

113.66

2.8

1.2

3.81

3.87

g/l

0.75

1204

3417

Dermatitis and eczema

2742

11214

1.63

112.80

2.1

2.2

3.83

3.82

g/l

0.06

2006

7946

Benign neoplasm: Colon

1605

8686

1.87

112.12

2.2

2.3

3.85

3.84

g/l

0.07

1093

6161

Other CVD (FINNGEN)

405

916

3.69

112.01

2.8

2.3

3.86

3.75

g/l

0.54

284

642

Purpura and other haemorrhagic conditions

491

1659

3.15

111.73

2.4

2.3

3.71

3.79

g/l

0.59

357

1194

Bleeding

2277

9951

1.70

111.50

2.2

2.3

3.89

3.83

g/l

0.88

1639

7018

Dermatitis

1612

8922

1.85

111.29

2.1

2.2

3.83

3.81

g/l

0.12

1158

6295

Neurological diseases

2118

6129

1.77

111.19

2.1

2.3

3.76

3.87

g/l

2.12

1478

4472

Valvular heart disease excluding rheumatic fever

1366

5158

1.99

110.65

2.3

3.79

3.85

g/l

0.68

960

3626

Extracorporeal dialysis

290

705

4.59

110.57

2.6

2.5

3.60

3.81

g/l

1.54

208

523

Rheumatoid arthritis, including avohilmo

1161

5804

2.07

110.10

1.8

2.3

3.90

3.79

g/l

1.54

848

4082

Asthma-related infections

1520

8146

1.88

110.04

2.2

3.83

3.80

g/l

0.26

1122

5741

Asthma, hospital admission 2, infections

1520

8146

1.88

110.04

2.2

3.83

3.80

g/l

0.26

1122

5741

Diabetic nephropathy

592

2207

2.84

109.87

1.7

2.0

3.95

4.00

g/l

0.38

454

1503

Non-rheumatic valve diseases

1359

5144

1.98

108.99

2.3

3.79

3.85

g/l

0.73

954

3619

Chronic periapical parodontitis

660

2634

2.62

108.20

4.5

2.1

3.76

3.87

g/l

0.74

457

1877

Non-follicular lymphoma

421

1340

3.43

107.33

2.6

2.5

3.74

3.85

g/l

0.32

324

967

Persons encountering health services for examination and investigation

1679

4553

1.88

107.29

2.1

3.77

3.95

g/l

4.73

1180

3374

Chronic lymphocytic leukaemia, helper endpoint

191

346

6.63

104.87

2.1

1.4

3.09

3.95

g/l

6.51

158

245

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

191

346

6.63

104.87

2.1

1.4

3.09

3.95

g/l

6.51

158

245

Genitourinary diseases

1439

3732

1.96

104.86

2.1

3.86

3.94

g/l

0.89

1063

2665

Lymphoid leukaemia

283

708

4.48

104.10

2.7

2.5

3.10

3.82

g/l

7.39

220

517

Spinal stenosis

1505

6456

1.88

103.92

2.2

3.73

3.88

g/l

3.04

1048

4589

Diaphragmatic hernia

1120

5671

2.05

102.74

2.3

2.2

3.81

3.80

g/l

0.04

801

3999

Follow-up examination after treatment for conditions other than malignant neoplasms

1134

3653

2.08

102.13

2.2

2.1

3.77

3.92

g/l

2.24

865

2723

Hypothyroidism (congenital or acquired)

438

746

3.43

102.05

2.3

1.2

3.66

3.70

g/l

0.23

319

532

Complications of medical and surgical care

1920

10852

1.71

101.75

2.4

2.2

3.85

3.80

g/l

0.65

1360

7716

Chronic gastritis

913

4312

2.20

101.32

2.1

2.3

3.82

3.78

g/l

0.28

664

3068

Adjustment and management of implanted device

660

2732

2.54

100.81

2.5

2.0

3.76

3.86

g/l

0.94

529

1913

Hypothyroidism, levothyroxine purchases

435

745

3.42

100.75

2.3

1.2

3.66

3.70

g/l

0.26

318

532

Hypothyroidism and >3 levothyroxin purchases

435

745

3.42

100.75

2.3

1.2

3.66

3.70

g/l

0.26

318

532

Arthropathies

2112

6358

1.71

100.49

2.1

2.2

3.82

3.80

g/l

0.32

1552

4539

Intestinal infectious diseases

2307

11149

1.64

99.87

2.8

2.1

3.82

g/l

0.02

1656

7930

Complications of procedures, not elsewhere classified

2049

10732

1.68

99.67

2.1

2.2

3.84

3.82

g/l

0.24

1482

7615

Amyloidosis, other/unspecified

140

197

9.04

98.95

8.5

2.1

3.31

3.74

g/l

2.07

104

145

Glucagon-like peptide-1 (GLP-1) analogues

1656

7826

1.79

98.48

2.1

2.4

4.03

3.79

g/l

6.93

1155

5549

Asthma-related pneumonia or sepsis

1053

5283

2.05

98.34

2.3

2.2

3.85

3.78

g/l

0.42

781

3642

Asthma, hospital admissions 3, pneumonia

1053

5283

2.05

98.34

2.3

2.2

3.85

3.78

g/l

0.42

781

3642

Asthma-related pneumonia

1050

5274

2.05

97.76

2.3

2.2

3.85

3.78

g/l

0.45

778

3633

Bacterial pneumoniae

1163

5325

1.99

97.58

3.7

1.9

3.95

3.81

g/l

0.91

826

3732

Diarrhoea and gastroenteritis of presumed infectious origin

1718

9100

1.75

97.31

2.7

2.0

3.85

3.83

g/l

0.19

1247

6458

ILD medications: azathioprine

393

1257

3.25

97.12

1.8

1.5

3.74

3.79

g/l

0.26

296

892

Bacterial pneumonia, not elsewhere classified

1119

5074

2.01

96.56

3.6

1.9

3.96

3.80

g/l

1.11

801

3553

Other disorders of white blood cells

256

628

4.51

96.28

2.0

2.5

3.57

3.83

g/l

1.71

199

460

Gastrointestinal diseases

1325

3451

1.95

95.07

2.5

1.8

3.79

3.84

g/l

0.54

965

2548

Dizziness and giddiness

1948

9561

1.69

94.83

2.0

2.3

3.70

3.84

g/l

4.53

1379

6769

Hypothyroidism, drug reimbursement

301

546

4.04

94.48

2.2

1.3

3.72

3.66

g/l

0.27

222

395

Diabetes mellitus

2519

9547

1.60

94.45

1.9

2.4

3.96

3.76

g/l

7.12

1752

6853

Benign neoplasms

1670

5359

1.79

94.42

2.2

1.4

3.78

3.86

g/l

1.19

1182

3879

Amyloidosis

150

239

7.65

93.90

8.2

2.2

3.36

3.68

g/l

1.54

112

180

Diabetes, varying definitions

2508

9532

1.60

93.46

1.9

2.4

3.96

3.77

g/l

6.95

1747

6838

Chronic lymphocytic leukaemia

191

385

5.93

93.43

2.1

2.5

3.09

3.75

g/l

4.32

158

272

Haemorrhage from respiratory passages

1006

4677

2.06

93.40

2.2

3.98

3.90

g/l

0.79

733

3244

Chronic lower respiratory diseases

2933

10405

1.54

93.35

2.0

2.3

3.87

3.81

g/l

0.88

2147

7365

Spondylosis

1449

6982

1.82

93.10

2.0

2.2

3.71

3.88

g/l

4.04

1044

5020

Other disorders of urethra and urinary system

1760

7770

1.73

93.00

2.1

2.2

3.81

3.80

g/l

0.10

1248

5473

Disorders of other endocrine glands

1118

5750

1.96

92.33

2.4

2.2

3.65

3.80

g/l

3.19

810

4056

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

2166

7903

1.65

91.26

3.8

1.4

3.81

3.86

g/l

0.51

1570

5659

Dorsopathies

2473

7976

1.60

91.26

2.3

2.1

3.75

3.85

g/l

2.38

1769

5728

Malignant neoplasm, wide definition for exclusion

2166

7903

1.65

91.25

3.8

1.4

3.80

3.86

g/l

0.61

1570

5659

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

2166

7903

1.65

91.23

3.8

1.4

3.80

3.86

g/l

0.61

1570

5659

Certain disorders involving the immune mechanism

599

2479

2.53

91.12

2.7

2.2

3.83

3.81

g/l

0.08

446

1778

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2407

9336

1.60

90.82

1.9

2.4

3.99

3.77

g/l

7.98

1684

6697

Other disorders of kidney and ureter

472

1752

2.87

90.69

2.3

2.4

3.96

3.79

g/l

0.95

353

1247

Other intervertebral disc disorders

2069

7760

1.66

90.42

2.2

2.1

3.77

3.86

g/l

1.34

1444

5567

Secondary hypertension

260

661

4.13

90.24

2.2

2.1

3.72

3.78

g/l

0.23

195

452

Cardiomyopathy

572

2336

2.56

89.58

2.6

2.2

3.66

3.86

g/l

2.27

460

1632

Hypertensive Heart Disease

715

2602

2.33

88.26

2.0

2.4

3.82

3.77

g/l

0.36

516

1821

Benign neoplasms

2342

8289

1.60

87.12

2.2

3.76

3.88

g/l

2.77

1653

5993

Nerve, nerve root and plexus disorders

2660

10975

1.54

87.08

2.2

3.81

3.83

g/l

0.29

1848

7854

Insulin medication

1577

7910

1.74

86.95

2.0

2.4

4.02

3.81

g/l

5.25

1086

5652

Diseases of the eye and adnexa

1833

5433

1.71

86.76

2.1

3.82

3.89

g/l

0.80

1319

3976

Disorders of choroid and retina

2154

9909

1.61

86.48

2.2

2.3

3.86

3.83

g/l

0.30

1472

7046

Malignant neoplasm

2206

8239

1.61

85.91

4.0

1.4

3.82

3.86

g/l

0.26

1574

5914

Disorders of parathyroid gland

681

3022

2.33

85.73

2.3

2.2

3.61

3.77

g/l

2.57

494

2094

Other joint disorders

1964

6355

1.67

85.64

2.0

2.2

3.82

3.80

g/l

0.27

1437

4537

Sicca syndrome [Sjögren]

329

1031

3.43

85.54

1.8

2.5

3.74

3.72

g/l

0.07

245

732

Type 2 diabetes

2442

9357

1.57

85.53

1.9

2.4

3.99

3.77

g/l

8.32

1704

6708

STROKE

1506

6033

1.77

84.64

2.4

3.81

3.85

g/l

0.43

1094

4265

Gastro-oesophageal reflux disease

1706

9142

1.68

84.14

2.0

2.3

3.74

3.85

g/l

2.21

1124

6595

2832

9949

1.52

84.09

2.9

2.0

3.80

3.82

g/l

0.17

2024

7067

Other antidepressants

2606

8880

1.55

84.05

2.1

2.3

3.80

3.86

g/l

1.03

1881

6284

1053

5532

1.93

83.54

2.3

2.2

3.77

3.78

g/l

0.09

781

3886

Sulfasalazine

725

3365

2.21

83.37

1.7

2.3

4.00

3.80

g/l

3.16

536

2378

Other diseases of urinary system

2508

9202

1.55

82.84

2.3

2.2

3.83

3.84

g/l

0.03

1819

6527

388

1353

3.00

82.83

2.2

2.3

3.81

3.80

g/l

0.06

312

964

Infections of the skin and subcutaneous tissue

1359

7766

1.78

82.83

2.4

2.2

3.93

3.83

g/l

1.30

1007

5540

Use of hypnotics and sedatives

2636

10081

1.53

82.15

2.5

2.2

3.79

3.85

g/l

1.01

1897

7176

Venous thromboembolism

1504

8646

1.73

82.15

2.6

2.2

3.88

3.83

g/l

0.78

1078

6069

Asthma, including avohilmo

2826

11021

1.51

82.04

1.9

2.3

3.86

3.82

g/l

0.57

2060

7808

Gonarthrosis [arthrosis of knee](FG)

1843

6605

1.67

81.98

2.0

2.4

3.86

3.82

g/l

0.39

1304

4662

Diabetes, insulin treatment (Kela reimbursement)

2514

10099

1.54

81.93

1.9

2.3

3.99

3.78

g/l

8.29

1763

7235

Hypertensive Renal Disease

181

386

5.23

81.36

1.8

2.7

3.82

3.73

g/l

0.29

140

278

Diseases of liver

942

4871

1.99

81.19

1.8

2.3

4.15

3.80

g/l

8.44

673

3492

Disorders of lens

1830

7078

1.66

80.86

2.6

2.3

3.88

3.87

g/l

0.06

1259

5196

Need for other prophylactic measures

232

601

4.22

80.79

2.4

2.5

3.95

3.77

g/l

0.70

185

445

Acquired haemolytic anaemia

148

269

6.47

80.64

3.6

2.2

3.43

3.84

g/l

1.73

108

194

Fracture of lumbar spine and pelvis

686

3170

2.25

80.51

2.3

2.1

3.73

3.80

g/l

0.56

450

2186

Diabetes medication

2485

9930

1.54

80.38

1.9

2.3

3.97

3.77

g/l

7.33

1716

7125

Bacterial pneumonia (organism specified)

1240

6364

1.82

79.91

3.9

2.0

3.94

3.81

g/l

0.98

883

4452

Azathioprine

393

1407

2.90

79.67

1.8

2.4

3.74

3.78

g/l

0.20

296

1005

Other/unspecified dorsalgia

943

4880

1.97

79.22

2.7

2.1

3.93

3.82

g/l

0.59

672

3478

Coxarthrosis [arthrosis of hip](FG)

1388

5794

1.77

78.79

2.1

2.5

3.81

3.83

g/l

0.16

955

4061

Other and unspecified disorders of white blood cells

196

460

4.76

78.39

1.9

2.6

3.52

3.76

g/l

1.46

160

340

Symptoms and signs involving the digestive system and abdomen

2513

8281

1.54

77.79

2.2

3.79

3.86

g/l

1.44

1782

5909

Myalgia

578

2517

2.37

77.76

2.0

2.1

3.66

3.83

g/l

2.39

404

1799

Other external causes of accidental injury

2029

6367

1.62

77.40

2.2

3.78

3.84

g/l

0.77

1451

4558

Injuries to the abdomen, lower back, lumbar spine and pelvis

1029

5522

1.90

77.18

2.3

2.2

3.75

3.80

g/l

0.44

705

3887

Thrombocytopenia, unspecified

279

847

3.56

76.66

2.0

2.5

3.64

3.83

g/l

1.12

196

617

SLE (Finngen)

159

319

5.51

76.53

1.8

2.2

3.57

3.71

g/l

0.61

127

233

Accidents

2022

6367

1.61

76.05

2.2

3.78

3.84

g/l

0.78

1451

4558

Diseases of oral cavity, salivary glands and jaws

2288

7611

1.56

75.97

2.4

2.0

3.78

3.83

g/l

0.77

1650

5322

Benign neoplasm: Colon, unspecified

721

3462

2.15

75.83

2.3

1.4

3.84

3.86

g/l

0.06

468

2451

Streptococcal septicaemia

298

946

3.36

75.69

4.0

2.1

4.17

3.79

g/l

1.63

208

677

Other arrhythmias

1493

6820

1.70

75.65

2.0

2.2

3.67

3.83

g/l

3.46

1038

4844

Falls/tendency to fall

2582

8602

1.52

75.64

2.2

3.78

3.83

g/l

0.76

1830

6210

Parodontitis or operation codes

2248

10889

1.54

75.58

2.3

2.2

3.84

g/l

0.00

1675

7704

Parodontitis

2246

10889

1.54

75.50

2.3

2.2

3.84

g/l

0.01

1673

7706

Haemolytic anaemias

169

364

5.21

75.24

3.4

2.1

3.48

3.82

g/l

1.54

124

263

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

165

351

5.42

75.18

2.3

1.4

3.72

3.87

g/l

0.46

109

246

Chronic periodontitis, including avohilmo

2234

10890

1.54

74.57

2.3

2.2

3.84

g/l

0.01

1662

7707

Abnormal findings on diagnostic imaging of lung

1350

7782

1.73

74.17

2.3

3.85

3.84

g/l

0.06

985

5459

Intracranial trauma

1213

5117

1.80

74.14

2.1

2.3

3.86

3.88

g/l

0.14

857

3717

Seronegative rheumatoid arthritis

357

1268

2.95

73.93

2.1

2.7

3.77

3.70

g/l

0.31

273

881

Injuries to the head

2572

11324

1.50

73.81

2.1

2.2

3.86

3.82

g/l

0.56

1837

8074

Diseases of the respiratory system

1588

4740

1.70

73.70

2.6

1.9

3.79

g/l

0.01

1164

3360

Explicit bacterial Sepsis

342

1191

3.03

73.68

4.0

2.1

4.11

3.81

g/l

1.36

243

854

Statin medication

1579

5308

1.69

73.57

2.0

2.4

3.79

3.81

g/l

0.24

1191

3667

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

184

433

4.78

73.57

2.2

1.4

3.72

3.83

g/l

0.37

126

303

Other and unspecified diseases of blood and blood-forming organs

146

285

5.93

73.44

5.4

2.6

3.76

3.75

g/l

0.02

124

213

Cough

1001

5211

1.88

73.41

2.4

2.1

3.82

3.85

g/l

0.21

720

3668

Weight loss

344

1213

3.02

72.89

2.2

2.3

3.57

3.80

g/l

2.32

251

875

Disorders of eyelid, lacrimal system and orbit

2097

10765

1.55

72.87

2.4

2.2

3.70

3.84

g/l

3.79

1489

7636

Presence of cardiac and vascular implants and grafts

1353

6029

1.74

72.85

1.8

2.2

3.79

3.89

g/l

1.85

883

4373

Factors influencing health status and contact with health services

793

1891

2.14

72.71

2.3

1.8

3.81

4.00

g/l

2.13

578

1427

Kidney transplant status

201

506

4.32

72.70

1.7

2.5

3.60

3.77

g/l

0.86

170

378

Insulin, intermediate and long-acting

1435

8531

1.68

71.74

1.9

2.3

4.04

3.82

g/l

5.53

993

6051

Other cataract

1223

5450

1.78

71.51

2.5

2.3

3.88

3.85

g/l

0.25

872

3995

Other functional intestinal disorders

1097

5874

1.82

71.49

2.5

2.2

3.70

3.82

g/l

1.54

740

4158

Pruritus

350

1256

2.93

71.34

2.0

2.4

3.74

3.73

g/l

0.03

270

900

Cerebrovascular diseases

1986

9228

1.57

71.27

2.3

3.84

g/l

0.06

1420

6521

Gingivitis and periodontal diseases

2235

7562

1.55

70.94

2.4

2.0

3.81

3.83

g/l

0.21

1672

5294

Seropositive rheumatoid arthritis, wide

795

4069

2.02

70.92

1.8

2.3

3.95

3.76

g/l

3.36

578

2847

Other nutritional deficiencies

1430

8476

1.68

70.84

1.9

2.2

4.13

3.77

g/l

13.08

1005

6144

Hypo-osmolality and hyponatraemia

523

2274

2.39

70.82

2.7

2.0

3.74

3.77

g/l

0.17

372

1569

Other disorders involving the immune mechanism, not elsewhere classified

147

298

5.52

70.20

2.1

2.5

4.42

3.87

g/l

2.82

112

224

Abdominal and pelvic pain

2459

8281

1.51

69.92

2.3

2.2

3.77

3.86

g/l

1.95

1750

5909

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

776

3959

2.03

69.92

1.9

2.3

3.96

3.76

g/l

3.46

566

2776

Abnormal weight loss

324

1133

3.06

69.88

2.0

2.4

3.60

3.79

g/l

1.69

234

825

Viral pneumonia

376

1414

2.78

69.85

3.2

1.9

3.72

3.79

g/l

0.29

274

987

Other/unspecified seropositive rheumatoid arthritis

786

4033

2.02

69.63

1.8

2.3

3.96

3.76

g/l

3.47

573

2823

DVT of lower extremities and pulmonary embolism

1167

6740

1.77

69.59

2.7

2.2

3.87

3.80

g/l

0.85

838

4719

Peripheral artery disease

1304

6219

1.73

69.46

1.9

2.3

3.90

3.84

g/l

0.66

951

4310

Giant cell arteritis

200

528

4.24

68.63

1.5

2.7

3.87

3.74

g/l

0.61

146

369

Paroxysmal tachycardia

495

1770

2.42

68.53

1.8

2.1

3.80

3.81

g/l

0.03

360

1270

Mixed connective tissue disease

245

736

3.58

68.35

1.7

2.5

3.72

3.75

g/l

0.09

195

534

Episodal and paroxysmal disorders

2612

9129

1.48

68.26

1.9

2.3

3.75

3.84

g/l

1.95

1831

6553

Isolated proteinuria

141

283

5.60

68.20

3.2

2.6

4.11

3.71

g/l

2.07

120

204

Insulin, combination of fast acting with intermediate-acting or long-acting

1577

9128

1.62

67.66

2.0

2.3

4.02

3.81

g/l

5.44

1086

6474

Unspecified haematuria

1153

5711

1.77

67.59

2.2

2.3

3.93

3.86

g/l

0.64

832

4024

Other specified/unspecified systemic involvement of connective tissue

222

630

3.80

67.59

1.7

2.6

3.79

3.74

g/l

0.15

181

454

Arthrosis

1727

5955

1.62

67.29

2.0

2.3

3.84

3.81

g/l

0.25

1222

4228

Senile cataract

1693

6610

1.62

67.22

2.6

2.3

3.87

g/l

0.04

1151

4860

Hernia

2251

10261

1.51

67.20

2.4

2.2

3.79

3.84

g/l

0.61

1601

7272

Systemic lupus erythematosus

159

358

4.90

66.79

1.8

2.1

3.57

3.74

g/l

0.87

127

259

Viral hepatitis, IBD co-morbidity

124

221

5.84

66.75

2.0

1.6

3.67

3.88

g/l

0.70

162

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

20.82

66.42

13.4

1.4

3.99

3.69

g/l

0.20

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1526

9544

1.62

66.29

2.3

2.2

3.85

3.81

g/l

0.43

1098

6771

Vasculitis limited to skin, not elsewhere classified

139

284

5.59

66.24

2.3

2.4

4.33

3.68

g/l

3.83

111

209

All influenza

640

3099

2.12

66.21

4.3

1.9

3.74

3.81

g/l

0.36

435

2200

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

2361

10451

1.49

66.15

2.4

2.2

3.89

3.83

g/l

0.74

1688

7445

Other diseases of pleura

1277

6784

1.71

66.05

2.4

2.3

3.94

3.83

g/l

0.85

945

4715

Other bacterial intestinal infections

531

2408

2.29

65.46

3.5

2.1

3.74

3.81

g/l

0.40

343

1690

Sleep disorders (combined)

2356

10523

1.49

65.24

1.9

2.3

3.87

3.82

g/l

0.62

1653

7561

Asthma, hospital admissions , main diagnosis only

1901

11218

1.54

65.16

2.0

2.2

3.81

g/l

0.07

1378

7968

Pulmonary heart disease, diseases of pulmonary circulation

909

5005

1.87

64.73

2.4

2.2

3.85

3.78

g/l

0.74

662

3511

Bronchitis

2491

11283

1.46

64.24

3.1

2.0

3.76

3.83

g/l

1.29

1784

8029

Parodontitis and operation codes

2074

10832

1.51

63.68

2.3

3.83

3.84

g/l

0.12

1550

7673

Hyperparathyroidism

572

2679

2.20

63.22

2.4

2.2

3.62

3.78

g/l

2.30

412

1849

Sciatica+with lumbago

1169

6584

1.72

62.92

2.1

3.75

3.85

g/l

1.50

868

4762

Cystitis

1989

8044

1.53

62.77

2.2

3.79

3.80

g/l

0.17

1454

5675

Other acute lower respiratory infections

1278

7423

1.67

62.45

3.2

2.1

3.74

3.82

g/l

1.19

936

5197

Obesity related asthma

830

4487

1.90

62.43

1.9

2.3

3.91

3.81

g/l

1.09

584

3215

Chronic periodontitis, complicated

328

1226

2.84

62.37

3.8

2.4

3.79

3.85

g/l

0.27

248

891

Direct fill therapy

374

1486

2.62

62.11

4.9

2.2

3.69

3.83

g/l

1.09

268

1092

Obesity and other hyperalimentation

1341

8217

1.64

61.41

1.8

2.3

4.14

3.77

g/l

12.75

947

5942

Coxarthrosis

1281

5244

1.69

61.16

2.1

2.4

3.82

g/l

0.03

881

3706

Other diseases of blood and blood-forming organs

251

820

3.28

61.10

4.3

2.5

3.73

3.81

g/l

0.33

199

598

Any event in cancer register

2121

8474

1.50

61.02

3.6

1.6

3.81

3.85

g/l

0.29

1526

6068

Obesity

1332

8170

1.64

60.94

1.8

2.3

4.14

3.77

g/l

12.74

944

5909

Fibromyalgia

238

751

3.32

60.61

2.2

2.1

3.79

3.75

g/l

0.17

175

541

Injuries to the hip and thigh

1222

6783

1.68

60.51

2.1

2.2

3.83

3.80

g/l

0.23

793

4782

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

131

275

5.30

60.06

1.9

2.6

4.50

3.88

g/l

3.36

101

204

Other retinal disorders

1645

8578

1.57

60.05

2.1

2.3

3.88

3.83

g/l

0.53

1108

6071

SLE, strict definition

153

365

4.62

59.82

1.8

1.9

3.54

3.74

g/l

1.08

121

266

SLE, ICD10

153

365

4.62

59.82

1.8

1.9

3.54

3.74

g/l

1.08

121

266

Other arthrosis

1264

5486

1.68

59.67

2.0

2.4

3.81

3.82

g/l

0.07

922

3893

Shoulder lesions

1845

7440

1.54

59.62

2.2

2.3

3.80

3.87

g/l

1.14

1317

5300

Visual disturbances and blindness

1229

7536

1.66

58.98

2.3

2.2

3.68

3.83

g/l

3.13

857

5356

Other and unspecified vasculitis limited to skin

126

262

5.49

58.89

2.4

2.5

4.34

3.65

g/l

3.72

192

Immunodeficiencies

183

501

3.95

58.88

4.5

2.3

3.45

3.73

g/l

0.60

132

377

Other autoimmune haemolytic anaemias

138

8.10

58.76

2.9

2.1

3.34

3.76

g/l

1.68

100

Dialysis

156

382

4.45

58.69

2.2

2.0

3.79

3.85

g/l

0.14

131

279

Chronic rhinitis, nasopharyngitis and pharyngitis

756

4044

1.91

58.63

2.0

2.2

3.73

3.83

g/l

1.19

572

2914

Bacterial intestinal infections, IBD co-morbidities

531

2521

2.18

58.41

3.6

2.1

3.72

3.83

g/l

0.67

349

1775

Other (not insulin) diabetes medications

2311

9640

1.46

58.34

1.9

2.4

4.01

3.78

g/l

8.45

1605

6903

Idiopathic gout

326

1260

2.76

58.23

2.1

2.3

4.04

3.83

g/l

1.13

249

890

Anaemia in chronic diseases classified elsewhere

124

257

5.49

58.11

1.8

2.5

3.44

3.75

g/l

1.56

188

Diseases of the digestive system

1180

7176

1.68

58.07

2.2

3.83

3.82

g/l

0.10

833

5047

Acute bronchitis

1022

5870

1.74

58.04

3.1

2.1

3.74

3.80

g/l

0.69

773

4087

Visual disturbances

1137

6870

1.69

57.87

2.3

2.2

3.69

3.84

g/l

3.26

801

4900

Type 2 diabetes, definitions combined

2239

9200

1.47

57.84

1.9

2.4

4.00

3.77

g/l

8.20

1547

6596

Polyuria

642

3283

2.02

57.63

2.0

2.3

3.82

3.85

g/l

0.18

495

2344

Other gastritis (incl. Duodenitis)

641

3275

2.02

57.53

2.3

3.88

3.81

g/l

0.36

450

2352

COPD (mode)

815

3528

1.88

57.35

1.8

1.9

4.07

3.81

g/l

2.07

614

2453

Disorders of gallbladder, biliary tract and pancreas

2369

10676

1.45

57.24

2.2

2.3

3.85

3.83

g/l

0.23

1665

7631

Pulmonary embolism

818

4535

1.86

57.04

2.5

2.3

3.87

3.78

g/l

1.09

596

3177

Type 2 diabetes, strict (exclude DM1)

2244

9264

1.46

56.72

1.9

2.4

4.00

3.78

g/l

8.18

1552

6642

Pulmonary heart disease

818

4548

1.85

56.51

2.5

2.2

3.87

3.78

g/l

1.14

596

3184

Other disorders of teeth and supporting structures

558

2731

2.11

56.35

3.2

2.1

3.76

3.84

g/l

0.66

355

1929

Hyperkalaemia

206

628

3.53

56.30

2.5

2.1

3.79

3.81

g/l

0.05

143

452

External causes of morbidity and mortality

1566

4990

1.59

56.30

2.2

3.82

3.83

g/l

0.12

1121

3612

Temporal arteritis

172

470

4.08

56.25

1.5

2.8

3.86

3.72

g/l

0.63

129

327

Fracture of rib(s), sternum and thoracic spine

800

4427

1.86

56.12

2.6

2.3

3.77

3.85

g/l

0.87

563

3133

Benzodiazepine use

2313

11541

1.44

55.95

2.1

2.2

3.77

3.84

g/l

0.92

1648

8222

Immunodeficiency with predominantly antibody defects

122

257

5.29

55.79

5.1

2.0

3.10

3.72

g/l

2.41

198

Osteonecrosis

213

670

3.42

55.37

7.2

2.1

3.65

3.80

g/l

0.48

150

494

Diabetic retinopathy, excluding more controls

656

1851

2.06

55.28

1.7

2.0

4.01

3.96

g/l

0.35

455

1276

Unspecified privation

325

1281

2.66

55.19

2.0

2.3

3.87

3.80

g/l

0.43

268

930

Gonarthrosis

1559

5756

1.58

55.19

2.0

2.3

3.86

3.81

g/l

0.44

1108

4074

Injuries to the thorax

1122

6841

1.67

55.16

2.3

2.2

3.79

3.83

g/l

0.43

792

4843

Atherosclerosis, excluding cerebral and coronary sclerosis

1196

5886

1.66

55.04

1.9

2.3

3.89

3.84

g/l

0.64

882

4069

Benign neoplasm: Colon, unspecified

721

3895

1.92

55.03

2.3

3.84

3.82

g/l

0.11

468

2765

Dysphagia

657

3443

1.96

54.67

2.3

3.74

3.82

g/l

0.73

456

2446

Abnormal findings on examination of urine, without diagnosis

175

490

3.88

54.64

3.5

2.6

4.09

3.77

g/l

1.87

139

360

Type 1 diabetes

590

2972

2.03

54.44

1.7

2.3

3.87

3.77

g/l

0.70

420

2168

ILD, hospital admission 2, with pulmonary infections

312

1218

2.70

54.30

2.3

1.8

3.94

3.79

g/l

0.52

236

855

Systemic lupus erythematosus, unspecified

133

311

4.72

53.43

1.8

1.9

3.61

3.72

g/l

0.44

104

230

Abnormalities of heart beat

810

4511

1.81

53.41

2.1

3.65

3.84

g/l

2.93

553

3159

Hard cardiovascular diseases

1973

8677

1.48

53.37

2.3

3.84

3.87

g/l

0.27

1419

6145

General examination and investigation of persons without complaint and reported diagnosis

1364

4543

1.62

53.21

2.3

2.1

3.61

3.95

g/l

10.76

875

3368

Irritable bowel syndrome

613

3159

1.98

53.21

2.1

2.2

3.63

3.80

g/l

1.80

419

2286

Insulin, fast-acting

882

5105

1.76

52.62

1.8

2.2

3.94

3.81

g/l

1.99

616

3643

Asthma/COPD (KELA code 203)

2110

10387

1.45

52.00

2.0

2.3

3.84

3.81

g/l

0.29

1511

7354

Type 2 diabetes, definitions combined, including avohilmo

2207

9157

1.44

51.85

1.9

2.4

4.00

3.77

g/l

8.11

1532

6582

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1385

9001

1.56

51.82

2.1

2.3

3.86

3.81

g/l

0.57

996

6364

Deposits [accretions] on teeth

204

621

3.33

51.81

6.1

1.9

3.56

3.83

g/l

1.52

151

460

Hernia of abdominal wall, postoperative

427

1947

2.26

51.70

2.0

3.90

3.87

g/l

0.18

310

1349

Exposure to other specified factors

1575

9848

1.52

51.55

2.1

2.2

3.94

3.83

g/l

1.27

1186

7040

Giant cell arteritis with polymyalgia rheumatica

172

500

3.83

51.39

1.5

2.7

3.86

3.73

g/l

0.60

129

354

IgA nephropathy (IgA glomerulonephritis)

111

232

5.34

51.28

1.7

2.5

4.45

3.87

g/l

3.13

168

Chronic nephritic syndrome

159

436

3.96

51.23

2.5

2.7

4.02

3.80

g/l

0.96

129

327

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

172

6.42

51.00

2.6

1.4

3.58

3.95

g/l

0.48

120

Obesity, other/unspecified

717

3946

1.85

50.78

1.6

2.2

4.18

3.75

g/l

8.37

524

2861

Soft tissue disorders related to use, overuse and pressure

654

3503

1.91

50.76

2.1

2.3

3.72

3.86

g/l

1.48

458

2511

Mood disorders, excluding more controls

2158

9210

1.44

50.73

2.0

2.3

3.81

3.82

g/l

0.13

1584

6586

Nausea and vomiting

640

3343

1.93

50.70

2.7

2.2

3.86

3.78

g/l

0.28

455

2350

Non-allergic asthma (mode), excluding more controls

448

2079

2.19

50.45

1.9

1.8

3.80

3.78

g/l

0.13

334

1447

Lumbar disc prolapse

1409

7300

1.56

50.08

2.3

2.1

3.79

3.87

g/l

1.02

1001

5277

Vocal cord dysfunction

287

1025

2.67

49.80

2.5

2.4

3.84

3.78

g/l

0.22

205

773

Other (seronegative) rheumatoid arthritis, wide

536

2713

2.04

49.64

2.0

2.2

3.80

3.78

g/l

0.09

395

1904

Depression or dysthymia

1703

6406

1.51

49.11

2.1

2.3

3.82

3.84

g/l

0.19

1223

4572

Biguanides

2247

9851

1.42

49.06

1.9

2.3

4.02

3.78

g/l

8.94

1580

7044

Conduction disorders

757

3534

1.82

48.94

2.2

2.1

3.74

3.84

g/l

1.04

533

2438

Enterocolitis due to Clostridium difficile

339

1444

2.46

48.88

4.1

2.2

3.77

3.79

g/l

0.09

225

1017

Other symptoms and signs involving cognitive functions and awareness

1125

6630

1.62

48.66

2.0

2.3

3.89

3.84

g/l

0.37

788

4667

Endocarditis

138

355

4.22

48.64

1.9

2.3

4.24

3.90

g/l

1.14

104

255

Seropositive rheumatoid arthritis, strict definition

435

2056

2.20

48.62

1.7

2.3

4.08

3.76

g/l

5.12

323

1476

Concussion

963

5015

1.68

48.29

2.0

2.3

3.83

3.87

g/l

0.33

679

3640

Prurigo nodularis

117

269

4.87

48.28

1.6

3.1

3.93

3.66

g/l

1.43

192

Cardiomyopathy, other and unspecified

254

949

2.82

48.25

2.3

2.1

3.66

3.82

g/l

0.82

210

666

Postmenopausal osteoporosis with pathological fracture

232

833

3.01

48.23

2.0

2.3

3.58

3.73

g/l

1.01

154

591

Other disorders of lacrimal gland

811

4729

1.75

47.41

2.6

2.3

3.59

3.82

g/l

5.36

575

3358

Undetermined asthma, excluding more controls

302

1233

2.52

47.14

2.0

1.7

4.07

3.84

g/l

0.46

209

870

Viral infections characterized by skin and mucous membrane lesions

925

5585

1.69

47.10

3.3

2.1

3.83

3.82

g/l

0.07

657

3991

Methotrexate

366

1630

2.32

47.09

1.8

2.5

3.87

3.73

g/l

1.01

279

1142

Any mental disorder

2619

9570

1.38

47.08

2.1

2.3

3.81

3.83

g/l

0.18

1863

6823

Agranulocytosis

322

1364

2.47

46.96

3.3

2.3

3.89

3.80

g/l

0.20

242

986

Other disorders of veins

934

5663

1.68

46.96

2.1

2.2

3.89

3.77

g/l

0.80

715

4009

Biological medication for rheuma

352

1544

2.35

46.86

1.5

2.3

4.26

3.80

g/l

5.79

261

1127

Other diseases of pericardium

158

459

3.70

46.58

1.7

2.3

4.03

3.88

g/l

0.53

112

325

Sleep apnoea

2130

10315

1.42

46.42

2.0

2.3

3.90

3.83

g/l

1.10

1491

7431

Fibrosis and cirrhosis of liver

249

943

2.80

46.33

1.6

2.6

4.39

3.75

g/l

6.05

170

689

Polyarthrosis

522

2565

2.01

46.18

2.2

2.4

3.78

3.73

g/l

0.31

345

1778

Secondary and unspecified malignant neoplasm of lymph nodes

275

1096

2.65

46.05

1.7

2.4

3.56

3.84

g/l

1.77

211

801

Insulin, fast-acting or short human

885

5321

1.70

45.94

1.8

2.2

3.94

3.82

g/l

1.75

618

3790

Cutaneous abscess, furuncle and carbuncle

586

3129

1.92

45.93

2.1

2.2

3.90

3.81

g/l

0.77

446

2262

Other diseases of intestine

351

1559

2.34

45.81

2.5

2.2

3.65

3.88

g/l

2.31

267

1120

Other diseases of anus and rectum

720

4096

1.80

45.73

2.3

3.80

3.83

g/l

0.20

483

2920

Psychiatric diseases

2539

9295

1.38

45.17

2.1

2.3

3.82

3.83

g/l

0.09

1809

6647

Secondary right heart disease

169

526

3.49

45.02

2.0

2.4

3.66

3.76

g/l

0.43

135

384

Urticaria and erythema

763

4434

1.75

44.90

2.3

2.1

3.77

3.78

g/l

0.05

563

3164

Persons encountering health services for specific procedures, not carried out

208

726

3.00

44.69

2.2

2.0

3.93

3.77

g/l

1.12

188

543

Persons with potential health hazards related to communicable diseases

655

3611

1.83

44.63

2.2

2.0

3.81

3.77

g/l

0.24

435

2689

Anxiety disorders, excluding more controls

1765

8125

1.46

44.58

2.1

2.3

3.74

3.82

g/l

1.01

1312

5831

Noninfective enteritis and colitis

1015

6353

1.62

44.57

2.3

2.2

3.84

3.81

g/l

0.19

710

4541

Diseases of pulp and periapical tissues, including avohilmo

2502

9513

1.38

44.52

2.2

3.81

g/l

0.04

1849

6671

Any operation in hilmo

11.52

44.42

1.8

1.3

3.88

4.08

g/l

0.24

Retention of urine

892

4563

1.69

44.38

1.9

2.3

4.00

3.86

g/l

1.27

640

3226

Obesity due to excess calories

946

5834

1.65

44.37

1.8

2.3

4.15

3.78

g/l

9.75

650

4240

Convulsions, not elsewhere classified

453

2211

2.06

44.12

1.7

2.0

3.98

3.86

g/l

0.59

336

1575

Coxibs

701

2050

1.85

43.98

2.1

2.2

3.77

3.84

g/l

0.54

520

1398

Sleep apnoea, including avohilmo

2215

10423

1.39

43.70

1.9

2.3

3.90

3.82

g/l

1.07

1552

7499

Cardiomyopathies, Primary/intrinsic

350

1583

2.30

43.70

1.9

2.2

3.72

3.88

g/l

1.29

279

1107

Subjective visual disturbances

588

3198

1.89

43.68

2.3

2.2

3.64

3.82

g/l

3.11

441

2286

Isolated proteinuria with specified morphological lesion

115

7.31

43.63

4.2

2.6

3.93

3.70

g/l

0.61

Dental pulpitis 4

2497

9529

1.37

43.42

2.2

3.82

3.81

g/l

0.04

1846

6687

GI-bleeding

840

5068

1.70

43.38

2.1

2.2

3.89

3.82

g/l

0.57

601

3556

Other diseases of the digestive system

837

5048

1.70

43.31

2.1

2.2

3.90

3.82

g/l

0.75

592

3545

Dental pulpitis 1

2496

9534

1.37

43.21

2.2

3.82

3.81

g/l

0.04

1846

6690

Special screening examination for other diseases and disorders

217

787

2.86

43.20

2.8

2.2

3.64

3.88

g/l

1.26

172

578

Injury, poisoning and certain other consequences of external causes

1235

3966

1.58

43.18

2.2

2.3

3.81

3.85

g/l

0.38

881

2856

Non-allergic asthma (mode)

448

2210

2.06

42.99

1.9

1.8

3.80

3.76

g/l

0.30

334

1550

Benign neoplasm of other and ill-defined parts of digestive system

459

2316

2.05

42.97

2.1

1.4

3.73

3.82

g/l

0.71

321

1621

Other headache syndromes

892

5471

1.66

42.76

1.8

2.4

3.64

3.81

g/l

3.19

639

3937

Mood disorders

2233

10687

1.39

42.74

2.0

2.3

3.80

3.83

g/l

0.29

1643

7616

Type 1 diabetes, wide definition, subgroup 1

454

2277

2.04

42.60

1.7

2.2

3.84

3.77

g/l

0.50

316

1668

Mood [affective] disorders

2225

10664

1.39

42.60

2.0

2.3

3.80

3.83

g/l

0.34

1637

7599

Hepatomegaly and splenomegaly, not elsewhere classified

8.51

42.50

1.8

3.49

3.73

g/l

0.64

Anxiety (asthma-related co-morbidities)

1102

5561

1.58

42.39

1.8

2.2

3.71

3.81

g/l

1.51

841

3994

Dental pulpitis 2

1768

6299

1.45

42.14

2.2

3.80

3.83

g/l

0.36

1290

4311

ILD, hospital admissions 3, with pneumonia sepsis

266

1090

2.57

42.04

2.2

1.9

3.80

3.78

g/l

0.06

204

758

Other anxiety disorders

798

4211

1.70

42.02

1.8

2.1

3.68

3.80

g/l

1.73

618

3052

Cardiomyopathy (excluding other)

357

1656

2.24

41.88

1.8

2.1

3.72

3.87

g/l

1.17

285

1154

Iron deficiency anaemia secondary to blood loss (chronic)

434

2167

2.07

41.85

2.0

2.3

3.68

3.77

g/l

0.59

279

1518

Early onset COPD, excluding more controls

482

2489

1.98

41.80

2.0

1.8

4.10

3.83

g/l

1.18

361

1775

Other CVD

546

2950

1.91

41.78

2.5

2.2

3.79

3.80

g/l

0.06

378

2026

Injuries to the shoulder and upper arm

1878

11273

1.41

41.67

2.4

2.2

3.84

g/l

0.01

1323

8036

Symptoms and signs involving speech and voice

793

4775

1.70

41.26

2.4

2.2

3.73

3.79

g/l

0.53

591

3354

In situ neoplasms

809

4659

1.69

41.24

2.2

1.4

3.69

3.81

g/l

1.47

596

3268

Undetermined asthma

302

1314

2.37

40.98

2.0

1.7

4.07

3.79

g/l

0.58

209

920

All anxiety disorders

1113

5800

1.56

40.86

1.8

2.2

3.70

3.83

g/l

2.12

849

4178

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

166

542

3.31

40.85

1.9

1.4

3.72

3.90

g/l

0.69

128

392

Diffuse large B-cell lymphoma, helper endpoint

166

542

3.31

40.85

1.9

1.4

3.72

3.90

g/l

0.69

128

392

Dental caries 1

1937

7048

1.42

40.72

2.2

3.80

3.83

g/l

0.35

1422

4842

Dental caries, including avohilmo

1935

7044

1.42

40.62

2.2

3.80

3.83

g/l

0.36

1420

4838

Other diseases of liver

443

2251

2.03

40.59

2.1

2.3

4.06

3.78

g/l

3.55

323

1619

AV-block

479

2261

1.98

40.40

2.2

2.1

3.87

g/l

0.00

330

1530

Calcific aortic valvular stenosis

832

4997

1.67

40.39

2.2

3.91

3.81

g/l

0.98

569

3458

Calcific aortic valvular stenosis, operated

832

4997

1.67

40.39

2.2

3.91

3.81

g/l

0.98

569

3458

Other medical care

946

5833

1.61

40.35

3.7

2.1

3.82

3.83

g/l

0.10

690

4131

Calcific aortic valvular stenosis, diagnosis (helper)

831

4996

1.67

40.18

2.2

3.91

3.81

g/l

1.00

568

3457

Operations 2 for CAVS

831

4996

1.67

40.18

2.2

3.91

3.81

g/l

1.00

568

3457

Conjunctivitis

1482

8926

1.46

40.15

2.2

3.76

3.78

g/l

0.18

1112

6361

Other dialysis

120

322

4.08

40.11

2.4

2.6

3.83

g/l

0.01

103

235

Non-Hodgkin lymphoma, all

163

534

3.32

39.99

3.8

2.5

3.86

3.84

g/l

0.04

119

389

Depression

2007

10018

1.39

39.98

2.0

2.3

3.78

3.83

g/l

0.73

1474

7154

Other respiratory diseases principally affecting the interstitium

511

2744

1.93

39.97

2.3

2.2

3.93

3.82

g/l

0.54

384

1925

Sequelae of external causes of morbidity and mortality

631

3607

1.79

39.86

2.4

2.3

3.88

3.81

g/l

0.41

471

2555

Calcific aortic valvular stenosis, including rheumatic fever

833

5017

1.67

39.86

2.2

3.91

3.81

g/l

0.99

570

3472

Volume depletion

260

1078

2.51

39.76

1.8

2.1

3.94

3.80

g/l

0.50

176

754

Benign neoplasm: Sigmoid colon

471

2465

1.97

39.73

2.3

1.4

3.88

3.85

g/l

0.09

333

1733

Disorder of lipoprotein metabolism, unspecified

381

1852

2.13

39.68

1.7

2.2

3.86

3.82

g/l

0.24

281

1296

Spondylopathies in diseases classified elsewhere

130

6.51

39.67

18.4

1.3

3.31

3.67

g/l

0.74

Adverse effects, not elsewhere classified

425

2142

2.03

39.62

2.2

3.92

3.77

g/l

0.81

343

1550

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

155

495

3.38

39.53

2.8

1.4

3.64

3.89

g/l

0.83

115

359

Other neurological diseases

1729

9906

1.42

39.44

2.2

2.3

3.69

3.85

g/l

4.18

1191

7009

Other and unspecified immunodeficiencies with predominantly antibody defects

120

6.63

39.32

5.4

2.2

3.02

3.70

g/l

4.24

Amputation

309

1395

2.32

39.02

1.7

2.3

4.10

3.83

g/l

1.89

246

971

Arthropathies in other diseases classified elsewhere

126

355

3.81

38.95

2.5

2.4

4.12

3.76

g/l

0.89

251

Idiopathic thrombocytopenic purpura

117

315

4.04

38.83

2.4

2.5

3.58

3.70

g/l

0.38

230

Fracture of femur

707

3822

1.73

38.82

2.3

2.1

3.89

3.77

g/l

1.11

429

2635

Cardiomyopathy in other diseases

10.56

38.76

9.1

2.1

3.28

3.71

g/l

1.23

Disorders of conjunctiva

1671

9940

1.42

38.71

2.2

3.76

3.80

g/l

0.30

1236

7067

Hypotension

474

2513

1.95

38.58

2.6

2.2

3.82

3.80

g/l

0.12

323

1735

Acetic acid derivatives and related substances

690

2045

1.79

38.49

2.1

2.2

3.81

3.84

g/l

0.19

523

1396

Disorders of lacrimal system

953

6102

1.59

38.47

2.6

2.2

3.59

3.81

g/l

5.27

662

4313

Fracture of shoulder and upper arm

829

5136

1.64

38.36

2.5

2.2

3.89

3.79

g/l

0.76

589

3639

Dental caries 1 and operation codes

2090

7815

1.39

38.26

2.2

3.77

3.84

g/l

1.00

1530

5422

Artrosis, including avohilmo

1939

7679

1.40

38.17

2.0

2.3

3.82

3.86

g/l

0.43

1389

5492

Other pulmonary heart/vessel disease

172

596

3.10

38.11

2.0

2.4

3.66

3.84

g/l

0.89

135

441

Dental pulpitis 2, only avohilmo

1785

6489

1.42

38.06

2.2

3.81

3.83

g/l

0.20

1301

4434

Fungal Sepsis

134

400

3.61

38.06

2.8

2.4

3.71

3.81

g/l

0.27

297

Abnormal involuntary movements

346

1648

2.17

37.97

2.1

2.3

3.69

3.85

g/l

1.32

260

1177

Rotator cuff syndrome

1398

7149

1.47

37.96

2.2

2.3

3.81

3.88

g/l

0.82

1000

5098

Ischaemic heart disease, wide definition

1876

8491

1.40

37.70

2.3

2.4

3.85

3.87

g/l

0.24

1345

6029

Asthma and allergy, excluding more controls

219

844

2.61

37.40

1.9

1.5

3.82

3.80

g/l

0.06

153

602

Other diseases of upper respiratory tract

2556

10059

1.34

37.38

2.2

3.80

3.84

g/l

0.42

1825

7141

Neurotic, stress-related and somatoform disorders

1793

9187

1.40

37.23

2.1

2.2

3.71

3.83

g/l

2.25

1338

6571

Non-invasive ventilation

439

2139

1.97

37.12

3.1

2.3

4.21

3.75

g/l

0.77

148

1585

Dental operations

1664

6020

1.44

37.09

2.3

2.0

3.79

3.86

g/l

1.07

1180

4246

Covid-19 suspected case

408

2073

2.01

37.08

2.4

2.2

3.84

3.79

g/l

0.20

243

1518

Ischemic heart diseases

1886

8574

1.39

37.04

2.3

2.4

3.83

3.87

g/l

0.43

1357

6081

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

1303

6063

1.49

37.01

2.6

1.4

3.77

3.86

g/l

1.01

940

4302

Zoster [herpes zoster]

472

2532

1.92

36.95

3.9

2.2

3.73

3.79

g/l

0.20

315

1791

Other and unspecified coagulation defects

147

472

3.30

36.84

2.6

2.4

3.69

3.77

g/l

0.35

120

345

Functional dyspepsia

596

3434

1.77

36.46

2.4

2.3

3.59

3.78

g/l

3.01

401

2470

Anxiety disorders

1811

9306

1.39

36.29

2.1

2.2

3.74

3.83

g/l

1.34

1350

6656

Lichen simplex chronicus and prurigo

197

750

2.77

36.25

1.9

2.7

3.94

3.74

g/l

1.29

151

539

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

398

2033

2.03

36.24

1.5

2.3

4.51

3.83

g/l

10.14

290

1461

Hypokalaemia

301

1383

2.26

36.23

2.7

2.1

3.87

3.79

g/l

0.40

204

972

Allergic asthma (mode), excluding more controls

404

2018

1.99

36.21

1.9

1.7

3.88

3.80

g/l

0.46

285

1449

Type 1 diabetes, wide definition

469

2515

1.90

36.16

1.7

2.2

3.81

3.78

g/l

0.22

327

1837

Pacemaker

891

5547

1.60

36.15

2.1

2.3

3.75

3.82

g/l

0.78

610

3827

Other coagulation defects

197

750

2.75

36.07

2.5

3.74

3.78

g/l

0.17

161

544

Rash and other nonspecific skin eruption

269

1184

2.36

35.99

2.0

2.3

3.63

3.79

g/l

1.32

207

848

Amputation of toe

231

955

2.56

35.99

1.8

2.5

4.07

3.86

g/l

1.01

184

691

ILD, hospital admissions

432

2277

1.97

35.95

2.3

3.91

3.83

g/l

0.28

327

1600

Parodontitis or/and operation codes

1380

5652

1.47

35.94

2.3

2.4

3.77

3.81

g/l

0.39

1041

3980

Other abnormalities of plasma proteins

161

5.46

35.92

4.7

2.9

4.14

3.76

g/l

0.63

115

Other and unspecified types of non-Hodgkin lymphoma, hilmo

155

526

3.17

35.71

2.8

2.6

3.64

3.81

g/l

0.47

115

382

Need for immunization against other single viral diseases

185

4.95

35.51

2.9

2.1

3.55

3.88

g/l

1.38

136

Drug-induced osteoporosis with pathological fracture

201

4.95

35.27

1.6

2.3

3.69

3.77

g/l

0.14

143

Pleural effusion

444

2375

1.94

35.25

2.6

2.2

3.97

3.80

g/l

1.35

344

1646

Other symptoms and signs involving the nervous and musculoskeletal systems

891

5730

1.58

35.20

2.0

2.3

3.55

3.84

g/l

8.14

625

4061

Other interstitial pulmonary diseases

435

2315

1.95

35.15

2.3

3.91

3.83

g/l

0.35

330

1622

Other noninfective gastroenteritis and colitis

549

3121

1.80

35.12

2.7

2.2

3.72

3.80

g/l

0.64

396

2199

Cirrhosis of liver, NAS

170

613

2.96

35.01

1.6

2.7

4.47

3.81

g/l

3.84

116

453

Interstitial lung disease

435

2320

1.94

34.93

2.3

3.91

3.83

g/l

0.34

330

1628

Interstitial lung disease endpoints

435

2320

1.94

34.93

2.3

3.91

3.83

g/l

0.34

330

1628

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

7.27

34.84

3.7

1.4

3.94

3.88

g/l

0.06

Asthma and allergy

219

875

2.52

34.73

1.9

1.6

3.82

3.77

g/l

0.18

153

620

Chronic sinusitis

909

5886

1.57

34.71

2.4

2.3

3.83

g/l

0.00

683

4220

Diseases of the myoneural junction and muscle

329

1594

2.14

34.68

1.6

2.3

3.62

3.82

g/l

1.84

230

1134

Cellulitis

504

2814

1.83

34.49

2.7

2.2

3.89

3.83

g/l

0.36

386

2017

Diffuse large B-cell lymphoma

166

598

2.99

34.42

1.9

2.7

3.72

3.79

g/l

0.21

128

436

Chronic ulcer of skin, not elsewhere classified

214

871

2.59

34.40

2.2

2.3

3.82

3.83

g/l

0.05

154

627

Pericarditis

118

346

3.63

34.31

1.9

2.2

4.26

3.91

g/l

1.04

247

Tumor necrosis factor alpha inhibitors

290

1338

2.22

34.29

1.5

2.4

4.23

3.79

g/l

5.17

213

980

COPD

1136

6356

1.50

34.18

1.9

2.4

4.00

3.83

g/l

1.62

846

4426

Peripheral artery operations in Hilmo

373

1900

2.03

34.17

1.9

2.3

3.98

3.83

g/l

0.92

295

1308

Stroke, excluding SAH

1511

8008

1.42

34.12

2.3

3.87

3.85

g/l

0.23

1077

5635

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1024

6707

1.52

34.10

1.9

2.1

3.72

3.77

g/l

0.53

783

4791

Reactive arthropathies, FINNGEN

171

622

2.85

34.06

2.3

2.7

4.01

3.74

g/l

1.46

129

444

Diabetic neuropathy

332

1621

2.13

34.01

2.0

4.07

4.00

g/l

0.30

235

1110

Trochanteric bursitis

337

1657

2.10

33.96

2.3

3.62

3.77

g/l

1.27

236

1181

Abnormal findings on diagnostic imaging of other body structures

338

1668

2.10

33.88

2.9

2.4

3.77

3.78

g/l

0.02

223

1199

Other reaction to severe stress, and adjustment disorders

635

3790

1.70

33.88

2.5

2.1

3.71

3.81

g/l

0.68

484

2736

Dental caries 3

1975

7442

1.37

33.77

2.2

3.77

3.83

g/l

0.92

1452

5147

Benign neoplasm: Ascending colon

347

1735

2.08

33.64

2.2

1.4

4.04

3.85

g/l

0.91

235

1216

Other abnormal findings of blood chemistry

138

452

3.25

33.60

3.4

2.3

3.92

3.77

g/l

0.32

121

338

Nonalcoholic fatty liver disease

235

1006

2.43

33.54

2.0

2.5

4.17

3.79

g/l

3.40

172

735

Implicit fungal Sepsis

122

373

3.52

33.44

2.9

2.4

3.65

3.81

g/l

0.51

278

Other and unspecified effects of external causes

530

3026

1.78

33.39

2.0

2.2

3.85

3.78

g/l

0.41

423

2177

Stroke, including SAH

1564

8335

1.41

33.35

2.3

3.88

3.85

g/l

0.23

1117

5870

Deforming dorsopathies

583

3422

1.73

33.32

2.3

2.2

3.63

3.81

g/l

2.25

407

2457

Acute upper respiratory infections of multiple and unspecified sites

1495

7996

1.41

33.21

3.1

2.0

3.73

3.81

g/l

1.34

1069

5722

Voice disturbances

615

3672

1.71

33.21

2.6

2.3

3.71

3.79

g/l

0.79

469

2593

Psoriatic and enteropathic arthropathies

252

1115

2.32

33.06

1.7

2.6

4.11

3.75

g/l

2.29

172

793

Benign neoplasm: Transverse colon

283

1322

2.24

32.99

2.4

1.4

3.86

3.83

g/l

0.10

193

923

Urticaria

572

3351

1.74

32.87

2.3

2.1

3.77

g/l

0.03

422

2404

Allergic conjunctivitis

1059

7048

1.50

32.83

1.9

2.1

3.72

3.76

g/l

0.40

809

5024

Injuries to the knee and lower leg

2551

11256

1.31

32.69

2.0

2.3

3.78

3.83

g/l

0.99

1818

8029

Dental caries 1, only avohilmo

1947

7364

1.37

32.66

2.2

2.3

3.80

3.83

g/l

0.37

1437

5056

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

109

315

3.73

32.59

4.3

1.4

3.39

3.86

g/l

1.87

223

Phlebitis and thrombophlebitis (not including DVT)

541

3137

1.77

32.58

2.7

2.2

3.86

3.80

g/l

0.36

383

2224

Ischaemic Stroke, excluding all haemorrhages

1430

7708

1.42

32.51

2.2

2.3

3.87

3.84

g/l

0.24

1021

5415

Diseases of spleen

170

4.97

32.50

2.1

3.31

3.80

g/l

2.36

122

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

232

1007

2.39

32.11

3.5

2.3

4.13

3.77

g/l

1.22

164

724

Papulosquamous disorders

879

5760

1.55

32.09

2.1

2.3

4.13

3.82

g/l

2.58

619

4142

Eosinophilic disease (BM)

117

5.83

32.09

2.4

1.5

3.73

3.68

g/l

0.08

Osteopathy in diseases classified elsewhere

8.00

32.03

15.1

2.3

3.51

3.61

g/l

0.18

Allergic asthma (mode)

404

2106

1.91

31.99

1.9

1.7

3.88

3.78

g/l

0.64

285

1506

Spondyloarthritis

407

2177

1.91

31.91

2.2

4.03

3.80

g/l

2.13

292

1538

Acute sinusitis

989

6180

1.51

31.79

3.2

2.0

3.76

3.82

g/l

0.46

716

4472

Viral pneumonia (unknown virus, not influenza)

173

659

2.74

31.67

2.1

2.4

3.66

3.82

g/l

0.84

134

486

Myeloproliferative diseases

253

1150

2.30

31.64

2.8

2.4

3.53

3.80

g/l

2.56

175

831

Unspecified fall

1062

7194

1.48

31.58

2.2

3.81

3.80

g/l

0.15

751

5085

Dental caries 3 and operation codes

2109

8144

1.34

31.50

2.2

3.76

3.84

g/l

1.33

1551

5672

Spondylopathies (FG)

272

1266

2.20

31.44

1.8

2.6

4.00

3.76

g/l

1.66

191

894

Heart failure and coronary heart disease

920

4531

1.55

31.31

1.9

2.3

3.89

3.84

g/l

0.38

651

3128

Cytomegalovirus infection, IBD co-morbidity

213

4.36

31.28

7.5

2.3

3.23

3.75

g/l

3.27

158

ILD, hospital admissions 1, main diag only

385

2049

1.95

31.24

2.4

2.3

3.95

3.81

g/l

0.52

288

1443

Selective serotonin reuptake inhibitors

2221

8880

1.33

31.23

2.1

2.3

3.81

3.86

g/l

0.85

1644

6284

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

1183

5620

1.47

31.01

2.7

1.4

3.79

3.85

g/l

0.52

858

3972

Gastroduodenal ulcer

657

4053

1.65

30.95

2.0

2.3

3.81

3.82

g/l

0.07

460

2893

Migraine

819

4496

1.57

30.94

1.9

2.2

3.64

3.79

g/l

2.27

609

3297

Overexertion and strenuous or repetitive movements

243

1092

2.30

30.92

2.5

2.4

3.94

3.81

g/l

0.72

192

806

Somatoform disorder

358

1857

1.97

30.89

2.3

3.68

3.80

g/l

0.81

258

1341

Open wound of head

1133

7746

1.46

30.86

2.1

2.2

3.90

3.84

g/l

0.53

823

5468

Open wound of lower leg

347

1787

2.00

30.71

2.0

2.1

3.82

3.85

g/l

0.09

257

1273

Other symptoms and signs involving the urinary system

281

1347

2.16

30.54

2.1

2.5

3.63

3.83

g/l

1.24

152

954

Other/unspecified cytomegaloviral diseases

179

4.68

30.41

8.1

2.4

3.17

3.79

g/l

4.18

132

Osteomyelitis

186

751

2.60

30.41

1.9

2.2

3.96

3.83

g/l

0.38

142

557

Injuries to the elbow and forearm

1421

9277

1.40

30.40

2.0

2.2

3.76

3.80

g/l

0.45

985

6621

Atopic dermatitis

941

5364

1.51

30.29

1.8

2.1

3.87

3.79

g/l

0.93

723

3848

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

107

6.29

30.26

3.7

2.0

3.94

3.69

g/l

0.35

Rheumatism, unspecified

328

1665

2.02

30.24

2.1

2.3

3.76

3.77

g/l

0.02

239

1190

Cytomegaloviral disease

224

4.17

30.01

7.5

2.3

3.24

3.78

g/l

3.46

169

Cholelithiasis, broad definition with cholecystitis

1944

10064

1.34

29.94

2.3

3.81

3.82

g/l

0.11

1333

7167

Later onset COPD, excluding more controls

543

2492

1.74

29.92

1.6

1.9

3.96

3.76

g/l

2.48

407

1683

Coronary atherosclerosis

1654

7870

1.37

29.72

2.2

2.4

3.85

3.88

g/l

0.28

1211

5591

Superficial injury of head

496

2878

1.76

29.70

1.9

2.2

3.81

3.79

g/l

0.13

377

2009

Benign neoplasm of other and ill-defined parts of digestive system

459

2618

1.80

29.55

2.1

2.3

3.73

3.80

g/l

0.46

321

1855

Migraine with aura

399

2170

1.87

29.52

1.5

2.3

3.62

3.74

g/l

0.99

310

1602

Motor neuron disease

162

4.78

29.48

1.3

1.9

3.63

3.69

g/l

0.15

121

Benign neoplasm of other and unspecified endocrine glands

302

1506

2.07

29.40

2.4

1.4

3.72

3.85

g/l

1.03

214

1069

DVT of lower extremities

479

2772

1.77

29.20

2.9

2.2

3.82

3.81

g/l

0.05

339

1956

Special screening examination for infectious and parasitic diseases

369

1441

1.94

29.20

2.4

2.1

3.74

3.96

g/l

1.91

297

1103

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

1137

5460

1.46

29.13

2.6

1.4

3.76

3.85

g/l

0.84

819

3853

Disorders of skin appendages

906

6093

1.50

28.99

2.2

3.89

3.81

g/l

0.59

656

4388

Psoriasis

626

3887

1.64

28.99

1.8

2.3

4.22

3.81

g/l

2.92

445

2801

Disorders of continuity of bone

218

964

2.34

28.84

4.0

2.1

3.71

3.78

g/l

0.36

157

718

Other disorders of bone

405

2237

1.85

28.72

3.5

1.9

3.91

3.83

g/l

0.32

272

1628

Dental operations, only avohilmo

1723

6547

1.36

28.50

2.2

3.79

3.86

g/l

1.14

1255

4558

Myeloproliferative diseases (CML excluded)

228

1039

2.30

28.41

3.0

2.5

3.52

3.80

g/l

2.44

160

752

Motor neuron disease (with DMD)

167

4.62

28.34

1.3

1.8

3.63

3.66

g/l

0.08

125

Rare circulating lymphoid malignancy

109

345

3.40

28.31

4.3

2.8

3.39

3.71

g/l

1.06

254

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

1146

5534

1.45

28.09

2.6

1.4

3.77

3.85

g/l

0.67

824

3904

Reactive arthropathies

206

902

2.36

27.87

2.1

2.4

4.01

3.77

g/l

1.56

153

642

Other inflammation of eyelid

318

1646

1.99

27.87

2.7

2.4

3.64

3.82

g/l

1.04

228

1175

Personality disorders, excluding more controls

421

2374

1.80

27.67

1.7

2.2

3.72

3.82

g/l

0.92

334

1730

Abnormal serum enzyme levels

732

4713

1.56

27.53

2.1

2.3

3.88

g/l

0.01

525

3381

Other diseases of hard tissues of teeth

1262

6744

1.41

27.53

3.0

2.0

3.70

3.83

g/l

2.50

897

4788

Failure and rejection of transplanted organs and tissues

119

5.43

27.51

7.2

2.4

3.33

3.89

g/l

2.32

Osteonecrosis due to drugs

144

5.09

27.50

14.8

1.8

3.72

3.71

g/l

0.01

103

Complications of internal orthopaedic prosthetic devices, implants and grafts

569

3507

1.66

27.42

2.0

2.3

3.92

3.78

g/l

1.10

390

2424

Phobic anxiety disorders

201

873

2.34

27.40

1.9

2.1

3.74

3.79

g/l

0.19

162

647

L01XX Other antineoplastic agents

185

788

2.49

27.21

3.8

2.6

3.26

3.83

g/l

5.83

130

571

Pain in thoracic spine

312

1614

1.98

27.18

2.9

2.1

3.60

3.82

g/l

1.39

224

1171

Gastric ulcer

454

2643

1.76

27.12

2.0

2.3

3.76

3.81

g/l

0.30

321

1879

Other chronic obstructive pulmonary disease

1066

6217

1.45

27.09

1.8

2.4

4.00

3.83

g/l

1.57

797

4323

Other disorders of skin and subcutaneous tissue, not elsewhere classified

353

1912

1.90

26.94

2.2

2.1

3.74

3.83

g/l

0.48

235

1342

Sub-endpoint used in defining T1D endpoints

624

3870

1.61

26.93

1.7

2.1

3.89

3.82

g/l

0.42

441

2743

Hypothyroidism, strict autoimmune

1441

6992

1.38

26.91

2.0

2.4

3.73

3.80

g/l

1.10

1020

4922

Adalimumab

182

770

2.43

26.61

1.4

2.2

4.21

3.78

g/l

3.66

131

571

Other diseases of arteries and capillaries

240

1143

2.18

26.60

2.0

2.3

3.84

3.83

g/l

0.01

174

809

Marginal zone B-cell lymphoma

105

5.97

26.60

2.0

1.9

3.97

3.83

g/l

0.08

Gonarthrosis,primary

2101

10247

1.30

26.51

2.0

2.3

3.84

3.85

g/l

0.04

1480

7275

L04AC Interleukin inhibitors

123

431

2.98

26.48

1.4

2.0

4.41

3.76

g/l

2.84

314

Injuries to the ankle and foot

1246

8210

1.39

26.48

2.1

2.2

3.86

3.80

g/l

0.38

929

5937

Meniscus derangement

1166

5669

1.42

26.48

2.1

2.3

3.75

3.82

g/l

0.79

819

4028

Cholelithiasis

1857

9958

1.32

26.41

2.3

3.81

3.82

g/l

0.12

1277

7093

Acute upper respiratory infections

2244

10990

1.29

26.37

2.9

2.1

3.79

3.82

g/l

0.34

1609

7825

Temporomandibular joint disorders

280

1409

2.02

26.28

2.4

2.1

3.73

3.78

g/l

0.20

196

1009

Substance abuse, excluding more controls

1133

7067

1.42

26.22

1.6

2.3

3.98

3.88

g/l

1.42

842

5064

Sequelae with surgical and medical care as external cause

485

2904

1.71

26.19

2.1

2.2

3.86

3.80

g/l

0.32

348

2053

Recurrent or chronic depression

737

3468

1.55

26.15

1.9

2.2

3.74

3.84

g/l

1.00

563

2534

Disorders of sclera, cornea, iris and ciliary body

1111

7931

1.42

26.04

2.1

2.2

3.89

3.82

g/l

0.60

793

5659

Other infectious diseases

218

1010

2.24

26.00

2.5

2.3

3.84

3.83

g/l

0.01

146

735

Fitting and adjustment of other devices

824

5176

1.51

25.98

2.3

2.1

3.59

3.83

g/l

3.32

450

3656

Secondary uncertain malignant neoplasm

337

1824

1.91

25.93

1.9

2.3

3.56

3.83

g/l

2.06

250

1280

Cervical disc disorders

786

5266

1.51

25.91

2.2

3.73

3.86

g/l

1.73

532

3808

Mycoses

569

3555

1.63

25.79

2.7

2.2

3.72

3.82

g/l

0.84

401

2540

Cardiodefibrillation

922

6386

1.47

25.72

2.1

2.3

3.99

3.84

g/l

1.81

696

4481

Systemic sclerosis (FG)

211

3.96

25.72

1.9

2.7

3.39

3.60

g/l

0.70

148

Other disorders of eye and adnexa

299

1556

1.97

25.71

1.9

2.3

3.63

3.77

g/l

1.23

237

1114

All influenza (not pneumonia)

313

1653

1.93

25.65

4.3

1.8

3.84

3.83

g/l

0.03

214

1178

Myositis

254

3.66

25.64

1.5

2.1

3.60

3.78

g/l

0.74

182

Disorders of muscles

231

1097

2.17

25.64

1.6

2.1

4.02

3.81

g/l

0.31

169

789

Other and unspecified drugs and medicaments

211

970

2.26

25.60

3.4

2.3

4.17

3.79

g/l

1.22

145

698

Hypoparathyroidism

123

443

2.97

25.54

1.6

2.3

3.59

3.75

g/l

0.62

330

Superficial injury of lower leg

488

2938

1.69

25.54

1.9

2.2

3.75

3.81

g/l

0.39

344

2081

Dental pulpitis 4, only avohilmo

2416

9955

1.28

25.46

2.0

2.3

3.83

3.81

g/l

0.24

1822

6956

Diseases of external ear

717

4733

1.54

25.45

2.1

2.3

3.84

3.83

g/l

0.07

462

3397

Dental caries 3, only avohilmo

1969

7743

1.31

25.40

2.2

2.3

3.78

3.84

g/l

0.86

1453

5351

Infection of intervertebral disc (pyogenic)

149

4.78

25.36

2.2

2.1

4.05

3.77

g/l

0.82

111

Stomatitis and related lesions

186

814

2.36

25.24

3.2

1.9

3.73

3.78

g/l

0.17

123

591

Dermatopolymyositis (FG)

132

4.92

25.21

3.0

2.7

3.49

3.52

g/l

0.06

100

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

354

1961

1.86

25.19

2.0

1.4

3.52

3.86

g/l

3.23

254

1392

In situ neoplasms

809

5489

1.50

25.18

2.2

3.69

3.78

g/l

0.87

596

3806

Carcinoma in situ of skin of other and unspecified parts of face

225

1072

2.19

25.15

2.0

1.5

3.61

3.80

g/l

1.46

175

729

Peripheral arterial reconstruction

457

2727

1.72

25.15

1.8

2.3

3.87

3.83

g/l

0.18

344

1885

Cerebral palsy and other paralytic syndromes

268

1355

2.03

25.14

1.9

2.3

3.80

3.81

g/l

0.03

204

981

Charcot foot

175

4.32

25.09

2.4

2.8

4.48

3.86

g/l

1.02

129

Other pleural conditions

286

1486

1.99

25.02

2.8

2.2

3.88

3.82

g/l

0.24

213

1034

Paralytic ileus and intestinal obstruction

562

3527

1.62

24.95

2.6

2.3

3.94

3.82

g/l

0.38

383

2506

Other and unspecified acquired haemolytic anaemias

103

5.70

24.90

2.9

1.6

3.80

3.79

g/l

0.01

Pyoderma gangrenosum

6.63

24.79

2.1

1.8

4.09

3.88

g/l

0.43

Benign neoplasm: Sigmoid colon

471

2844

1.70

24.77

2.3

3.88

3.83

g/l

0.17

333

2016

Dermatopolymyositis

134

4.82

24.73

3.0

2.0

3.49

3.72

g/l

0.80

Other peripheral vascular diseases

207

958

2.24

24.71

1.7

2.3

3.45

3.81

g/l

3.85

156

695

Hypertrophic cardiomyopathy

130

491

2.81

24.62

2.7

2.8

3.53

3.86

g/l

2.06

113

361

Pneumonia due to other infectious organisms, not elsewhere classified

306

3.32

24.56

6.0

1.9

3.59

3.66

g/l

0.14

220

Essential (haemorrhagic) thrombocythaemia

121

441

2.92

24.54

2.4

1.4

3.54

3.86

g/l

1.80

314

Pyogenic arthritis

170

727

2.42

24.45

3.0

2.4

4.02

3.72

g/l

1.09

126

499

Benign neoplasm: Transverse colon

283

1479

1.99

24.44

2.4

3.86

3.83

g/l

0.12

193

1060

Other chronic obstructive pulmonary disease, including avohilmo

1281

7847

1.38

24.44

1.8

2.4

3.96

3.84

g/l

1.22

951

5500

Polyarthritis, unspecified

109

375

3.06

24.42

2.6

2.2

3.88

3.70

g/l

0.59

259

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

677

4456

1.54

24.36

2.4

2.2

3.74

3.79

g/l

0.31

490

3162

Other overlap syndromes

179

4.18

24.27

1.8

2.5

3.62

3.80

g/l

0.47

133

Benign neoplasm: Rectum, anus and anal canal

461

2780

1.70

24.25

2.1

1.4

3.75

3.85

g/l

0.99

335

1955

Psoriatic arthropathies

218

1038

2.16

24.03

1.7

2.4

4.18

3.73

g/l

2.93

146

740

Sequelae of cerebrovascular disease

865

5252

1.47

24.02

2.0

2.3

3.89

3.81

g/l

0.66

581

3662

Degeneration of macula and posterior pole

1154

6916

1.40

23.99

2.1

2.3

3.85

3.79

g/l

0.49

770

4835

Other enthesopathies

590

3781

1.58

23.90

1.9

2.3

3.79

3.86

g/l

0.45

428

2709

Carcinoma in situ of skin of scalp and neck

299

3.41

23.88

1.8

1.4

3.83

3.91

g/l

0.18

209

Myeloid leukaemia

277

3.45

23.83

1.8

1.4

3.58

3.88

g/l

1.34

200

Diseases of salivary glands

404

2359

1.75

23.80

2.4

2.1

3.80

3.83

g/l

0.12

273

1647

Heart failure and hypertrophic cardiomyopathy

207

3.95

23.60

2.9

2.3

3.80

3.71

g/l

0.26

145

Dental pulpitis 1, only avohilmo

2407

10009

1.26

23.58

2.0

2.3

3.83

3.81

g/l

0.22

1810

6993

Erosion of teeth

5.52

23.53

4.0

2.3

3.51

3.73

g/l

0.56

Injuries to unspecified part of trunk, limb or body region

233

1149

2.09

23.52

1.8

2.4

3.82

3.80

g/l

0.09

169

832

Encephalitis

279

3.39

23.43

2.0

2.5

3.93

3.70

g/l

0.30

207

Oter anti-inflammatory and antirheumatic agents, non-steroids

556

1913

1.64

23.35

2.3

3.75

3.86

g/l

0.97

405

1289

Behavioural syndromes associated with physiological disturbances and physical factors

531

3334

1.61

23.34

1.9

2.0

3.67

3.78

g/l

1.05

382

2400

Other encephalitis

265

3.46

23.31

2.0

2.6

3.94

3.70

g/l

0.30

196

Diabetic retinopathy

799

3425

1.50

23.30

1.8

2.0

4.03

3.97

g/l

0.40

553

2397

Nonorganic sleeping disorders, excluding more controls

322

1773

1.85

23.12

1.6

2.3

3.70

3.78

g/l

0.48

234

1278

Migraine without aura

291

1551

1.90

23.06

2.1

2.2

3.61

3.70

g/l

0.59

217

1160

Valvular operations

341

1918

1.82

23.06

1.6

2.1

3.90

g/l

0.01

251

1322

Donors of organs and tissues

5.36

23.02

8.5

1.9

2.92

3.85

g/l

1.96

Other and unspecified aplastic anaemias

114

5.10

22.92

1.5

2.0

3.97

3.66

g/l

0.55

Benign neoplasm: Ascending colon

347

1973

1.82

22.86

2.2

2.4

4.04

3.82

g/l

1.11

235

1392

Myelodysplastic syndrome

104

5.44

22.65

2.1

1.8

3.66

3.73

g/l

0.12

Bipolar affective disorders

320

1770

1.84

22.62

1.8

2.2

3.78

3.80

g/l

0.12

243

1273

Metatarsalgia

211

1018

2.13

22.55

2.2

3.83

3.79

g/l

0.11

166

730

Benign neoplasm: Stomach

241

1224

2.04

22.53

2.4

1.4

3.74

3.84

g/l

0.49

169

855

Oxicams

554

1972

1.62

22.52

2.2

2.3

3.84

3.85

g/l

0.03

392

1336

Pneumonia derived septicemia

101

349

3.06

22.52

5.7

2.6

4.30

3.71

g/l

1.05

258

1192

8082

1.37

22.52

1.6

2.3

4.03

3.87

g/l

3.37

904

5779

Dentofacial anomalies [including malocclusion]

457

2761

1.66

22.51

2.3

2.0

3.77

g/l

0.02

338

1963

Other general symptoms and signs

105

364

2.95

22.49

1.4

2.5

3.57

3.87

g/l

1.62

263

Missing teeth due to accident, extraction or parodontitis

277

1474

1.93

22.46

3.8

2.0

3.78

3.80

g/l

0.11

188

1053

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

317

3.14

22.42

1.5

2.1

3.71

3.78

g/l

0.22

240

Sequelae of other external causes

143

591

2.52

22.33

2.9

2.5

4.01

3.84

g/l

0.41

120

433

Benign neoplasm: Caecum

261

1369

1.98

22.28

2.8

1.4

3.59

3.84

g/l

2.79

185

961

Discitis, unspecified

173

4.11

22.18

3.6

2.0

4.13

3.62

g/l

2.09

121

Renal tubulo-interstitial disorders in diseases classified elsewhere

106

5.23

22.03

5.3

2.0

3.93

3.60

g/l

0.37

Acute myeloid leukaemia and myelodysplastic syndromes

207

3.79

21.96

1.9

2.4

3.73

3.66

g/l

0.14

153

Presence of other functional implants

1331

7075

1.35

21.88

2.3

2.2

3.81

3.86

g/l

0.39

831

5132

Benign neoplasm of other and unspecified endocrine glands

302

1667

1.86

21.85

2.4

2.3

3.72

3.81

g/l

0.60

214

1217

Pneumocystosis

190

3.96

21.77

6.9

2.5

3.55

3.71

g/l

0.30

135

Other symptoms and signs involving the circulatory and respiratory systems

153

658

2.40

21.74

2.0

2.3

3.73

3.86

g/l

0.48

463

Other/unspecified reactive arthropathies

160

703

2.36

21.71

2.4

3.97

3.80

g/l

0.69

122

514

Elevated blood glucose level

193

915

2.18

21.70

2.0

2.2

3.82

3.76

g/l

0.33

136

667

Filling of root of tooth

303

3.18

21.69

5.4

2.6

3.63

3.73

g/l

0.27

230

Other viral diseases

490

3068

1.61

21.66

3.5

2.1

3.64

3.81

g/l

1.68

365

2224

Paracetamol of NSAID medication

335

918

1.86

21.58

2.4

1.9

3.72

3.79

g/l

0.42

244

640

Fracture of foot, except ankle

448

2758

1.65

21.57

2.3

2.1

3.89

3.80

g/l

0.25

325

2005

Other enthesopathy of foot (+metatarsalgia)

218

1083

2.07

21.53

2.2

3.81

3.78

g/l

0.08

172

781

Benign neoplasm: Rectum

403

2424

1.70

21.51

2.1

1.4

3.78

3.85

g/l

0.49

296

1700

Myocardial infarction

1224

6536

1.36

21.51

2.2

2.3

3.84

3.88

g/l

0.33

885

4613

Alcohol use disorder, Swedish definition

1140

7820

1.37

21.51

1.7

2.3

4.02

3.87

g/l

2.82

868

5580

Hypersplenism

8.73

21.22

1.6

1.3

3.37

3.92

g/l

1.00

Intracranial injury

1153

8269

1.36

21.21

2.1

2.2

3.87

3.82

g/l

0.49

803

5857

Disorders of synovium and tendon

995

6488

1.39

21.20

1.9

2.3

3.65

3.86

g/l

4.99

684

4655

Mixed and other personality disorders

152

658

2.37

21.18

1.6

2.0

3.91

3.81

g/l

0.41

131

485

Budesonide

251

1315

1.95

21.18

2.0

2.5

3.80

3.77

g/l

0.14

185

932

1233

8272

1.35

21.14

1.6

2.3

4.01

3.87

g/l

2.46

936

5913

Superficial injury of hip and thigh

330

1887

1.79

21.08

1.9

2.3

3.69

3.79

g/l

0.55

220

1325

Pneumococcal septicemia

335

3.03

21.06

5.6

2.7

4.24

3.71

g/l

0.88

245

Kela reimbursement Agammaglobulinemia (D80-84)

6.00

21.06

3.4

2.4

2.81

3.73

g/l

3.34

Noninfectious colitis NAS

292

1615

1.85

20.89

2.4

2.2

3.77

3.80

g/l

0.12

211

1155

Decubitus ulcer and pressure area

160

720

2.32

20.67

1.8

2.3

4.16

3.79

g/l

1.68

106

501

Disorders of the thyroid gland

1988

10330

1.27

20.67

2.0

2.3

3.77

3.84

g/l

0.76

1423

7331

Migraine with aura and triptan purchases

229

1172

1.99

20.62

1.4

1.9

3.57

3.74

g/l

1.11

174

834

Other embolism and thrombosis

303

1704

1.82

20.60

2.8

2.2

3.78

3.79

g/l

0.07

230

1209

Amiodarone users

271

1478

1.90

20.59

2.0

2.3

3.84

3.85

g/l

0.03

201

1059

Protozoal diseases

308

3.12

20.59

6.0

2.6

3.65

3.73

g/l

0.16

229

Other complications of surgical and medical care, not elsewhere classified

220

1116

2.03

20.57

2.5

2.3

3.78

3.77

g/l

0.03

153

802

Etanercept

139

588

2.44

20.55

1.6

2.3

4.18

3.73

g/l

3.33

104

428

Carcinoma in situ of skin of scalp and neck

328

3.10

20.43

1.8

2.5

3.83

3.67

g/l

0.43

231

Other metabolic disorders

253

1346

1.92

20.43

3.5

2.1

3.84

3.73

g/l

0.36

201

976

Cervicalgia

418

2567

1.66

20.41

2.1

2.2

3.68

3.83

g/l

1.78

296

1829

Radiculopathy

378

2270

1.70

20.25

2.5

2.2

3.75

3.86

g/l

0.68

278

1620

Myeloid leukaemia

306

3.11

20.22

1.8

2.6

3.58

3.69

g/l

0.36

219

Haemorrhage, not elsewhere classified

103

382

2.83

20.16

2.4

2.7

3.71

3.90

g/l

0.57

271

Inflammatory bowel disease

599

4002

1.52

20.13

2.1

2.2

3.95

3.82

g/l

0.70

408

2903

Eosinophilia

171

3.95

20.11

2.4

1.8

3.73

3.74

g/l

0.02

125

Wegener granulomatosis

139

4.28

20.08

1.2

2.4

3.76

3.83

g/l

0.18

Non-selective monoamine reuptake inhibitors

832

5739

1.42

20.07

2.1

2.3

3.74

3.81

g/l

0.76

609

4022

Other specified/unspecified necrotizing vasculopathies

144

4.26

20.07

1.4

3.1

3.54

3.69

g/l

0.34

104

Major coronary heart disease event excluding revascularizations

1549

8313

1.30

19.74

2.2

2.4

3.84

3.87

g/l

0.25

1108

5867

Recurring oral aphthae, including avohilmo

293

1653

1.81

19.69

2.6

2.3

3.74

3.78

g/l

0.20

201

1202

Progressive vascular leukoencephalopathy

113

448

2.69

19.62

2.3

2.5

4.00

3.80

g/l

0.35

306

Other skin changes

386

2354

1.68

19.58

3.0

2.3

3.65

3.82

g/l

0.98

244

1668

5-aminosalicylic acid

358

2133

1.70

19.57

1.8

2.3

3.93

3.82

g/l

0.46

260

1518

Cramp and spasm

118

475

2.59

19.56

2.5

2.4

3.65

3.77

g/l

0.47

355

Other specified and unspecified disorders of eye and adnexa

111

435

2.68

19.51

2.2

2.3

3.70

3.78

g/l

0.30

319

Opening and dilatation of root channel of tooth

139

603

2.38

19.42

4.2

2.2

3.73

3.80

g/l

0.21

444

Basal cell carcinoma, including avohilmo

1361

8238

1.32

19.35

2.5

2.2

3.79

3.83

g/l

0.30

965

5742

Retinal detachments and breaks

803

5726

1.42

19.31

2.4

2.3

3.85

3.80

g/l

0.34

566

4072

Basal cell carcinoma

1332

8141

1.32

19.26

2.5

2.2

3.78

3.83

g/l

0.43

945

5676

Neuromuscular dysfunction of bladder

217

1125

1.99

19.15

2.0

2.5

3.84

3.80

g/l

0.11

147

801

Viral pneumonia (known virus, not influenza)

246

3.30

19.14

5.7

2.6

3.96

3.76

g/l

0.22

179

Panic disorder

221

1147

1.96

19.12

1.6

2.2

3.62

3.80

g/l

1.44

166

827

Generalized anxiety disorder

225

1175

1.94

19.11

1.7

2.3

3.71

3.80

g/l

0.41

169

852

Disorders of adult personality and behaviour

448

2839

1.60

19.11

1.7

2.1

3.73

3.81

g/l

0.66

353

2072

Major coronary heart disease event

1660

8721

1.28

19.01

2.1

2.4

3.83

3.86

g/l

0.33

1200

6159

Postprocedural endocrine and metabolic disorders, not elsewhere classified

234

1245

1.92

18.95

3.4

2.1

3.86

3.73

g/l

0.42

185

901

Angina pectoris

1409

7345

1.31

18.94

2.2

2.4

3.83

3.87

g/l

0.40

946

5198

Suppurative and necrotic conditions of lower respiratory tract

147

663

2.31

18.94

2.7

2.6

4.01

3.91

g/l

0.30

104

488

Vitreous haemorrhage

240

1292

1.91

18.92

2.0

2.4

3.96

3.85

g/l

0.29

176

928

Other or unspecified ileus, impaction or obstruction

399

2474

1.64

18.83

2.4

2.2

3.93

3.87

g/l

0.13

275

1766

Carpal tunnel syndrome

1241

8548

1.32

18.82

2.2

2.3

3.78

3.81

g/l

0.26

878

6130

Disorders of vitreous body and globe

1104

8107

1.34

18.73

2.3

3.76

3.83

g/l

0.50

783

5754

Psoriasis vulgaris

394

2440

1.65

18.73

1.7

2.2

4.32

3.81

g/l

2.15

279

1772

Fissure and fistula of anal and rectal regions

480

3110

1.57

18.71

2.2

2.3

3.77

3.85

g/l

0.61

349

2274

Benign neoplasm: Adrenal gland

182

897

2.10

18.65

2.1

1.4

3.73

3.84

g/l

0.60

124

648

Drug-induced polyneuropathy

5.37

18.63

13.7

1.3

3.94

3.72

g/l

0.11

Spondylolisthesis/Spondylolysis

372

2275

1.67

18.57

2.6

2.2

3.69

3.85

g/l

1.15

260

1644

Coxarthrosis, primary

1384

9324

1.30

18.53

2.1

2.3

3.80

3.84

g/l

0.48

950

6578

988

6904

1.37

18.41

2.7

2.2

3.81

3.80

g/l

0.03

688

4805

Carcinoma in situ of skin of other and unspecified parts of face

225

1202

1.95

18.40

2.0

2.3

3.61

3.78

g/l

1.17

175

831

Thyroiditis, ILD-related definition

221

1167

1.94

18.33

2.4

2.3

3.59

3.72

g/l

0.88

165

834

Substance abuse

1133

8196

1.33

18.31

1.6

2.3

3.98

3.87

g/l

1.52

842

5881

Actinic keratosis

923

6451

1.38

18.29

2.8

2.2

3.79

3.81

g/l

0.06

640

4486

Systemic sclerosis

264

3.14

18.20

1.9

2.1

3.39

3.77

g/l

2.14

191

Acute pancreatitis

433

2763

1.60

18.19

1.7

2.3

4.00

3.81

g/l

1.95

316

1978

Other viral hepatitis

119

496

2.47

18.16

2.2

1.8

3.63

3.88

g/l

1.23

361

Fracture of forearm

1075

7572

1.34

18.15

2.0

2.2

3.76

3.79

g/l

0.25

730

5377

Transient ischemic attack

1216

7706

1.32

18.13

2.1

2.3

3.68

3.83

g/l

3.44

851

5404

Other diseases of lip and oral mucosa

340

2046

1.70

18.12

2.5

2.1

3.71

3.80

g/l

0.50

240

1431

Other and unspecified myopathies

213

1120

1.96

18.12

1.6

2.3

3.72

3.83

g/l

0.61

144

805

Open wound of ankle and foot

212

1110

1.96

18.11

2.2

2.3

4.00

3.85

g/l

0.71

164

805

Extrapyramidal and movement disorders

816

5901

1.40

18.09

2.0

2.3

3.68

3.80

g/l

1.65

581

4146

Gout due to impairment of renal function

129

4.37

18.07

2.7

1.8

3.74

3.69

g/l

0.08

Disorders of vitreous body

1072

7912

1.34

18.05

2.3

3.72

3.83

g/l

1.33

761

5624

Other diseases of the respiratory system

482

3162

1.55

17.95

2.1

2.2

3.78

3.80

g/l

0.09

336

2219

Other respiratory disorders and diseases

482

3162

1.55

17.95

2.1

2.2

3.78

3.80

g/l

0.09

336

2219

Idiopathic urticaria

169

3.70

17.94

1.2

1.9

3.92

3.77

g/l

0.35

133

Mental and behavioural disorders due to psychoactive substance use

1163

8364

1.32

17.88

1.6

2.3

3.98

3.87

g/l

1.60

864

5990

Hallux valgus (acquired)

661

3308

1.46

17.86

2.1

2.4

3.87

3.71

g/l

0.69

453

2315

Diplopia

291

1690

1.76

17.78

2.1

2.2

3.64

3.81

g/l

1.31

194

1212

Enthesopathies of lower limb, excluding foot

407

2570

1.61

17.76

2.2

3.64

3.86

g/l

2.08

307

1871

Other extrapyramidal and movement disorders in other diseases

497

3292

1.54

17.68

2.1

2.3

3.72

3.82

g/l

0.96

368

2317

Myocardial infarction, without ST-elevation

962

6606

1.36

17.64

2.1

2.3

3.83

3.84

g/l

0.10

668

4611

Amputation of foot

314

2.94

17.61

1.4

2.7

4.12

3.72

g/l

2.04

222

Memory loss

247

1376

1.86

17.60

2.1

2.4

3.77

3.78

g/l

0.04

190

1002

Skin changes due to chronic exposure to nonionizing radiation

939

6599

1.37

17.56

2.8

2.2

3.79

3.80

g/l

0.04

651

4587

Fenamates

330

1315

1.72

17.52

2.0

2.2

3.82

3.78

g/l

0.15

256

904

Lupus erythematosus

270

3.07

17.52

2.1

3.74

3.77

g/l

0.05

198

Pyothorax

116

490

2.48

17.46

3.0

2.5

4.01

3.89

g/l

0.30

357

Injury of unspecified body region

176

877

2.07

17.45

1.6

2.5

3.89

3.81

g/l

0.34

128

647

Hypertension, Pulmonary Arterial

5.01

17.36

2.6

1.8

3.87

3.49

g/l

1.17

Ankylosing spondylitis

183

924

2.03

17.36

1.7

2.0

4.02

3.90

g/l

0.46

133

684

Exclusions for E4_PCOS_BROAD

315

1880

1.70

17.25

3.0

2.2

3.68

3.81

g/l

0.91

225

1366

Scoliosis

162

784

2.11

17.24

2.3

2.2

3.45

3.77

g/l

2.53

120

564

Bronchiectasis

215

1155

1.93

17.23

2.6

2.5

3.79

3.75

g/l

0.15

167

804

Bullous disorders

154

737

2.17

17.15

2.0

2.5

3.70

3.82

g/l

0.50

119

535

Invasive ventilation

181

918

2.04

17.15

2.6

2.4

4.06

3.81

g/l

0.66

147

661

Benign neoplasm: Caecum

261

1490

1.81

17.13

2.8

2.3

3.59

3.82

g/l

2.17

185

1068

Persistent mood disorders

379

2377

1.62

17.08

2.0

2.2

3.86

3.80

g/l

0.24

300

1694

Unspecified acute lower respiratory infection

301

1782

1.72

17.07

3.1

2.1

3.75

3.85

g/l

0.59

195

1268

COPD, early/later onset

1077

6902

1.33

17.03

1.8

2.3

3.99

3.84

g/l

1.35

806

4817

Vitamin B12 deficiency anaemia

264

1512

1.79

17.00

1.9

2.4

3.74

3.77

g/l

0.15

187

1062

Malignant neoplasm of skin

1452

8611

1.28

17.00

2.5

2.3

3.78

3.84

g/l

0.55

1024

6041

Insomnia

283

1650

1.74

16.93

1.6

2.3

3.72

3.80

g/l

0.46

206

1203

Collagenous colitis

207

1103

1.93

16.91

3.1

2.4

3.68

3.76

g/l

0.34

150

793

Familial hypercholesterolemia

359

2233

1.64

16.89

2.3

2.2

3.72

3.84

g/l

0.78

236

1555

Conjunctivitis (acute, non atopic)

489

3242

1.52

16.88

2.7

2.1

3.86

3.79

g/l

0.22

356

2308

Nonischemic cardiomyopathy

143

669

2.22

16.84

1.7

2.3

3.74

3.80

g/l

0.24

113

488

Use of pramipexole

497

3329

1.52

16.82

1.9

2.3

3.60

3.81

g/l

3.31

352

2336

Fall on and from stairs and steps

514

3462

1.51

16.81

2.2

3.80

3.81

g/l

0.06

356

2451

Sleep disorders

376

2362

1.61

16.80

1.5

2.2

3.74

3.82

g/l

0.44

269

1711

Myocardial infarction, strict

1118

6221

1.33

16.76

2.1

2.3

3.84

3.88

g/l

0.46

806

4376

COPD, hospital admissions

1066

6859

1.33

16.70

1.8

2.3

3.99

3.84

g/l

1.26

794

4788

111

467

2.41

16.49

1.4

1.7

3.56

3.71

g/l

0.82

337

Atopic dermatitis, strict definition with reimbursement

413

2576

1.57

16.46

1.8

2.0

3.91

3.73

g/l

1.63

312

1882

Other hammer toe(s) (acquired)

375

2218

1.62

16.45

1.9

2.5

3.72

3.70

g/l

0.06

262

1524

Sarcoidosis

292

1736

1.72

16.41

1.9

2.2

3.71

3.80

g/l

0.56

215

1264

KRA_PSY_EATING, excluding more controls

342

2.66

16.41

1.7

3.48

3.77

g/l

1.30

247

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

995

7362

1.33

16.40

2.3

3.78

3.87

g/l

1.19

704

5290

Primary biliary cholangitis (PBC)

221

3.22

16.37

1.4

1.9

4.12

3.71

g/l

1.34

163

Other disorders of eyelid

992

7253

1.34

16.32

2.1

2.3

3.71

3.82

g/l

1.66

703

5092

Viral hepatitis

139

649

2.20

16.29

2.2

2.0

3.68

3.86

g/l

0.76

108

478

Other interventions on the root canals of the tooth

156

3.68

16.28

5.4

1.7

3.71

3.75

g/l

0.07

114

Substance use, excluding alcohol

339

2094

1.64

16.25

1.6

2.3

3.78

3.83

g/l

0.18

252

1529

Ulcerative colitis

462

3064

1.53

16.24

2.2

3.98

3.82

g/l

0.75

320

2211

Other specified/unspecified inflammatory spondylopathies

400

2.55

16.23

1.7

1.9

3.79

3.83

g/l

0.08

289

Hyperplasia of prostate

851

3549

1.38

16.20

2.5

2.4

3.82

4.01

g/l

2.05

583

2603

Personality disorders

421

2738

1.55

16.13

1.7

2.1

3.72

3.81

g/l

0.74

334

1990

Nonorganic sleeping disorders

322

1968

1.66

16.12

1.6

2.2

3.70

3.81

g/l

0.74

234

1431

Sequelae of injuries of lower limb

196

1041

1.93

16.10

2.2

2.4

3.79

g/l

0.01

149

760

COPD related to multimorbidity

929

5865

1.35

16.07

1.7

2.3

3.94

3.84

g/l

1.38

685

4099

Other degenerative diseases of the nervous system

563

2933

1.47

15.97

1.9

2.3

3.82

3.86

g/l

0.16

365

2087

Heartburn

215

1179

1.86

15.96

2.1

2.4

3.63

3.79

g/l

1.00

152

866

Hypermobility syndrome

338

2.67

15.96

2.1

1.8

3.63

3.74

g/l

0.40

257

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

221

1225

1.85

15.95

2.9

2.4

3.76

3.77

g/l

0.04

157

890

Other benign neoplasms of skin

714

5057

1.40

15.93

3.0

1.4

3.80

3.83

g/l

0.17

483

3573

Agoraphobia

167

3.46

15.87

1.8

1.7

3.59

3.94

g/l

1.09

123

Iridocyclitis

456

3034

1.53

15.86

2.3

2.1

4.00

3.82

g/l

0.93

330

2162

Melanocytic naevi

482

3241

1.50

15.83

2.2

1.4

3.73

3.82

g/l

0.39

364

2338

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

9.25

15.82

2.5

1.1

3.54

3.62

g/l

0.08

Hydronephrosis

234

1321

1.81

15.81

1.8

2.1

4.03

3.79

g/l

1.61

165

935

Vasomotor and allergic rhinitis

615

4265

1.43

15.79

2.1

2.2

3.87

3.84

g/l

0.18

439

3083

Chronic pancreatitis

276

1635

1.73

15.78

1.9

2.4

3.94

3.81

g/l

0.79

213

1182

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

405

2623

1.56

15.77

1.9

2.2

3.77

3.80

g/l

0.19

291

1908

Insulin, fast-acting (human)

259

1503

1.75

15.77

1.6

2.1

3.59

3.82

g/l

2.05

182

1106

Diseases of the ear and mastoid process

2382

10012

1.21

15.77

2.2

3.72

3.86

g/l

3.50

1625

7327

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

274

1622

1.73

15.73

2.0

1.4

3.90

3.85

g/l

0.22

196

1129

Candidiasis

270

1590

1.73

15.70

3.1

2.3

3.67

3.77

g/l

0.54

182

1144

Allergic purpura

275

2.88

15.64

1.7

2.5

4.17

3.74

g/l

1.83

200

Other and unspecified injuries of head

137

649

2.18

15.59

1.6

2.4

3.99

3.81

g/l

0.58

102

473

Systemic atrophies primarily affecting the central nervous system

115

510

2.36

15.56

1.4

2.7

3.74

3.77

g/l

0.05

373

Localized swelling, mass and lump of skin and subcutaneous tissue

607

4290

1.43

15.41

2.2

2.3

3.77

3.81

g/l

0.13

452

3031

Erosion of teeth, including avohilmo

311

1838

1.66

15.40

2.5

1.9

3.86

3.75

g/l

0.43

234

1291

Benign neoplasm: Stomach

241

1387

1.79

15.40

2.4

3.74

3.78

g/l

0.17

169

995

Fracture of lower leg, including ankle

1073

8248

1.31

15.26

2.0

2.3

3.83

3.82

g/l

0.10

768

5866

Other local infections of skin and subcutaneous tissue

211

1169

1.85

15.22

3.0

2.3

4.13

3.78

g/l

1.26

148

852

Other disorders of glucose regulation and pancreatic internal secretion

177

927

1.96

15.21

2.0

2.3

3.92

3.85

g/l

0.29

128

669

Restless leg syndrome

265

1569

1.73

15.20

2.0

2.3

3.64

3.77

g/l

0.88

197

1131

Lesion of lateral popliteal nerve

116

521

2.31

15.13

2.4

2.3

3.77

3.85

g/l

0.20

382

Guillain-Barre syndrome

160

3.55

15.03

2.4

2.5

3.42

3.83

g/l

1.80

118

Other malignant neoplasms of skin (=non-melanoma skin cancer)

1277

7953

1.28

14.97

2.6

2.2

3.82

3.83

g/l

0.08

898

5556

Other and unspecified urticaria

345

2188

1.60

14.90

2.4

2.2

3.65

3.77

g/l

1.10

253

1573

Alcohol induced polyneuropathy

105

4.30

14.88

1.3

2.0

4.03

3.80

g/l

0.50

Other and unspecified local infections of skin and subcutaneous tissue

199

1091

1.87

14.87

3.1

2.3

4.14

3.78

g/l

1.22

142

794

Persons encountering health services in other circumstances

652

4690

1.40

14.80

2.3

2.2

3.78

3.81

g/l

0.25

474

3299

Migraine without aura and triptan purchases

214

1196

1.81

14.80

1.6

1.9

3.54

3.71

g/l

1.22

164

860

Inflammatory diseases of the central nervous system

174

915

1.95

14.80

2.7

2.3

3.84

3.78

g/l

0.10

116

662

Thyrotoxicosis

482

3291

1.49

14.78

1.9

2.2

3.76

3.77

g/l

0.03

357

2331

Systemic sclerosis, icd10

291

2.81

14.77

1.9

3.39

3.77

g/l

2.20

212

Demyelinating diseases of the central nervous system

155

783

2.02

14.75

1.6

2.1

3.50

3.76

g/l

2.05

116

565

Intestinal stricture

656

4740

1.40

14.74

2.5

2.2

3.89

3.80

g/l

0.30

446

3352

Acute pancreatitis (for exclusion)

433

2899

1.52

14.72

1.7

2.2

4.00

3.83

g/l

1.76

316

2061

Alcoholic liver disease

226

1293

1.79

14.71

1.3

2.4

4.65

3.85

g/l

8.22

168

926

Pain and other conditions associated with female genital organs and menstrual cycle

288

1676

1.67

14.71

2.0

3.47

3.76

g/l

3.26

210

1227

Special screening examination for neoplasms

107

470

2.36

14.70

3.3

2.3

3.75

3.88

g/l

0.51

349

Cyst of kidney

175

928

1.95

14.69

2.6

2.5

4.19

3.80

g/l

1.15

124

677

Crystal arthropathies, rheuma endpoint

204

3.20

14.66

1.7

3.1

3.80

3.59

g/l

0.55

142

Vascular disorders of the intestines

165

857

1.99

14.65

2.4

2.3

3.85

3.92

g/l

0.21

119

605

Herpesviral [herpes simplex] infections

227

1300

1.78

14.62

3.2

2.3

3.93

3.78

g/l

0.30

172

939

Chronic tubulo-interstitial nephritis

100

428

2.43

14.62

2.1

3.61

3.69

g/l

0.27

310

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

183

3.31

14.61

6.9

1.3

3.54

3.75

g/l

0.56

131

Cervicobrachial syndrome

397

2612

1.54

14.55

2.1

3.63

3.84

g/l

2.96

280

1874

Other disorders of peripheral nervous system

5.41

14.53

3.6

1.7

4.68

3.75

g/l

0.39

Carcinoma in situ of skin

192

1052

1.89

14.53

1.9

1.5

3.77

3.84

g/l

0.23

146

731

Recurring oral aphthae

110

492

2.32

14.52

3.5

2.6

3.62

3.71

g/l

0.29

364

Benign neoplasm of mouth and pharynx

229

1321

1.77

14.43

3.1

1.4

3.77

3.89

g/l

0.42

159

930

Faecal incontinence

210

1186

1.82

14.31

1.6

2.3

3.67

3.78

g/l

0.44

154

852

Benign neoplasm: Adrenal gland

182

986

1.91

14.29

2.1

2.6

3.73

3.81

g/l

0.35

124

722

Abnormality of white blood cells, not elsewhere classified

4.82

14.23

2.0

1.7

3.63

3.78

g/l

0.26

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

300

2.68

14.22

1.5

1.7

3.33

3.88

g/l

3.57

222

Thoracic aortic aneurysm

318

2009

1.62

14.20

2.2

2.4

3.85

3.87

g/l

0.08

235

1426

Ascites

172

916

1.94

14.19

1.6

2.4

4.07

3.82

g/l

0.93

127

668

Chronic viral hepatitis

390

2.45

14.10

1.9

1.7

3.57

3.93

g/l

1.93

290

Abnormal results of function studies

178

959

1.90

14.09

2.4

2.5

3.61

3.81

g/l

0.98

124

705

COPD-related respiratory insufficiency

295

1836

1.65

14.06

1.9

2.3

4.06

3.80

g/l

0.51

201

1261

Dementia in Alzheimer disease

166

2592

0.54

14.06

1.5

2.2

3.74

3.75

g/l

0.01

1769

Other/unspecified rheumatoid arthritis

293

1819

1.65

14.05

1.9

2.3

3.84

3.77

g/l

0.31

203

1268

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

239

1409

1.74

14.01

1.8

1.4

3.89

3.85

g/l

0.17

168

998

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

836

5537

1.34

13.99

2.6

1.4

3.72

3.86

g/l

1.76

591

3914

Other specified/unspecified bacterial intestinal infections

155

802

1.99

13.95

2.9

2.4

3.66

3.80

g/l

0.49

100

588

Benign neoplasm: Rectum, anus and anal canal

461

3165

1.48

13.92

2.1

2.3

3.75

3.81

g/l

0.44

335

2236

Diagnoses used for exclusion with ILD

550

3896

1.43

13.91

2.2

3.72

3.80

g/l

0.75

385

2752

Other shoulder lesions

176

950

1.89

13.80

1.6

2.1

3.63

3.82

g/l

1.38

127

685

Problems related to lifestyle

176

949

1.89

13.79

1.5

2.3

4.18

3.90

g/l

0.30

120

687

Thyrotoxicosis, other and/or unspecified

369

2421

1.55

13.78

2.0

2.3

3.78

g/l

0.00

278

1735

Other and unspecified visual disturbances

199

1119

1.82

13.74

2.7

2.3

3.74

3.80

g/l

0.26

150

806

Mucosal proctocolitis

223

1294

1.75

13.69

2.2

2.3

4.28

3.81

g/l

1.88

181

950

Juvenile arthritis (FINNGEN)

254

2.78

13.63

1.8

2.0

4.03

3.68

g/l

0.78

181

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

279

1724

1.66

13.63

2.4

1.4

3.72

3.83

g/l

0.56

198

1162

Diabetic retinopathy, strict definition

382

2223

1.54

13.54

1.7

1.9

4.00

3.97

g/l

0.16

250

1548

Other disorders of ear

1929

10678

1.21

13.51

2.3

2.2

3.65

3.87

g/l

7.04

1229

7768

Open wound of forearm

179

979

1.87

13.49

2.1

2.3

3.74

3.82

g/l

0.32

138

721

Folate deficiency anaemia

100

4.22

13.37

2.2

1.8

4.17

3.62

g/l

1.19

Internal derangement of knee

658

4814

1.38

13.37

2.0

2.3

3.76

3.81

g/l

0.46

467

3448

Keratitis

646

4729

1.38

13.36

2.0

2.2

3.81

3.80

g/l

0.06

457

3384

Respiratory insufficiency

177

969

1.87

13.27

1.6

3.69

3.82

g/l

0.62

121

667

Other inflammatory liver diseases

146

755

1.99

13.16

1.7

2.7

3.88

3.79

g/l

0.35

101

551

Nummular dermatitis

181

1004

1.85

13.13

2.3

2.5

3.89

3.77

g/l

0.46

120

722

Other lack of coordination

169

3.28

13.12

1.7

2.6

3.57

3.76

g/l

0.62

120

Spirochaetal infections, other/unspecified

188

1056

1.83

13.11

2.3

2.5

3.56

3.81

g/l

1.05

132

773

Aortic aneurysm

521

3636

1.43

13.04

2.1

2.4

3.82

3.85

g/l

0.16

382

2554

Haemorrhoids and perianal venous thrombosis

584

4223

1.40

13.02

2.1

2.3

3.70

3.84

g/l

1.06

380

3011

Fibroblastic disorders

481

3368

1.45

12.99

2.3

3.81

3.86

g/l

0.25

345

2393

Excessive attrition of teeth

639

2505

1.40

12.97

2.3

2.0

3.71

3.76

g/l

0.33

459

1741

Congenital malformations, deformations and chromosomal abnormalities

952

7078

1.30

12.94

1.9

2.2

3.74

3.80

g/l

0.62

695

5112

Transport accidents

751

4998

1.34

12.89

1.8

2.2

3.77

3.85

g/l

0.79

516

3594

Other diseases of pancreas

176

975

1.86

12.88

2.2

2.4

3.83

3.78

g/l

0.20

125

708

Other crystal arthropathies

220

2.96

12.87

1.7

2.2

3.80

3.54

g/l

0.84

148

Unspecified nephritic syndrome

254

2.78

12.79

2.1

2.5

3.82

3.80

g/l

0.04

184

Early onset COPD

482

3391

1.44

12.76

2.0

2.4

4.10

3.83

g/l

1.18

361

2424

Misadventures to patients during surgical and medical care

285

1802

1.61

12.66

1.8

2.2

3.94

3.77

g/l

1.07

179

1287

Unknown and unspecified causes of morbidity

136

695

2.00

12.60

2.4

2.2

3.43

3.89

g/l

2.86

494

Propionic acid derivatives

579

2072

1.42

12.57

2.4

2.2

3.90

3.84

g/l

0.35

417

1413

Other viral diseases, not elsewhere classified

303

1937

1.58

12.57

3.2

2.2

3.69

3.80

g/l

0.54

228

1405

Sequelae of injuries, of poisoning and of other consequences of external causes

438

3034

1.46

12.54

2.4

2.2

3.88

3.84

g/l

0.21

306

2196

Pemphigoid

341

2.51

12.51

1.6

2.5

3.70

g/l

0.02

237

Barrett oesophagus

119

585

2.11

12.48

2.2

2.7

4.02

3.84

g/l

0.57

444

Anterior Iridocyclitis

395

2687

1.49

12.46

2.3

2.2

3.99

3.81

g/l

0.80

283

1930

Acute posthaemorrhagic anaemia

371

2.41

12.43

3.3

2.5

4.22

3.83

g/l

0.59

269

Benign neoplasm: Rectosigmoid junction

104

487

2.23

12.42

2.0

1.4

3.91

3.89

g/l

0.04

348

Ocular pain

152

812

1.92

12.39

1.6

2.3

3.55

3.77

g/l

1.48

119

587

Temporomandibular joint disorders, including avohilmo

620

4556

1.37

12.37

2.1

3.63

3.77

g/l

1.77

444

3298

Nonhereditary hypogammaglobulinemia

110

3.84

12.36

3.9

1.6

2.60

3.85

g/l

6.53

Other and unspecified paralytic syndromes

134

3.50

12.34

3.0

2.4

3.86

3.74

g/l

0.21

Congenital malformations of the urinary system

111

532

2.14

12.32

2.0

2.4

3.77

3.78

g/l

0.01

399

Traumatic subdural haemorrhage

276

1717

1.61

12.21

2.3

3.85

3.87

g/l

0.08

182

1194

Otitis externa

403

2764

1.48

12.18

2.1

2.2

3.85

3.81

g/l

0.17

265

1992

Benign neoplasm: Rectum

403

2771

1.48

12.17

2.1

2.3

3.78

3.81

g/l

0.14

296

1957

COPD, hospital admissions 3, with asthma pneumonia sepsis

629

3955

1.37

12.14

1.9

2.3

4.07

3.82

g/l

1.42

464

2735

Allergic rhinitis

432

2971

1.45

12.09

2.2

2.1

3.84

3.75

g/l

0.50

317

2164

Personal history of other diseases and conditions

157

848

1.87

12.09

4.2

2.0

3.67

3.79

g/l

0.59

107

628

Allergic urticaria

147

783

1.92

12.08

2.1

2.3

3.82

3.72

g/l

0.39

105

572

Hypothyroidism, other/unspecified

1763

9693

1.21

12.06

2.0

2.3

3.74

3.82

g/l

1.36

1253

6886

Ptosis of eyelid

250

1554

1.65

12.05

2.6

2.5

3.63

3.80

g/l

1.50

200

1112

Arthropathic psoriasis

226

1367

1.69

12.04

1.7

2.4

4.23

3.81

g/l

2.64

153

1007

Alcohol-induced chronic pancreatitis

143

758

1.94

12.03

1.8

2.4

3.92

3.89

g/l

0.10

107

569

Other diseases of stomach and duodenum

149

801

1.91

12.02

2.1

2.7

4.07

3.86

g/l

0.81

110

595

Anti-inflammatory and antirheumatic products, non-steroids

575

2072

1.41

12.02

2.6

2.2

3.82

3.84

g/l

0.08

422

1413

Total colectomy

421

2.28

12.00

2.6

2.4

3.90

3.78

g/l

0.38

316

Total colectomy operation

421

2.28

12.00

2.6

2.4

3.90

3.78

g/l

0.38

316

Diseases of male genital organs

1038

4113

1.29

11.95

2.1

2.3

3.82

4.00

g/l

2.66

741

3012

Ankylosing spondylitis, ICD10

171

959

1.82

11.94

1.7

2.4

4.02

3.82

g/l

0.83

124

709

Follicular lymphoma

110

535

2.14

11.93

1.4

3.40

3.86

g/l

3.62

383

COPD, hospital admission 2, with asthma infections

728

4706

1.34

11.90

1.8

2.3

4.04

3.83

g/l

1.26

535

3285

Poisoning by drugs, medicaments and biological substances

364

2456

1.50

11.89

2.0

2.2

3.90

3.79

g/l

0.64

277

1799

Artificial joint operation, meniscal resection

1941

10871

1.20

11.88

2.2

2.3

3.85

g/l

0.05

1369

7721

Dermatitis due to substances taken internally

113

554

2.10

11.85

4.1

2.6

3.54

3.72

g/l

0.72

404

Other forms of systemic lupus erythematosus

4.51

11.83

1.9

2.5

3.04

3.75

g/l

3.08

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

154

3.27

11.77

2.5

1.4

3.08

3.88

g/l

5.05

108

Carcinoma in situ of skin of upper limb, including shoulder

278

2.64

11.77

2.5

1.4

4.11

3.84

g/l

0.50

190

Oesophageal varices

100

471

2.21

11.76

1.6

2.4

4.35

3.83

g/l

2.49

337

Mental and behavioural disorders due to sedatives or hypnotics

122

616

2.03

11.75

1.4

2.1

3.74

3.80

g/l

0.20

449

Other immunodeficiencies

104

3.82

11.75

4.5

1.9

5.40

3.66

g/l

0.97

Microscopic polyangiitis

4.56

11.74

1.5

1.9

4.04

3.80

g/l

0.32

Cystic kidney disease

313

2.49

11.69

1.8

2.4

3.74

3.76

g/l

0.03

235

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

119

3.61

11.69

7.2

1.3

3.58

3.71

g/l

0.22

Atopic dermatitis, strict definition

382

2556

1.48

11.68

1.8

2.0

3.89

3.75

g/l

1.14

295

1868

Other specified/unspecified soft tissue disorders

111

544

2.10

11.68

2.4

2.1

3.81

3.82

g/l

0.01

385

Psoriatic arthropathies, ICD10

212

1272

1.70

11.68

1.7

2.4

4.20

3.83

g/l

2.12

141

933

Disorders of vestibular function (Vertigo)

956

7493

1.28

11.63

2.0

2.3

3.76

3.81

g/l

0.41

642

5292

Poisoning by medicine

329

2185

1.52

11.63

2.1

2.2

3.89

3.79

g/l

0.51

253

1600

Fracture of skull and facial bones

380

2601

1.48

11.61

2.5

2.2

3.70

3.82

g/l

0.93

277

1873

Paraplegia, diplegia of upper limbs

226

2.79

11.61

1.8

2.5

4.00

3.79

g/l

0.42

164

Delirium, not induced by alcohol and other psychoactive substances

254

1598

1.62

11.57

2.0

2.3

3.87

3.80

g/l

0.28

168

1135

Other disorders of the musculoskeletal system and connective tissue

306

2010

1.55

11.56

2.2

2.3

3.80

3.82

g/l

0.10

221

1455

Epilepsy

568

4161

1.37

11.56

2.0

2.3

3.73

3.83

g/l

0.83

384

2973

Mental and behavioural disorders due to alcohol

968

7444

1.28

11.55

1.6

2.3

4.00

3.87

g/l

2.18

726

5357

Neuralgia and neuritis, unspecified

106

513

2.12

11.53

2.8

2.2

3.50

3.88

g/l

2.60

376

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

100

472

2.16

11.49

1.5

1.8

3.65

3.86

g/l

0.82

354

Other disorders of gingiva or/and edentulous alveolar ridge

103

494

2.15

11.48

2.3

1.9

3.92

3.80

g/l

0.33

367

Acute gastritis

170

965

1.80

11.47

1.6

2.5

3.80

3.84

g/l

0.13

110

708

Biomechanical lesions, not elsewhere classified

113

563

2.08

11.44

2.3

2.5

3.79

3.80

g/l

0.03

412

Mental disorders, not otherwise specified

137

726

1.92

11.44

1.6

2.1

3.79

3.76

g/l

0.10

102

535

Cholecystectomy

1430

10425

1.22

11.40

2.3

2.2

3.79

3.80

g/l

0.15

990

7382

Exclusions for E4_PCOS_CONSORTIUM

1233

6241

1.25

11.38

2.1

3.71

3.76

g/l

0.47

871

4463

Speech disturbances, not elsewhere classified

193

1139

1.74

11.38

1.9

2.3

3.80

3.82

g/l

0.06

132

823

Acute and subacute iridocyclitis

365

2491

1.49

11.38

2.4

2.2

4.01

3.81

g/l

0.81

263

1787

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

265

1634

1.59

11.30

1.8

2.3

3.70

3.80

g/l

0.74

204

1199

Hypothyreosis and Thyroxine purchase for inclusion criteria

1826

10135

1.20

11.27

2.1

2.3

3.74

3.82

g/l

1.32

1299

7208

Polymyositis

4.15

11.26

1.9

2.2

3.28

3.76

g/l

1.99

Macular pucker

346

2350

1.50

11.23

1.9

2.4

3.94

3.78

g/l

0.77

240

1666

Benign neoplasm: Descending colon

153

849

1.86

11.23

2.2

1.4

3.88

3.85

g/l

0.10

608

Diseases of inner ear

1109

8753

1.25

11.19

1.9

2.3

3.75

3.81

g/l

0.67

743

6206

Autoimmune hepatitis

4.45

11.18

1.4

2.3

3.93

3.80

g/l

0.20

Other bursopathies

264

1690

1.59

11.18

2.3

2.2

3.75

3.87

g/l

0.80

193

1209

Colectomy operation

372

2562

1.48

11.17

2.6

2.3

3.92

3.80

g/l

0.82

266

1799

Chronic myeloproliferative disease

165

3.14

11.15

3.3

2.7

3.21

3.65

g/l

1.91

125

Malignant neoplasm of bone and articular cartilage

3.86

11.11

6.9

2.1

3.57

3.73

g/l

0.36

Ovarian cyst

622

2662

1.36

11.10

1.9

2.1

3.59

3.76

g/l

2.38

426

1930

Sulfonylureas

859

5358

1.29

11.08

1.8

2.4

4.03

3.77

g/l

5.34

598

3763

Hypoglycaemia, other or unspecified

134

714

1.92

11.08

1.7

2.4

3.92

3.80

g/l

0.46

102

522

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

144

3.27

11.07

1.5

1.3

4.30

3.96

g/l

0.42

104

Social phobias

472

2.13

11.07

1.4

1.8

3.74

3.82

g/l

0.21

350

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

519

3779

1.38

11.01

2.0

2.1

3.84

3.78

g/l

0.55

386

2759

Other and unspecified mood [affective] disorders

474

2.12

10.98

1.5

2.1

3.70

3.72

g/l

0.08

338

Emotionally unstable personality disorder

156

872

1.81

10.94

1.6

1.8

3.63

3.75

g/l

0.67

126

644

Intestinal adhesions without obstruction

179

1046

1.75

10.94

3.1

2.2

4.13

3.87

g/l

0.28

127

749

Lung transplant status

4.51

10.93

1.3

2.0

3.63

3.83

g/l

0.37

Mixed hyperlipidaemia

478

2.14

10.93

1.3

2.2

3.86

3.80

g/l

0.19

365

Lung transplantation

4.51

10.93

1.3

2.0

3.63

3.83

g/l

0.37

Other abnormal immunological findings in serum

160

3.07

10.93

2.5

2.4

3.97

3.73

g/l

0.49

116

Inflammatory diseases of female pelvic organs

988

5914

1.27

10.91

1.7

2.2

3.73

3.70

g/l

0.27

694

4229

Gingival hyperplasia

311

2.43

10.89

2.4

1.9

3.93

3.88

g/l

0.08

221

Synovial cyst of popliteal space [Baker]

158

893

1.81

10.85

2.6

2.2

3.77

3.81

g/l

0.19

118

634

Hernia of abdominal wall

902

7137

1.28

10.79

2.2

2.3

3.82

3.85

g/l

0.21

659

5063

Artificial opening status

127

674

1.95

10.76

2.5

2.3

4.40

3.86

g/l

0.58

103

496

Ventral hernia

482

3497

1.40

10.74

2.4

2.2

3.86

3.81

g/l

0.34

343

2463

Selective deficiency of immunoglobulin G [IgG] subclasses

4.45

10.74

2.7

1.2

4.24

3.91

g/l

0.16

Mental and behavioural disorders due to alcohol, excluding acute intoxication

847

6645

1.28

10.73

1.6

2.3

4.02

3.86

g/l

2.58

637

4784

Primary gonarthrosis, bilateral

1106

7831

1.25

10.69

1.9

2.4

3.82

3.83

g/l

0.06

780

5538

Panniculitis, unspecified

3.75

10.59

2.8

1.9

3.62

3.79

g/l

0.38

Polycystic ovarian syndrome, consortium definition

1178

5755

1.24

10.58

2.0

2.1

3.61

3.72

g/l

1.86

754

4180

Fall on same level involving ice and snow

1065

8604

1.25

10.57

2.0

2.3

3.83

3.81

g/l

0.19

724

6147

Artificial joint re-operation

170

993

1.77

10.54

2.1

2.6

4.00

3.79

g/l

1.14

134

707

Melanocytic naevi of trunk

201

1222

1.67

10.53

2.1

1.4

3.69

3.85

g/l

0.69

146

876

Symptoms and signs involving emotional state

225

2.66

10.51

1.7

1.9

3.87

3.76

g/l

0.26

166

Drug-induced cataract

250

2.60

10.50

2.5

3.09

3.72

g/l

4.04

185

Retinal vascular occlusion

274

1799

1.56

10.48

2.4

2.3

4.03

3.80

g/l

1.20

194

1256

Myocarditis

353

2.28

10.45

2.3

2.1

3.78

3.64

g/l

0.19

237

Polyarteritis nodosa and related conditions

118

3.40

10.34

2.9

2.2

3.81

3.77

g/l

0.05

Lesion of ulnar nerve

270

1770

1.55

10.31

2.1

3.84

3.85

g/l

0.08

202

1297

Benign neoplasm: Small intestine

490

2.10

10.30

2.3

1.4

3.77

3.88

g/l

0.21

351

Other diseases of oesophagus

206

1270

1.66

10.28

1.9

2.5

3.61

3.81

g/l

1.58

145

930

Background retinopathy and retinal vascular changes

235

2.64

10.28

1.8

2.8

3.81

3.67

g/l

0.30

174

Cholangitis (primary sclerosing, PSC), with reimbursement 202

139

3.16

10.26

2.5

1.9

4.30

3.67

g/l

1.48

105

686

4674

1.32

10.25

2.1

2.2

3.89

3.77

g/l

0.87

438

3216

Asthma and opportunity respiratory infection

120

637

1.95

10.23

2.4

2.6

3.73

3.75

g/l

0.06

450

Benign neoplasm of major salivary glands

195

1188

1.68

10.21

1.8

1.4

3.85

3.87

g/l

0.05

136

846

Retinal vascular disorders

276

1827

1.54

10.17

2.4

4.03

3.80

g/l

1.22

196

1274

Colonic or urogenital fistula

516

3819

1.37

10.15

2.3

2.2

3.77

3.84

g/l

0.57

377

2747

Other disorders of adrenal gland

438

2.14

10.12

2.7

2.5

3.67

3.75

g/l

0.18

328

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

450

3263

1.40

10.08

1.5

2.6

4.33

3.78

g/l

13.45

328

2399

Fall involving bed

375

2.26

10.07

2.3

2.2

3.75

3.69

g/l

0.17

263

Other localized connective tissue disorders

208

2.73

10.07

2.8

2.1

3.53

3.67

g/l

0.36

159

Olecranon bursitis

131

718

1.87

10.01

2.3

2.1

3.91

3.92

g/l

0.04

514

Benign neoplasm of mouth and pharynx

229

1459

1.60

10.00

3.1

2.4

3.77

3.81

g/l

0.10

159

1065

Excessive, frequent and irregular menstruation

644

2706

1.33

10.00

1.9

2.0

3.59

3.75

g/l

2.34

409

1959

Other psoriatic arthropathies

201

1241

1.65

9.98

1.8

2.4

4.22

3.83

g/l

2.09

134

910

Coeliac disease

221

1395

1.61

9.98

2.4

2.3

3.60

3.80

g/l

1.38

145

1008

Crohn disease

214

1340

1.62

9.96

1.6

2.3

3.95

3.80

g/l

0.62

143

977

Adrenocortical insufficiency

369

2.24

9.96

2.8

2.4

3.57

3.76

g/l

0.44

276

Cervicocranial syndrome

194

1189

1.66

9.88

2.0

2.2

3.65

3.82

g/l

1.05

142

856

Causalgia

132

3.17

9.83

1.3

2.1

3.56

3.92

g/l

0.98

Other and unspecified nerve root and plexus disorders, also in other diseases

337

2333

1.46

9.83

2.5

2.1

3.78

3.83

g/l

0.26

190

1713

Other disorders of nervous system

145

825

1.80

9.82

2.6

2.4

3.69

3.84

g/l

0.32

600

Melanocytic naevi of lower limb, including hip

390

2.19

9.82

2.3

1.4

3.91

3.83

g/l

0.11

287

Specific personality disorders

335

2314

1.46

9.80

1.7

2.1

3.66

3.80

g/l

1.41

258

1683

Mastocytosis

5.24

9.80

3.2

1.8

3.66

3.91

g/l

0.37

Postviral fatigue syndrome

5.57

9.77

1.1

2.1

3.37

3.57

g/l

0.40

Other nonthrombocytopenic purpura

3.65

9.76

2.2

1.9

3.80

3.61

g/l

0.34

Supplementary factors related to causes of morbidity and mortality classified elsewhere

535

4008

1.35

9.70

1.9

2.2

3.72

3.82

g/l

0.97

299

2890

Late syphilis

145

3.09

9.67

2.7

1.9

3.88

3.74

g/l

0.30

105

Hereditary motor and sensory neuropathy

3.85

9.64

1.9

2.1

3.15

3.96

g/l

4.16

Carcinoma in situ of skin of upper limb, including shoulder

306

2.39

9.62

2.5

2.9

4.11

3.67

g/l

0.98

207

Cholera

103

530

2.01

9.61

3.7

2.3

3.68

3.74

g/l

0.24

379

Follicular lymphoma, hilmo

110

580

1.97

9.61

1.4

2.9

3.40

3.81

g/l

2.64

422

Carcinoma in situ of skin

192

1188

1.66

9.60

1.9

2.4

3.77

3.80

g/l

0.09

146

837

Speech and linguistic disorders, excluding more controls

386

2.12

9.58

1.7

2.0

3.77

3.73

g/l

0.13

269

Dislocation, sprain and strain of joint and ligaments of hip

422

2.14

9.57

1.8

2.3

4.09

3.73

g/l

0.64

315

Exfoliative dermatitis

109

3.43

9.56

1.5

2.5

3.95

3.78

g/l

0.47

Benign neoplasm: Rectosigmoid junction

104

539

2.00

9.56

2.0

2.8

3.91

3.80

g/l

0.28

392

Deviated nasal septum

633

4864

1.31

9.55

2.6

2.3

3.90

3.89

g/l

0.02

458

3536

Traumatic subarachnoid haemorrhage

330

2.28

9.52

2.6

1.9

3.66

3.90

g/l

0.95

237

Cardiomyopathy, Hypertrophic obstructive

191

2.75

9.48

1.6

2.7

3.57

3.73

g/l

0.42

138

Other/unspecified crystal arthropathies

4.30

9.47

1.7

2.1

4.03

3.69

g/l

0.46

Carcinoma in situ of other and unspecified digestive organs

295

2.38

9.43

2.1

1.4

3.95

3.89

g/l

0.10

212

Hyperhidrosis

202

2.64

9.41

2.6

2.5

3.65

3.91

g/l

0.92

142

Dermatographic urticaria

114

609

1.91

9.41

1.9

2.2

4.00

3.74

g/l

1.55

453

Carbimazole or st.post thyroidectomy, condition for graves disease

357

2521

1.43

9.36

2.5

2.2

3.68

3.76

g/l

0.55

264

1807

Leukaemia of unspecified cell type

3.85

9.36

2.3

1.2

3.50

3.99

g/l

1.25

Xerosis cutis

182

2.81

9.33

1.6

2.4

3.56

3.68

g/l

0.23

134

Drug-induced osteoporosis

132

3.16

9.32

1.7

2.4

3.44

3.71

g/l

0.43

Injuries to the neck

366

2599

1.42

9.27

2.6

2.1

3.77

3.82

g/l

0.32

256

1874

Superficial injury of thorax

272

1830

1.51

9.23

1.5

2.3

3.87

3.83

g/l

0.17

182

1307

Alcohol-induced acute pancreatitis

381

2.17

9.22

2.1

2.5

4.12

3.90

g/l

0.70

287

Pain associated with micturition

220

1416

1.58

9.20

2.4

2.3

3.81

3.80

g/l

0.02

147

1001

Tubulo-interstitial nephritis, not specified as acute or chronic

137

781

1.79

9.19

2.7

2.0

3.71

3.77

g/l

0.20

561

Carcinoma in situ of skin of lower limb, including hip

237

2.54

9.17

3.0

1.4

3.73

3.77

g/l

0.06

163

Intestinal malabsorption

469

2.04

9.16

2.0

2.6

3.86

3.85

g/l

0.01

350

Other diseases of jaws

125

694

1.84

9.15

4.5

1.9

3.72

3.82

g/l

0.27

508

Emphysema

162

971

1.71

9.14

2.4

2.5

4.37

3.80

g/l

0.79

123

684

Use of anticholinesterases

447

4872

0.73

9.13

1.8

2.2

3.89

3.77

g/l

0.56

284

3312

N06DA Anticholinesterases

447

4872

0.73

9.13

1.8

2.2

3.89

3.77

g/l

0.56

284

3312

Eating disorder

446

2.04

9.12

1.7

1.6

3.48

3.73

g/l

1.09

339

Algoneurodystrophy

279

2.36

9.10

1.3

1.9

3.58

3.81

g/l

0.83

211

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

4.36

9.08

9.0

2.5

3.58

3.75

g/l

0.29

Adhesive capsulitis of shoulder

318

2213

1.46

9.08

1.8

2.2

3.76

3.87

g/l

0.76

228

1583

Other and unspecified erythematous conditions

338

2.24

9.06

2.6

2.2

3.54

3.78

g/l

0.69

246

Acute generalized exanthematous pustulosis

492

2.01

9.05

4.3

2.6

3.58

3.80

g/l

0.91

362

Hodgkin lymphoma

249

2.45

9.05

1.3

3.80

3.89

g/l

0.14

181

Left bundle-branch block

147

860

1.75

9.04

1.7

2.3

3.49

3.81

g/l

2.28

595

MS-disease / Multiple Sclerosis

115

624

1.88

9.03

1.6

2.0

3.42

3.75

g/l

2.32

458

Other prurigo

113

3.30

9.03

1.2

3.0

3.70

3.64

g/l

0.08

Hypothyroidism, strict autoimmune, 3 medication purchases required

1619

9383

1.18

9.03

2.0

2.2

3.73

3.80

g/l

1.24

1148

6665

Ulcerative colitis, NAS

237

1556

1.54

9.02

2.1

2.3

3.82

3.80

g/l

0.11

169

1128

Juvenile rheumatoid arthirtis

133

3.02

9.02

1.3

1.9

4.10

3.69

g/l

0.58

Dissociative [conversion] disorders

274

2.35

8.96

1.2

1.9

3.79

3.75

g/l

0.06

201

Calculus of kidney and ureter

610

4714

1.31

8.95

2.0

2.3

3.80

3.85

g/l

0.50

449

3355

Anogenital herpesviral [herpes simplex] infection

424

2.06

8.93

2.1

1.7

3.63

3.79

g/l

0.58

313

Exposure to other and unspecified inanimate mechanical forces

119

656

1.85

8.92

2.5

2.4

3.80

3.87

g/l

0.21

478

Acute nephritic syndrome

221

2.55

8.91

2.2

2.6

3.68

3.81

g/l

0.35

165

Striking against or struck by other objects

513

3867

1.34

8.90

1.9

2.2

3.85

3.87

g/l

0.09

376

2791

Infection due to other mycobacteria

169

2.81

8.87

1.6

2.0

3.72

3.80

g/l

0.14

116

Other/unspecified enthesopathies of lower limb, excluding foot

125

701

1.82

8.85

1.9

2.1

3.54

3.83

g/l

2.11

101

518

Impacted cerumen

207

1329

1.59

8.83

2.3

3.64

3.81

g/l

0.89

113

966

Infections with a predominantly sexual mode of transmission

399

2898

1.39

8.77

2.0

3.62

3.73

g/l

1.16

301

2129

therapeutic use

377

2.16

8.74

1.6

2.3

3.76

g/l

0.01

265

Vitamin deficiency

101

534

1.94

8.70

2.5

2.3

4.04

3.72

g/l

1.37

386

Vitamin deficiency, wide

101

534

1.94

8.70

2.5

2.3

4.04

3.72

g/l

1.37

386

Superficial injury of abdomen, lower back and pelvis

252

1690

1.51

8.69

1.9

2.2

3.72

3.83

g/l

0.64

190

1216

Sacroiliitis, not elsewhere classified

329

2.20

8.68

2.0

1.7

3.97

3.78

g/l

0.77

239

Hallux rigidus

267

1814

1.49

8.68

2.1

2.4

3.71

3.74

g/l

0.14

189

1272

Dipeptidyl peptidase 4 (DPP-4) inhibitors

263

1785

1.50

8.68

1.7

2.3

4.13

3.74

g/l

4.59

192

1288

Mature T/NK-cell lymphomas, hilmo

166

2.83

8.67

1.5

2.5

4.30

3.72

g/l

0.87

122

ILD and respiratory illness in diseases classified elsewhere

4.43

8.65

1.5

2.4

3.67

3.66

g/l

0.00

Carcinoma in situ of colon

149

2.93

8.65

2.5

1.3

4.07

3.93

g/l

0.22

101

Other and unspecified glaucoma

162

987

1.68

8.63

1.7

2.5

3.97

3.77

g/l

0.89

117

688

Acute pharyngitis

191

1199

1.60

8.55

2.6

2.0

3.94

3.81

g/l

0.54

146

895

Multifocal fibrosclerosis

3.85

8.55

1.4

2.4

3.53

3.82

g/l

0.51

Other/unspecified soft tissue disorders related to use, overuse and pressure

262

2.36

8.53

2.0

3.72

3.90

g/l

0.41

186

Other sleep disorders

202

1300

1.58

8.48

1.7

2.3

3.86

3.88

g/l

0.06

115

951

Other infective otitis externa

119

668

1.82

8.48

2.3

2.4

3.67

3.84

g/l

0.83

483

Mental and behavioural disorders due to opioids

225

2.45

8.46

1.7

1.6

3.55

3.84

g/l

0.89

171

Eating disorders

123

695

1.79

8.41

2.2

1.8

3.57

3.71

g/l

0.66

516

Somnolence, stupor and coma

463

1.99

8.41

1.5

2.8

3.74

3.89

g/l

0.47

337

Ulcerative ileocolitis

354

2.14

8.40

2.9

2.2

3.84

3.80

g/l

0.09

258

Syphilis

252

2.39

8.39

2.4

2.3

3.93

3.78

g/l

0.42

187

Post-traumatic stress disorder

434

2.00

8.36

1.6

1.8

3.62

3.77

g/l

0.56

319

Alcohol use disorder, ICD-based

765

6127

1.26

8.36

1.6

2.3

4.02

3.86

g/l

2.29

579

4403

Benign neoplasm: Pancreas

298

2.28

8.35

2.5

1.4

3.70

3.81

g/l

0.33

210

Type of accident

493

3737

1.33

8.33

1.8

2.2

3.74

3.82

g/l

0.57

267

2679

Mouth breathing

732

5831

1.26

8.33

2.4

2.3

3.75

3.87

g/l

1.50

537

4236

Other demyelinating diseases of the central nervous system

290

2.26

8.32

1.6

1.9

3.57

3.80

g/l

0.79

216

Carcinoma in situ of skin of trunk

385

2.11

8.31

2.7

1.4

3.74

3.87

g/l

0.47

270

Primary coxarthrosis, bilateral

619

4846

1.29

8.30

2.2

2.3

3.73

3.79

g/l

0.36

407

3390

Rosacea

206

1339

1.56

8.30

2.0

2.3

3.97

3.79

g/l

0.56

148

967

Benign neoplasm: Descending colon

153

931

1.69

8.24

2.2

2.5

3.88

3.80

g/l

0.31

682

Oral leukoplakia and related diseases, including avohilmo

182

1155

1.61

8.20

2.1

2.4

3.87

3.78

g/l

0.34

134

827

Benign neoplasm: Parotid gland

154

938

1.68

8.19

1.9

1.4

3.86

g/l

0.00

107

666

Menorrhagia

610

2606

1.30

8.19

1.9

2.1

3.74

3.76

g/l

0.05

378

1879

Psoriasis (vulgaris), strict definition

306

2.22

8.17

1.4

2.4

4.54

3.83

g/l

2.11

232

Cluster headache, strict

286

2.26

8.16

1.7

2.7

3.58

3.86

g/l

1.18

218

Pollen allergy

209

1349

1.55

8.15

2.3

2.0

3.79

3.77

g/l

0.05

158

1000

Listeriosis

4.90

8.15

3.1

1.6

3.47

3.97

g/l

0.69

Bullous pemphigoid

276

2.32

8.14

1.5

2.6

3.76

3.68

g/l

0.22

192

Other erythematous conditions

380

2.09

8.13

2.6

2.2

3.57

3.77

g/l

0.57

280

1078

0.43

8.13

1.2

2.4

4.46

3.83

g/l

2.33

765

Other disorders of bladder

249

1695

1.49

8.10

2.1

2.4

3.64

3.83

g/l

1.62

167

1188

Follicular cysts of skin and subcutaneous tissue

331

2372

1.41

8.08

2.5

2.2

3.83

3.82

g/l

0.02

251

1706

Other dermatomyositis

4.45

8.06

1.3

2.1

3.61

3.53

g/l

0.10

Chronic laryngitis and laryngotracheitis

269

1859

1.47

8.05

1.8

2.2

3.86

3.82

g/l

0.13

183

1328

Coronary revascularization (ANGIO or CABG)

1030

5938

1.22

8.04

1.9

2.3

3.79

3.88

g/l

1.30

746

4185

Disorders of ocular muscles, binocular movement, accommodation and refraction

742

5896

1.26

8.04

2.1

2.2

3.77

3.81

g/l

0.20

530

4231

Inguinal hernia

1166

6565

1.20

8.03

2.6

2.2

3.81

3.90

g/l

0.83

839

4643

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

232

1557

1.51

7.98

1.9

2.2

3.88

3.81

g/l

0.35

173

1149

Gonarthrosis, primary, with knee surgery

1212

8329

1.20

7.96

2.2

2.4

3.88

3.84

g/l

0.41

864

5880

Other juvenile arthritis

213

2.44

7.95

1.9

1.7

4.21

3.61

g/l

1.14

151

Malignant melanoma, excluding all cancers (controls excluding all cancers)

330

2372

1.41

7.95

2.3

1.4

3.55

3.85

g/l

4.98

239

1664

Other disorders of patella

245

1664

1.49

7.94

2.0

2.3

3.81

3.76

g/l

0.21

171

1199

Umbilical hernia

492

3759

1.32

7.91

2.0

2.3

3.76

3.88

g/l

1.35

372

2718

Other spirochaetal diseases

475

3613

1.33

7.90

2.6

2.3

3.68

3.81

g/l

0.74

349

2580

Certolizumab pegol

111

3.08

7.88

1.3

1.9

4.66

3.86

g/l

1.37

Carcinoma in situ of other and unspecified digestive organs

319

2.20

7.88

2.1

2.9

3.95

3.77

g/l

0.42

226

Other specified/unspecified hearing loss

174

1104

1.61

7.87

2.7

2.2

3.78

3.85

g/l

0.19

111

811

Erythema multiforme

228

2.41

7.87

1.7

2.4

3.46

3.74

g/l

0.86

171

Benign neoplasm: Other and unspecified parts of mouth

372

2.08

7.83

3.1

1.4

3.55

3.83

g/l

1.19

271

Cholecystitis

288

2028

1.44

7.82

2.1

2.3

3.73

3.78

g/l

0.20

190

1424

Benign neoplasm: Duodenum

300

2.23

7.81

2.6

1.4

3.99

3.85

g/l

0.17

209

Disease of hard tissues of teeth, NOS

3.50

7.81

6.4

1.6

3.49

3.83

g/l

0.60

Drug-induced adrenocortical insufficiency

187

2.58

7.78

3.1

2.1

3.70

3.79

g/l

0.09

141

Idiopathic pulmonary fibrosis

174

1109

1.61

7.77

2.1

2.4

4.08

3.79

g/l

0.98

122

790

Collapsed vertebra, not elsewhere classified

103

3.27

7.75

14.0

1.7

3.50

3.65

g/l

0.10

Exposure to other and unspecified forces of nature

4.44

7.75

3.0

1.2

4.19

3.84

g/l

0.42

Melanocytic naevi of lower limb, including hip

428

1.99

7.74

2.3

2.4

3.91

3.74

g/l

0.27

320

Postmenopausal bleeding

552

2333

1.31

7.74

2.0

2.2

3.75

3.78

g/l

0.21

397

1671

Other follicular disorders

116

664

1.78

7.73

2.3

2.4

4.03

3.82

g/l

0.77

496

4.34

7.72

1.5

2.6

3.69

3.70

g/l

0.01

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

405

3016

1.35

7.72

1.9

2.1

3.77

3.78

g/l

0.07

291

2214

Allergic contact dermatitis

216

1441

1.52

7.70

1.4

2.3

3.95

3.74

g/l

1.35

142

1029

Alcohol abuse, main dg, excluding more controls

242

1652

1.48

7.70

1.2

2.5

4.09

3.87

g/l

1.39

180

1207

Blepharochalasis

594

4672

1.28

7.69

1.9

2.3

3.68

3.84

g/l

2.13

411

3293

Respiratory disorders in diseases classified elsewhere

153

2.76

7.67

1.6

2.1

3.84

3.75

g/l

0.15

111

Disorders of oesophagus in diseases classified elsewhere

232

2.39

7.62

3.7

2.5

3.51

3.67

g/l

0.48

170

Benign neoplasm: Small intestine

546

1.88

7.62

2.3

2.7

3.77

3.84

g/l

0.12

391

Secondary thrombocytopenia

131

2.91

7.60

3.1

1.6

3.38

3.84

g/l

1.42

Abrasion of teeth

424

2330

1.35

7.60

2.5

2.0

3.74

3.77

g/l

0.16

301

1613

Other congenital malformations

120

696

1.75

7.59

1.8

2.3

3.66

3.77

g/l

0.48

509

Melanocytic naevi

482

3694

1.32

7.57

2.2

3.73

3.79

g/l

0.26

364

2652

Type 1 diabetes, definitions combined

117

672

1.75

7.56

1.9

2.0

3.35

3.75

g/l

2.96

520

Portal vein thrombosis

160

2.69

7.54

1.8

2.0

3.69

3.77

g/l

0.15

117

CR(E)ST syndrome

172

2.63

7.54

2.3

1.8

3.32

3.81

g/l

2.61

130

Lyme disease

468

3578

1.32

7.53

2.6

2.3

3.68

3.81

g/l

0.73

344

2558

D07AA Corticosteroids, weak (group I)

223

1502

1.50

7.53

1.8

2.3

4.15

3.78

g/l

2.52

159

1093

Chondrocostal junction syndrome [Tietze]

398

2.02

7.53

2.0

2.1

3.80

3.78

g/l

0.03

287

Superficial injury of ankle and foot

162

1019

1.61

7.51

1.8

2.2

3.65

3.80

g/l

0.84

116

743

Crohn's disease NAS

108

611

1.80

7.50

1.9

2.3

4.01

3.81

g/l

0.48

454

Trigger finger

243

1670

1.47

7.50

1.6

2.2

3.63

3.78

g/l

1.33

183

1208

Squamous cell neoplasms and carcinomas of the skin

279

1972

1.44

7.50

2.4

3.72

3.80

g/l

0.39

198

1371

Astigmatism

538

1.85

7.49

2.3

2.5

3.64

3.80

g/l

0.52

395

Abnormal spermatozoa

109

1853

0.58

7.47

1.9

2.5

4.01

3.88

g/l

0.16

1337

Pneumonia due to Streptococcus pneumoniae

413

1.98

7.44

4.8

2.0

4.27

3.84

g/l

0.56

294

Sacrococcygeal disorders, not elsewhere classified

285

2.20

7.43

2.0

3.57

3.78

g/l

0.79

206

Henoch-Schönlein purpura nephritis (HSPN)

5.91

7.43

1.2

2.1

4.13

3.72

g/l

—

IBD patients in KELA-register

358

2635

1.37

7.41

2.3

2.1

4.05

3.81

g/l

1.24

257

1921

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

543

1.86

7.41

1.5

1.4

4.11

3.88

g/l

0.69

401

Type 1 diabetes, strict (exclude DM2)

116

669

1.75

7.40

1.9

2.0

3.36

3.75

g/l

2.90

518

Hemiplegia

103

578

1.82

7.40

1.5

2.2

3.87

3.74

g/l

0.32

426

Cardiac arrest

114

563

1.77

7.40

2.2

2.3

3.69

3.78

g/l

0.25

387

Cluster headache, wide

325

2.11

7.38

1.8

2.7

3.66

3.84

g/l

0.54

247

Fracture of neck

125

743

1.72

7.38

3.2

2.4

3.75

3.89

g/l

0.53

542

Generalized skin eruption due to drugs and medicaments

429

1.97

7.37

4.5

2.5

3.56

3.82

g/l

1.01

319

Monoplegia

156

2.69

7.37

2.0

2.5

3.82

3.74

g/l

0.19

109

Superficial injury of wrist and hand

290

2065

1.42

7.34

1.8

2.2

3.82

3.79

g/l

0.13

215

1512

Other and unspecified injuries of lower leg

121

712

1.73

7.33

2.1

2.3

3.89

3.80

g/l

0.17

519

Crushed, pushed or stepped on by crowd or human stampede

549

1.83

7.33

2.7

2.2

3.81

3.82

g/l

0.01

411

Acute bronchiolitis

231

2.24

7.33

6.1

1.9

3.36

3.60

g/l

0.67

177

Other/unspecified disorders of vestibular function

473

1.92

7.33

1.9

2.4

3.66

3.73

g/l

0.25

345

Benign neoplasm: Parathyroid gland

117

3.00

7.32

2.5

1.3

3.56

3.94

g/l

0.65

Panniculitis affecting regions of neck and back

374

2.03

7.32

1.8

2.0

4.05

3.93

g/l

0.19

280

Other specified and unspecified personality disorders

134

810

1.68

7.32

1.9

2.1

3.57

3.82

g/l

1.82

104

593

Other and unspecified disorders of vitreous body

812

6616

1.23

7.32

2.3

3.59

3.82

g/l

5.50

573

4719

Disorders of optic nerve and visual pathways

160

1012

1.61

7.31

2.2

2.5

3.64

3.80

g/l

0.73

117

738

Superficial injury of shoulder and upper arm

192

1266

1.54

7.29

2.1

2.2

3.76

3.79

g/l

0.12

138

914

Acute peritonitis

130

783

1.70

7.29

2.3

2.5

3.65

3.81

g/l

0.74

569

Suggestive for eosinophilic asthma

183

1196

1.56

7.29

2.2

2.4

4.34

3.79

g/l

0.91

140

861

Diseases of peritoneum

204

1365

1.52

7.27

2.0

2.4

3.69

3.81

g/l

0.58

143

974

Chronic conjunctivitis

288

2.18

7.26

2.2

3.79

3.74

g/l

0.08

205

ILD-related respiratory insufficiency

426

1.97

7.26

2.1

2.6

3.74

3.76

g/l

0.03

306

Infarction of spleen

3.83

7.25

1.4

2.3

3.37

3.75

g/l

0.80

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

425

1.96

7.25

2.1

2.6

3.74

3.77

g/l

0.06

317

Carcinoma in situ of skin of ear and external auricular canal

164

2.65

7.24

1.7

1.4

3.49

3.83

g/l

0.91

110

Hodgkin lymphoma, hilmo

276

2.20

7.19

1.3

2.7

3.80

3.74

g/l

0.08

209

Leukaemia of unspecified cell type

3.20

7.14

2.3

2.2

3.50

3.75

g/l

0.52

Parkinson's disease, strict definition, excluding more controls

256

1761

1.45

7.13

1.9

2.3

3.69

3.85

g/l

0.95

178

1249

Coxarthrosis, primary, with hip surgery

996

7904

1.20

7.13

2.1

2.3

3.85

3.82

g/l

0.23

683

5588

Hypopituitarism

106

606

1.78

7.11

2.7

2.4

3.74

3.86

g/l

0.32

462

Anosmia

127

2.78

7.11

2.7

1.3

3.59

3.76

g/l

0.31

Other and unspecified rosacea

158

1005

1.60

7.10

2.0

2.4

3.93

3.77

g/l

0.43

113

731

Right bundle-branch block

407

1.97

7.09

2.9

2.1

3.56

3.83

g/l

1.01

293

Atypical facial pain

557

1.82

7.08

1.9

2.3

4.33

3.73

g/l

0.72

394

Otalgia

134

819

1.66

7.07

2.1

2.3

3.61

3.80

g/l

0.79

602

Other nutritional anaemias

108

3.04

7.07

2.2

2.0

3.88

3.58

g/l

0.38

6-mercaptopurine

158

2.58

7.07

1.3

2.6

3.76

3.73

g/l

0.05

121

Other benign neoplasms of skin

714

5792

1.24

7.07

3.0

2.3

3.80

3.81

g/l

0.04

483

4089

Bacterial, viral and other infectious agents

135

826

1.66

7.06

3.0

2.2

3.79

3.82

g/l

0.08

104

617

Emotional disorders starting during childhood or adolecense, excluding more controls

2.99

7.03

1.1

1.5

3.51

3.65

g/l

0.25

Other/unspecified enthesopathies, not elsewhere classified

167

1078

1.57

7.02

1.6

2.1

3.58

3.83

g/l

2.10

124

774

Erythema nodosum

319

2.10

7.02

3.1

2.1

3.92

3.68

g/l

0.54

239

Urolithiasis

644

5171

1.26

7.02

2.0

2.3

3.80

3.86

g/l

0.51

473

3684

Melanocytic naevi of trunk

201

1350

1.51

7.01

2.1

2.3

3.69

3.82

g/l

0.53

146

989

Endometriosis

566

2637

1.29

7.00

1.9

2.1

3.60

3.76

g/l

1.90

397

1906

Event of undetermined intent

101

573

1.79

6.99

2.0

2.3

3.68

3.85

g/l

0.63

427

Carcinoma in situ of skin of trunk

411

1.97

6.98

2.7

2.4

3.74

3.71

g/l

0.07

290

Benign neoplasm: Oesophagus

120

2.90

6.98

1.2

1.3

3.53

3.89

g/l

0.77

Other and unspecified psoriasis

132

809

1.67

6.94

2.0

2.5

4.15

3.84

g/l

1.57

590

Parkinson's disease, excluding more controls

273

1899

1.42

6.90

1.9

2.2

3.68

3.84

g/l

1.09

190

1347

Other abnormal uterine and vaginal bleeding

421

2276

1.33

6.90

2.1

2.2

3.63

3.76

g/l

1.01

234

1627

Unspecified/other endometriosis

120

716

1.70

6.89

1.9

1.8

3.57

3.77

g/l

0.74

513

Superficial injury of forearm

146

917

1.61

6.88

1.7

2.2

3.69

3.81

g/l

0.42

103

681

Bronchitis, not specified as acute or chronic

161

1036

1.58

6.86

1.9

2.3

3.65

3.79

g/l

0.84

112

729

Parodontitis, under 40 years

381

1.96

6.85

1.3

1.4

3.65

3.73

g/l

0.22

275

Arterial embolism and thrombosis

124

751

1.69

6.82

1.4

2.5

3.74

3.83

g/l

0.28

526

Disorders of orbit

491

1.86

6.82

2.9

2.5

4.18

3.79

g/l

0.58

353

Cushing syndrome

116

2.91

6.81

2.5

2.2

3.72

3.71

g/l

0.01

Impingement syndrome of shoulder

438

3368

1.31

6.79

2.5

2.4

3.84

3.88

g/l

0.16

278

2437

Duodenal ulcer

227

1574

1.46

6.78

1.7

2.5

3.88

3.85

g/l

0.12

157

1126

Viral and other specified intestinal infections

247

1692

1.43

6.78

1.8

1.9

3.81

3.79

g/l

0.06

170

1207

Injuries to the wrist and hand

1802

11453

1.14

6.77

2.0

2.2

3.80

3.84

g/l

0.51

1312

8190

Disorders of magnesium metabolism

3.50

6.77

1.2

4.13

3.75

g/l

0.74

Common variable immunodeficiency

3.71

6.76

1.5

2.50

3.81

g/l

4.69

Parodontitis, under 40 years, or operation codes

383

1.95

6.76

1.3

1.4

3.65

3.73

g/l

0.22

275

Monoarthritis, not elsewhere classified

414

1.93

6.72

1.6

2.3

4.25

3.69

g/l

1.91

288

Other or ill-defined heart diseases

514

1.82

6.71

1.5

2.0

3.74

3.85

g/l

0.35

369

Aspergillosis

101

3.09

6.71

2.3

1.4

4.13

3.89

g/l

0.17

Hyperkinetic disorders, excluding more controls

346

1.98

6.71

1.4

1.7

3.49

3.82

g/l

1.85

249

Carcinoma in situ of skin of lower limb, including hip

273

2.20

6.70

3.0

2.4

3.73

3.70

g/l

0.05

189

Dermatopolymyositis, unspecified

3.96

6.68

6.3

2.5

3.49

3.61

g/l

0.21

Speech and linguistic disorders

458

1.84

6.63

1.7

1.8

3.75

3.77

g/l

0.04

337

Other disorders of optic [2nd] nerve and visual pathways

113

673

1.71

6.63

2.2

2.7

3.66

3.81

g/l

0.47

500

Wet age-related macular degeneration

382

2845

1.34

6.62

2.3

2.2

3.93

3.74

g/l

1.04

258

1942

Benign neoplasm: Skin of eyelid, including canthus

278

2007

1.40

6.62

3.1

1.4

3.63

3.83

g/l

2.09

198

1402

Disorders of breast

780

5955

1.22

6.57

2.0

2.2

3.59

3.73

g/l

2.30

541

4236

Nontoxic goitre/thyroid nodule

568

4534

1.26

6.56

2.1

2.3

3.73

3.75

g/l

0.06

398

3180

Combinations of oral blood glucose lowering drugs

559

4456

1.27

6.55

1.7

2.4

4.03

3.81

g/l

3.00

388

3214

Dental caries 2 and operation codes

1207

8196

1.17

6.55

2.6

2.2

3.74

3.81

g/l

0.65

925

5896

Suicide or other Intentional self-harm

363

2733

1.34

6.53

2.0

2.2

3.82

3.81

g/l

0.05

264

2004

Benign neoplasm: salivary glands, exclude unknown (D119)

174

1155

1.53

6.51

1.9

2.4

3.90

3.82

g/l

0.28

119

838

Myasthenia gravis

191

2.41

6.51

1.3

2.4

3.51

3.66

g/l

0.34

134

Childhood asthma (age<16), excluding more controls

411

1.80

6.50

1.4

1.3

3.96

3.78

g/l

0.35

315

Cerebral cysts

542

1.79

6.49

1.6

2.3

3.57

3.76

g/l

0.65

405

COPD, hospital admissions 1, only main diagnosis

745

5212

1.23

6.48

1.9

2.3

4.03

3.83

g/l

1.14

538

3669

Enteropathic arthropathies

178

2.43

6.47

1.5

2.2

3.71

3.60

g/l

0.15

123

Open wound of abdomen, lower back and pelvis

248

2.19

6.47

1.8

2.1

4.01

3.85

g/l

0.33

185

Dental caries 2

1235

8318

1.17

6.46

2.6

2.1

3.75

3.81

g/l

0.64

947

5992

Polycythaemia vera

414

1.92

6.46

2.7

1.4

3.42

3.90

g/l

2.47

284

Inflammatory bowel disease, strict (require KELA)

358

2696

1.34

6.45

2.3

2.2

4.05

3.81

g/l

1.24

257

1974

Additional codes for the location of defect, injury or illness

106

626

1.73

6.44

1.4

2.5

3.68

3.84

g/l

0.50

457

Carcinoma in situ of colon

174

2.50

6.44

2.5

2.1

4.07

3.76

g/l

0.62

121

Benign neoplasm: Duodenum

325

2.05

6.40

2.6

3.99

3.68

g/l

0.45

234

Unspecified lump in breast

275

1994

1.40

6.38

1.9

2.2

3.52

3.75

g/l

3.02

205

1410

Exophthalmic conditions

109

2.90

6.37

3.5

1.8

4.15

3.78

g/l

0.45

Other bursitis of elbow

3.25

6.37

1.9

3.78

3.76

g/l

0.04

Malignant neoplasm of kidney, except renal pelvis

193

1316

1.49

6.37

1.8

2.4

3.95

3.83

g/l

0.50

134

949

Other specified and unspecified retinal disorders

409

1.91

6.36

2.3

2.5

4.01

3.69

g/l

0.59

304

Disorders of refraction and accommodation

376

2846

1.33

6.35

2.0

2.1

3.71

3.78

g/l

0.42

278

2053

Chondropathies

250

1785

1.42

6.34

1.9

2.1

4.14

3.81

g/l

1.25

164

1306

Hepatic failure, not elsewhere classified

403

1.91

6.30

1.5

2.7

4.04

3.76

g/l

0.63

289

Retinal detachment with retinal break

259

1866

1.41

6.29

2.5

2.4

3.84

3.79

g/l

0.20

190

1327

Childhood asthma (age<16)

416

1.78

6.27

1.4

1.3

3.96

3.78

g/l

0.36

321

Visual impairment including blindness (binocular or monocular)

132

831

1.62

6.26

2.1

3.73

3.79

g/l

0.18

579

Injury of eye and orbit

218

1522

1.45

6.26

1.9

2.2

3.65

3.85

g/l

1.75

150

1117

Benign paroxysmal vertigo

546

4368

1.26

6.22

2.0

2.3

3.74

3.78

g/l

0.23

370

3085

Other acute viral hepatitis

2.95

6.22

2.3

1.8

3.92

3.96

g/l

0.04

Thyrotoxicosis with toxic multinodular goitre

128

803

1.63

6.20

1.7

2.3

3.72

3.69

g/l

0.08

564

Melanoma in situ

500

1.81

6.20

2.3

1.4

3.62

3.88

g/l

1.25

358

Nail disorders

139

887

1.59

6.20

1.7

2.3

3.96

3.82

g/l

0.38

646

Benign neoplasm of major salivary glands

195

1339

1.48

6.20

1.8

2.4

3.85

3.82

g/l

0.09

136

957

Personal history of allergy to drugs, medicaments and biological substances

3.01

6.17

2.0

1.5

4.00

3.92

g/l

0.10

Chronic hepatitis, not elsewhere classified

363

1.95

6.17

1.6

2.6

4.06

3.64

g/l

1.97

270

Abscess of anal and rectal regions

132

833

1.61

6.15

1.2

2.2

3.90

3.88

g/l

0.07

106

627

Mental and behavioural disorders due to use of other stimulants, including caffeine

139

2.57

6.15

1.1

1.5

3.56

3.98

g/l

1.13

106

Disorders of sphingolipid metabolism and other lipid storage disorders

4.95

6.15

2.1

1.5

4.32

3.72

g/l

—

Somnolence

111

2.82

6.14

1.6

2.0

3.80

3.76

g/l

0.05

Benign neoplasm: Other and unspecified parts of mouth

407

1.90

6.13

3.1

2.6

3.55

3.70

g/l

0.49

297

Testicular dysfunction

294

2.05

6.13

1.4

2.5

3.76

3.89

g/l

0.31

215

Malignant neoplasm of urinary organs

207

1442

1.46

6.12

1.7

2.4

3.98

3.81

g/l

0.83

145

1031

Type1 diabetes, definitions combined, early onset

312

2.00

6.12

1.4

1.5

3.14

3.84

g/l

6.14

236

Postprocedural disorders of nervous system

551

1.75

6.11

2.2

2.0

3.82

3.78

g/l

0.08

418

Parodontitis, under 40 years and operation codes

355

1.93

6.10

1.3

1.4

3.55

3.77

g/l

0.67

260

Seborrhoeic keratosis

435

3398

1.29

6.08

2.6

2.2

3.83

3.80

g/l

0.09

302

2355

Disorders of myoneural junction and muscle in diseases classified elsewhere

3.09

6.08

1.8

2.2

3.61

3.95

g/l

0.43

Thyroiditis

126

790

1.62

6.08

2.2

2.4

3.57

3.74

g/l

1.16

569

Crohn's disease of small intestine

105

628

1.70

6.07

1.7

2.3

3.75

3.83

g/l

0.23

465

Disorders of synovium and tendon in diseases classified elsewhere

203

2.29

6.07

1.6

1.8

4.04

3.89

g/l

0.23

148

Hyperaldosteronism

310

2.03

6.07

2.4

2.5

3.74

3.80

g/l

0.15

228

Benign neoplasm: Parathyroid gland

130

2.69

6.06

2.5

1.9

3.56

3.77

g/l

0.32

Parodontitis, operation under 40 years and operation codes

356

1.92

6.05

1.3

1.4

3.55

3.77

g/l

0.66

261

Visual field defects

166

1110

1.52

6.03

2.2

3.82

3.85

g/l

0.08

114

802

Emergency coronary revascularization (for ACS)

1199

7413

1.17

6.03

1.9

2.4

3.81

3.87

g/l

0.69

857

5189

Scleritis

118

2.75

6.03

2.1

2.0

3.92

3.81

g/l

0.12

Seborrhoeic dermatitis

171

1150

1.51

6.02

2.2

2.4

4.04

3.80

g/l

0.80

121

828

Disorders of psychological development

106

587

1.69

6.01

1.6

1.8

3.74

3.77

g/l

0.09

432

Defects in the complement system

3.60

6.00

6.2

1.5

5.62

3.63

g/l

0.66

Benign neoplasm: Pancreas

340

1.99

6.00

2.5

2.6

3.70

3.69

g/l

0.02

246

Other symptoms and signs involving the digestive system and abdomen

278

2042

1.38

5.97

1.9

2.3

3.55

3.78

g/l

1.39

141

1469

Lichen ruber planus, wide definition including periferal and oral lichen planus

385

2970

1.31

5.93

2.4

2.3

3.77

3.79

g/l

0.07

281

2112

Psychotic depression

101

602

1.70

5.92

1.9

2.7

3.92

3.79

g/l

0.34

433

Carcinoma in situ of skin of ear and external auricular canal

181

2.39

5.92

1.7

2.3

3.49

3.69

g/l

0.45

122

Bell's palsy

205

1433

1.45

5.91

2.3

2.2

3.69

3.81

g/l

0.74

141

1031

Diseases of tongue

117

726

1.64

5.91

2.4

2.0

3.70

3.79

g/l

0.21

516

Ganglion

312

2335

1.35

5.90

2.0

2.2

3.63

3.82

g/l

1.47

215

1677

Benign neoplasm: Parotid gland

154

1019

1.54

5.90

1.9

2.5

3.86

3.84

g/l

0.06

107

748

Assault

161

1072

1.52

5.89

1.6

2.2

3.96

3.87

g/l

0.34

117

795

Fracture at wrist and hand level

547

4401

1.25

5.86

2.3

2.2

3.74

3.86

g/l

1.11

401

3174

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

243

1752

1.40

5.84

2.4

2.2

4.12

3.82

g/l

1.16

178

1277

Other and unspecified vascular occlusions

197

1374

1.46

5.81

2.5

4.02

3.79

g/l

0.92

139

974

Malignant neoplasm of pancreas

864

0.47

5.80

1.4

2.5

3.75

3.82

g/l

0.10

620

Other disorders of penis

168

1135

1.50

5.80

1.6

2.3

3.79

3.98

g/l

1.05

119

833

Carrier of infectious disease

220

2.20

5.80

1.3

1.8

3.68

3.79

g/l

0.24

165

Varicose veins

1254

8209

1.16

5.78

2.3

2.2

3.88

3.80

g/l

0.77

831

5799

Benign neoplasm: Oesophagus

133

2.61

5.77

1.2

2.2

3.53

3.69

g/l

0.27

Unspecific neurodegenerative disorder

648

5429

0.82

5.77

1.9

2.3

3.87

3.79

g/l

0.45

393

3744

Benign neoplasm of breast

198

1382

1.45

5.76

2.2

1.5

3.64

3.77

g/l

0.85

136

959

Other and/or unspecified nontoxic goitre

163

1099

1.51

5.72

2.3

3.58

3.78

g/l

1.33

134

780

Monoamine oxidase A inhibitors

214

1518

1.43

5.70

1.9

2.4

3.97

3.82

g/l

0.76

170

1079

Other chondrocalcinosis

159

2.47

5.69

1.6

2.2

3.82

3.66

g/l

0.39

112

Cardiac murmurs and other cardiac sounds

131

831

1.58

5.69

2.7

2.2

3.80

3.84

g/l

0.13

577

Ulcerative colitis (strict definition, require KELA)

250

1820

1.39

5.68

2.5

2.2

4.13

3.82

g/l

1.23

183

1325

Other eating disorders

247

2.09

5.68

1.3

1.7

3.47

3.73

g/l

0.98

192

Coronary artery bypass grafting

621

3863

1.23

5.68

1.7

2.3

3.87

3.90

g/l

0.23

443

2710

Other specified/unspecified spondylopathies

297

2.02

5.67

2.9

2.0

3.45

3.68

g/l

0.97

212

Vitamin D deficiency

152

2.45

5.65

1.3

2.1

4.04

3.65

g/l

0.95

113

Other/unspecified synovitis and tenosynovitis

191

1329

1.45

5.65

1.9

2.1

3.60

3.79

g/l

1.32

136

954

Other Crohn's disease

100

604

1.68

5.60

1.4

2.2

3.82

3.77

g/l

0.12

445

Entropion and trichiasis of eyelid

185

1286

1.46

5.58

2.2

2.4

3.70

3.83

g/l

0.51

131

898

Disorders of speech understanding and production

258

2.05

5.56

1.9

2.2

3.72

3.73

g/l

0.03

184

Plantar fascial fibromatosis

160

1080

1.50

5.55

2.5

2.2

3.83

3.80

g/l

0.07

119

783

Other secondary coxarthrosis

399

1.85

5.54

1.5

2.3

3.88

3.71

g/l

0.52

297

Adenomyosis (Endometriosis of uterus)

239

1737

1.39

5.54

2.2

3.63

3.75

g/l

0.85

178

1253

Amenorrhoea

455

1.78

5.54

2.0

1.9

3.53

3.79

g/l

1.17

335

Palmar fascial fibromatosis [Dupuytren]

309

2338

1.34

5.52

2.3

2.2

3.80

3.88

g/l

0.41

218

1653

Abscess of lung

148

2.46

5.51

1.4

2.3

3.87

3.73

g/l

0.28

107

Benign neoplasm: Pituitary gland, craniopharyngeal duct

502

1.75

5.50

2.8

1.4

3.81

3.83

g/l

0.05

361

Cachexia

3.99

5.50

2.2

1.5

3.96

3.80

g/l

—

Other injuries of lower limb, level unspecified

3.08

5.44

2.5

1.6

3.64

3.76

g/l

0.15

Other and unspecified haemorrhagic conditions

168

2.35

5.43

4.9

2.0

3.67

3.77

g/l

0.17

121

Otitis externa, unspecified

169

1159

1.48

5.42

1.9

2.4

3.82

3.79

g/l

0.11

114

838

Liver disorders in diseases classified elsewhere

5.09

5.41

2.2

1.2

3.49

4.16

g/l

1.06

Alzheimer’s disease (Early onset)

606

0.39

5.40

1.0

2.0

4.24

3.73

g/l

1.04

416

Bursitis of shoulder

247

2.08

5.39

2.4

1.9

3.85

3.94

g/l

0.16

173

Pustulosis palmaris et plantaris

491

1.75

5.39

1.9

2.4

4.17

3.69

g/l

2.27

360

Alzheimer disease

437

4133

0.79

5.36

1.9

2.2

3.87

3.76

g/l

0.47

263

2818

Inflammatory disease of uterus

188

1317

1.44

5.36

1.7

2.1

3.57

3.68

g/l

0.52

134

956

Scleritis and episcleritis

102

628

1.65

5.35

1.6

2.2

4.02

3.79

g/l

0.65

461

Testicular hypofunction

261

2.04

5.35

1.4

2.6

3.75

3.85

g/l

0.19

187

Other epidermal thickening

477

1.76

5.35

2.0

2.5

3.64

3.82

g/l

0.58

349

Iridocyclitis in diseases classified elsewhere

182

2.28

5.33

1.9

2.4

4.88

3.81

g/l

0.48

132

Other obstetric conditions, not elsewhere classified

267

1275

1.37

5.33

1.5

1.7

3.52

3.61

g/l

0.71

210

942

Fentanyl

177

1229

1.46

5.32

6.6

1.7

3.66

3.78

g/l

0.44

115

823

Drug-induced neutropenia

137

906

1.54

5.32

2.9

2.5

3.68

3.81

g/l

0.33

106

651

Biological medicines for asthma

114

2.64

5.31

1.7

1.8

3.62

3.84

g/l

0.57

Oral leukoplakia and related diseases

114

724

1.61

5.31

1.8

2.5

3.82

3.84

g/l

0.05

529

Pustular psoriasis

546

1.70

5.31

1.9

2.3

4.07

3.71

g/l

1.58

396

Unstable angina pectoris

842

5915

1.19

5.30

2.2

2.3

3.83

3.86

g/l

0.28

574

4118

Other and unspecified tonsillitis

398

2644

1.28

5.30

1.8

2.0

4.02

3.88

g/l

1.13

301

1972

Unspecified visual impairment (binocular)

151

2.41

5.29

1.7

1.8

3.56

3.67

g/l

0.19

103

Benign neoplasm: Spinal meninges

115

2.66

5.28

1.3

3.51

3.87

g/l

0.75

Complications of cardiac and vascular prosthetic devices, implants and grafts

250

2.08

5.27

1.8

2.7

3.82

3.64

g/l

0.62

174

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

175

2.26

5.27

1.6

1.7

3.64

3.71

g/l

0.14

134

Other orthopaedic follow-up care

101

623

1.65

5.27

1.8

2.0

4.37

3.82

g/l

0.47

464

Ulcer of oesophagus

140

932

1.53

5.27

2.2

2.7

3.68

3.82

g/l

0.61

691

Specific development disorders of speech and language

332

1.88

5.26

1.9

2.0

3.77

3.76

g/l

0.02

238

Conductive and sensorineural hearing loss

1615

9917

1.13

5.24

2.4

2.2

3.65

3.87

g/l

6.35

992

7207

Other misadventures during surgical and medical care

230

2.11

5.24

1.6

2.6

4.14

3.73

g/l

1.63

166

Use of donepezil

247

3187

0.74

5.23

1.9

2.3

3.93

3.74

g/l

0.58

141

2169

Benign lipomatous neoplasm

483

3891

1.25

5.23

2.5

1.4

3.63

3.84

g/l

2.64

311

2800

Bulimia nervosa (incl. atypical)

157

2.33

5.21

1.3

1.6

3.79

3.84

g/l

0.07

128

Benign neoplasm: Other and unspecified parts of small intestine

191

2.24

5.21

1.6

1.4

3.40

3.89

g/l

1.19

135

Urethral stricture

118

759

1.59

5.20

2.1

2.5

3.92

3.86

g/l

0.17

539

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

270

2021

1.35

5.18

2.4

2.2

4.09

3.83

g/l

1.06

199

1468

Procreative management

413

2750

1.27

5.18

1.7

2.0

3.72

3.81

g/l

0.52

322

2029

Pneumothorax

132

871

1.54

5.17

2.5

2.3

4.34

3.88

g/l

0.47

105

624

Intracranial and intraspinal abscess and granuloma

110

2.67

5.17

4.0

2.9

4.30

3.81

g/l

0.49

Clear cell adenocarcinoma of kidney

605

1.66

5.17

1.5

2.8

4.11

3.79

g/l

1.06

442

Abnormal findings on diagnostic imaging of central nervous system

437

1.77

5.16

2.4

2.6

3.52

3.77

g/l

0.94

328

Unspecified misadventure during surgical and medical care

102

636

1.64

5.13

1.8

2.5

4.01

3.83

g/l

0.45

466

Follow-up examination after treatment for malignant neoplasms

180

1264

1.44

5.13

2.3

2.1

3.93

3.87

g/l

0.21

134

913

Tinnitus

421

3350

1.27

5.12

2.3

2.2

3.69

3.86

g/l

1.76

312

2467

Pediculosis, acariasis and other infestations

521

1.70

5.08

1.9

2.2

3.76

3.82

g/l

0.20

393

Hidradenitis suppurativa

259

2.01

5.07

1.3

1.9

4.36

3.86

g/l

1.26

193

Irregular menses

619

4150

1.22

5.07

2.1

3.59

3.73

g/l

1.62

434

3062

Other maltreatment syndromes

232

2.07

5.06

1.5

4.22

3.98

g/l

0.56

165

Other otitis externa (chronic)

116

748

1.58

5.05

2.5

3.74

3.81

g/l

0.26

543

Papilloedema, unspecified

186

2.21

5.05

1.2

2.3

3.75

3.71

g/l

0.07

137

Malignant neoplasm of bronchus and lung

235

2956

0.74

5.05

2.0

2.2

4.04

3.80

g/l

1.12

180

2053

Attention to artificial openings

456

1.75

5.03

2.3

2.1

4.19

3.77

g/l

1.64

340

Alcohol abuse, main dg

242

1791

1.36

5.03

1.2

2.2

4.09

3.86

g/l

1.51

180

1318

Other obstructive and reflux uropathy

381

1.82

5.03

1.9

2.0

3.69

3.67

g/l

0.05

280

Benign neoplasm of urinary organs

547

1.68

5.02

2.0

1.4

3.54

3.89

g/l

2.33

388

Melanoma in situ of other and unspecified parts of face

143

2.44

5.02

2.3

1.2

3.50

3.71

g/l

0.59

454

3458

1.26

5.01

2.1

2.2

3.84

3.75

g/l

0.52

276

2369

Tobacco use

501

1.71

5.01

1.7

2.5

4.72

3.82

g/l

0.45

381

Vascular diseases of the intestine

487

1.73

5.00

2.9

2.3

4.01

3.79

g/l

0.74

353

Acne

537

1.67

4.99

1.9

1.6

3.84

3.81

g/l

0.08

399

Other disorders of cornea

166

1156

1.46

4.98

1.9

2.3

3.85

3.81

g/l

0.13

116

836

Other noninflammatory disorders of vulva and perineum

137

918

1.51

4.96

1.5

2.1

3.64

3.77

g/l

0.62

653

Ulcerative colitis (strict definition, all Crohn cases excluded)

212

1540

1.39

4.95

2.7

2.3

4.14

3.83

g/l

1.01

157

1138

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

118

2.53

4.94

4.9

1.6

3.35

3.78

g/l

0.75

Operations for atrial fibrillation

189

2.21

4.94

1.3

3.0

4.09

3.66

g/l

1.04

141

Iron deficiency

124

2.47

4.93

2.2

2.1

3.79

3.61

g/l

0.16

101

Degenerative macular diseases

249

1861

1.36

4.93

1.9

2.3

3.61

3.75

g/l

0.95

165

1299

Dermatophytosis

237

1757

1.37

4.92

2.4

2.3

3.75

3.82

g/l

0.36

173

1247

Lichen planus, including avohilmo

328

2546

1.30

4.91

2.5

2.3

3.79

g/l

0.02

240

1818

Haemangioma, any site

133

889

1.52

4.90

2.6

1.3

3.51

3.84

g/l

2.83

640

Viral warts

148

1011

1.48

4.89

2.0

2.4

3.65

3.80

g/l

0.59

101

741

Golimumab

256

1.99

4.88

1.3

1.7

4.09

3.87

g/l

0.46

196

Coronary angioplasty

812

5304

1.18

4.88

2.0

2.3

3.78

3.88

g/l

1.30

584

3723

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

254

1222

1.35

4.86

1.4

1.7

3.55

3.61

g/l

0.41

200

905

Viral conjunctivitis

176

2.22

4.85

2.4

1.7

3.66

3.91

g/l

0.51

135

Pulmonary oedema

210

2.12

4.84

1.6

2.3

4.39

3.71

g/l

1.23

143

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

259

1951

1.34

4.84

2.3

1.4

3.54

3.86

g/l

4.46

183

1377

Vulvovaginal ulceration/inflammation in other diseases

430

1.74

4.83

1.7

2.0

3.51

3.68

g/l

0.73

319

Oesophagitis

103

654

1.60

4.82

2.1

2.6

3.70

3.82

g/l

0.43

489

Haemangioma and lymphangioma, any site

140

949

1.49

4.82

2.9

1.3

3.50

3.83

g/l

2.85

675

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

621

1.61

4.81

2.0

2.3

3.72

3.73

g/l

0.01

445

Lactose intolerance

272

1.95

4.79

1.4

1.7

3.84

3.75

g/l

0.12

208

Chronic myeloid leukaemia

3.51

4.79

1.5

2.6

3.72

3.74

g/l

—

Congenital malformations and deformations of the musculoskeletal system

101

634

1.60

4.78

1.4

2.0

4.03

3.75

g/l

1.18

475

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

3.98

4.78

2.9

1.6

4.40

3.85

g/l

—

Lumbosacral root disorders, not elsewhere classified

127

2.46

4.76

2.5

2.0

3.89

3.83

g/l

0.11

Congenital malformations of the circulatory system

200

1403

1.39

4.76

1.7

2.3

3.72

3.81

g/l

0.47

150

1027

Alzheimer disease, including avohilmo

539

4713

0.82

4.75

1.9

2.2

3.84

3.77

g/l

0.34

346

3206

Deficiency of other B group vitamins

246

2.01

4.74

3.7

2.0

3.95

3.63

g/l

0.92

183

Atypical mycobacterium lung infection

134

2.42

4.72

1.6

2.0

3.71

3.78

g/l

0.10

Status epilepticus

360

1.81

4.72

1.6

2.6

3.98

3.78

g/l

0.36

271

Other and unspecified pemphigoid

110

2.61

4.71

1.5

2.6

3.43

3.66

g/l

0.65

Other and unspecified nonorganic psychotic disorders

250

1878

1.34

4.71

1.5

2.2

3.76

3.82

g/l

0.32

176

1377

Type 1 diabetes, strict definition

424

1.73

4.70

1.4

1.5

3.32

3.85

g/l

3.59

321

Other specified congenital malformation syndromes affecting multiple systems

2.70

4.70

1.5

1.9

3.73

3.77

g/l

0.07

Other deformities of toe(s)

383

1.79

4.69

2.3

2.2

3.80

3.60

g/l

0.44

266

Perineal laceration during delivery

927

0.56

4.68

1.6

3.51

3.61

g/l

0.31

707

Personal history of medical treatment

2.74

4.68

1.4

1.8

3.85

3.64

g/l

0.33

Benign neoplasm of meninges

177

1263

1.42

4.67

1.9

1.4

3.49

3.84

g/l

3.93

123

882

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

489

1.69

4.67

4.0

1.4

4.01

3.89

g/l

0.12

357

Presence of other devices

453

3674

1.24

4.67

2.5

2.2

3.44

3.84

g/l

6.84

282

2625

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

2.68

4.67

1.2

1.3

3.40

3.86

g/l

1.12

Other and unspecified follicular disorders

376

1.79

4.67

3.0

2.4

3.93

3.82

g/l

0.24

292

Unspecified protein-energy malnutrition

3.28

4.66

1.7

2.7

3.19

3.73

g/l

—

Recurrent dislocation and subluxation of joint

518

1.66

4.65

2.0

2.2

3.74

3.70

g/l

0.09

375

Obsessive-compulsive disorder

353

1.80

4.64

2.1

2.0

3.64

3.81

g/l

0.62

268

Hyphaema and other vascular disorders of iris and ciliary body

200

2.12

4.64

2.1

2.8

4.22

3.68

g/l

1.62

144

Viral infections of the central nervous system

116

763

1.54

4.64

2.3

3.77

3.81

g/l

0.06

553

Melanoma in situ

545

1.66

4.64

2.3

2.7

3.62

3.79

g/l

0.66

394

Other specific arthropathies, wide

193

2.13

4.63

1.4

2.5

3.58

g/l

0.00

141

Nail dystrophy

3.04

4.63

1.4

2.3

3.86

3.84

g/l

0.02

Benign neoplasm: Skin of ear and external auricular canal

460

1.71

4.62

2.5

1.4

4.36

3.89

g/l

0.46

332

Nontoxic multinodular goitre

373

2966

1.27

4.62

1.9

2.4

3.83

3.76

g/l

0.11

242

2085

Other disorders of electrolyte and fluid balance, not elsewhere classified

2.84

4.62

1.6

1.5

3.88

3.64

g/l

0.34

Ulcerative proctitis

590

1.62

4.61

1.4

2.1

3.77

3.80

g/l

0.07

433

Other surgical follow-up care

283

1.91

4.61

2.5

1.9

4.13

3.77

g/l

1.01

227

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

177

2446

0.72

4.60

1.8

1.4

3.78

3.86

g/l

0.36

109

1729

Disorder of external ear, unspecified

349

1.82

4.59

2.5

2.4

4.29

3.82

g/l

0.60

258

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

230

1713

1.36

4.59

2.5

1.4

3.99

3.87

g/l

0.49

159

1212

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

404

3242

1.25

4.57

1.6

2.2

3.87

3.82

g/l

0.25

299

2365

Disorders of optic nerve, not elsewhere classified

250

1.99

4.56

2.4

2.9

3.35

3.72

g/l

1.66

177

Congenital malformations of cardiac septa

549

1.62

4.55

1.7

2.3

3.70

3.77

g/l

0.22

400

Autoimmune hyperthyroidism

553

1.63

4.55

2.2

2.5

3.94

3.70

g/l

0.32

403

Triptan medication for migraine, min. 3 purchases

718

4797

1.19

4.54

2.2

2.1

3.59

3.78

g/l

3.29

536

3506

Alzheimer’s disease (Atypical or mixed)

1342

0.62

4.53

2.1

3.72

3.74

g/l

0.04

895

Ankylosing spondylitis, strict definition

372

1.78

4.51

1.5

2.3

4.22

3.81

g/l

1.30

277

Use of memantine

355

3877

0.79

4.51

1.8

2.2

3.76

3.77

g/l

0.05

205

2631

Use of other anti-dementia drugs

355

3877

0.79

4.51

1.8

2.2

3.76

3.77

g/l

0.05

205

2631

Shock, not elsewhere classified

2.80

4.51

3.5

2.0

3.86

3.84

g/l

0.02

Other condition

211

1558

1.37

4.51

2.1

2.2

3.80

3.81

g/l

0.01

133

1146

Maternal care for other conditions predominantly related to pregnancy

210

1526

1.37

4.50

1.9

3.60

3.64

g/l

0.15

159

1141

Polyarteritis nodosa

3.16

4.50

3.4

2.3

3.20

3.77

g/l

1.01

Other and specified injuries of hip and thigh

244

1.98

4.49

1.4

2.2

3.99

3.74

g/l

0.26

178

Cluster headache, strict, including avohilmo

425

1.72

4.49

1.6

2.3

3.57

3.84

g/l

1.37

318

Other other unspecified disorders of the circulatory system

442

1.71

4.47

1.8

2.6

3.62

3.73

g/l

0.35

316

Other bursitis of hip

210

2.06

4.46

2.0

1.7

3.87

3.84

g/l

0.03

142

Other hearing loss

569

4667

1.21

4.44

2.5

2.2

3.78

3.84

g/l

0.33

373

3337

Familial hypercholesterolemia, with ischemic heart disease

205

1515

1.37

4.43

1.9

2.3

3.77

3.84

g/l

0.31

127

1050

Benign neoplasm: Kidney

383

1.77

4.43

2.1

1.4

3.36

3.88

g/l

4.00

268

Postprocedural disorders of digestive system, not elsewhere classified

368

1.78

4.43

1.8

2.6

4.08

3.75

g/l

1.26

269

Third [oculomotor] nerve palsy

218

2.04

4.42

1.7

2.8

3.86

3.68

g/l

0.48

156

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

604

1.59

4.42

1.8

2.2

3.65

3.75

g/l

0.36

451

Lichen planus

235

1772

1.34

4.41

2.8

2.3

3.90

3.75

g/l

0.37

166

1289

Other retinal artery occlusion

296

1.88

4.41

2.0

2.8

4.14

3.69

g/l

0.72

215

Viral agents as the cause of diseases classified to other chapters

204

2.07

4.40

2.8

2.0

3.49

3.83

g/l

1.27

147

Open wound of hip and thigh

295

1.87

4.39

1.3

2.5

3.77

3.78

g/l

0.03

215

Other symptoms and signs involving general sensations and perceptions

391

1.75

4.38

2.5

2.6

3.96

3.76

g/l

0.53

289

!Aliquae complicationes praecoces traumatis

421

1.72

4.38

2.5

2.3

3.83

3.78

g/l

0.12

315

Early complications of trauma

421

1.72

4.38

2.5

2.3

3.83

3.78

g/l

0.12

315

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

318

2465

1.28

4.38

2.1

2.0

3.60

3.76

g/l

1.34

229

1794

Other superficial mycoses

184

2.12

4.38

1.9

2.3

3.68

3.78

g/l

0.19

139

Other and unspecified iridocyclitis

444

1.70

4.38

2.9

2.2

4.09

3.80

g/l

0.99

321

Leisure time condition

290

2252

1.30

4.37

1.7

2.2

3.69

3.81

g/l

0.78

140

1629

Cluster headache, wide,, including avohilmo

459

1.68

4.36

1.7

2.3

3.64

3.83

g/l

0.68

343

Perioral dermatitis

171

2.16

4.35

1.6

2.1

3.71

3.77

g/l

0.11

130

Benign neoplasm: Spinal meninges

127

2.40

4.33

1.3

1.8

3.51

3.84

g/l

0.68

Spontaneous abortion

457

3796

0.82

4.33

1.9

2.3

3.63

3.73

g/l

0.88

323

2694

Bicipital tendinitis

546

1.62

4.32

2.1

2.4

3.72

3.86

g/l

0.41

395

Benign neoplasm: Pituitary gland, craniopharyngeal duct

539

1.62

4.29

2.8

2.5

3.81

3.79

g/l

0.05

398

Localized scleroderma [morphea]

153

2.24

4.28

1.7

1.8

3.45

3.68

g/l

0.48

119

Glucosamine medication

1057

7402

1.15

4.27

2.3

3.70

3.82

g/l

1.93

761

5180

Other keratitis

165

1182

1.41

4.27

2.0

2.3

3.95

3.82

g/l

0.57

121

863

Other specified disorders of muscle

284

1.87

4.26

1.3

2.2

3.68

3.89

g/l

0.56

197

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

103

2.55

4.25

1.5

1.3

3.61

3.85

g/l

0.38

Other noninfective disorders of lymphatic vessels and lymph nodes

380

1.75

4.25

1.6

2.4

3.94

3.68

g/l

0.68

275

Other disorders of iris and ciliary body

292

1.86

4.24

2.2

2.7

4.05

3.72

g/l

1.01

211

Other bullous disorders

292

1.86

4.24

2.8

2.3

3.81

3.71

g/l

0.18

215

Pure hyperglyceridaemia

228

1.98

4.24

1.9

2.4

4.04

3.79

g/l

0.59

176

Other specified/unspecified disorders of bone/cartilage

292

1.86

4.23

2.7

1.9

3.63

3.82

g/l

0.44

210

Other congenital malformations of skin

365

1.76

4.23

1.9

2.4

3.72

3.70

g/l

0.04

272

Hypotension due to drugs

154

2.23

4.23

3.6

1.8

4.20

3.76

g/l

1.21

105

Other and unspecified corneal deformities and disorders

336

1.80

4.23

2.1

2.3

3.96

3.77

g/l

0.27

240

Leiomyoma of uterus

697

3326

1.19

4.22

2.1

1.4

3.74

3.71

g/l

0.18

485

2381

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

805

5404

1.17

4.22

2.0

1.4

3.79

3.86

g/l

0.82

562

3819

Other salmonella infections

404

1.72

4.19

2.4

2.1

3.62

3.70

g/l

0.24

286

Benign neoplasm of other and unspecified intrathoracic organs

110

2.46

4.17

2.4

1.2

3.53

3.95

g/l

1.12

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

586

2997

1.20

4.14

2.0

1.4

4.01

4.00

g/l

0.04

412

2178

Other aneurysm

108

721

1.53

4.12

2.0

2.4

3.97

3.83

g/l

0.34

517

Non-small cell lung cancer, squamous, helper endpoint

684

0.50

4.09

2.1

2.4

4.53

3.84

g/l

0.57

467

Non-small cell lung cancer, squamous

684

0.50

4.09

2.1

2.4

4.53

3.84

g/l

0.57

467

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

468

3866

1.22

4.09

2.6

2.2

3.77

3.86

g/l

0.68

345

2794

Alcohol dependence

477

3949

1.22

4.09

1.6

2.4

3.99

3.87

g/l

1.18

357

2840

Post-traumatic wound infection, not elsewhere classified

238

1.94

4.08

1.7

2.3

3.77

3.75

g/l

0.03

177

Benign neoplasm: Skin of other and unspecified parts of face

183

1346

1.38

4.07

3.5

1.4

3.76

3.83

g/l

0.27

100

941

Unspecified urinary incontinence

159

1144

1.41

4.06

1.4

2.2

3.68

3.74

g/l

0.19

808

Postprocedural musculoskeletal disorders, not elsewhere classified

133

928

1.46

4.06

2.2

2.5

3.84

3.81

g/l

0.09

668

Other and unspecified bullous disorders

118

2.40

4.06

3.2

2.0

3.75

3.80

g/l

0.05

Acidosis

218

1.99

4.06

2.0

2.2

3.81

3.82

g/l

0.03

162

Extreme obesity with alveolar hypoventilation

462

1.66

4.06

1.6

2.7

4.30

3.71

g/l

2.74

338

Impetigo

325

1.78

4.04

2.6

2.0

4.59

3.84

g/l

0.84

245

severe traumatic brain injury, does not include concussion

413

3376

1.23

4.04

2.3

2.2

3.89

3.82

g/l

0.47

280

2371

Colitis, primary sclerosing

2.50

4.03

2.0

3.91

3.75

g/l

0.31

Other noninflammatory disorders of uterus, except cervix

408

2262

1.24

4.02

2.4

2.2

3.86

3.76

g/l

0.32

267

1610

Salpingitis and oophoritis

278

2173

1.29

4.01

1.7

2.4

3.83

3.76

g/l

0.37

206

1562

Congenital iodine-deficiency syndrome/hypothyroidism

380

1.72

4.00

3.0

2.1

3.51

3.77

g/l

0.76

267

Malignant neoplasm of respiratory system and intrathoracic organs

289

3363

0.78

3.99

2.2

3.95

3.81

g/l

0.66

219

2339

Other ulcerative colitis

549

1.59

3.98

1.3

2.3

4.04

3.79

g/l

1.00

404

Acne vulgaris

393

1.69

3.98

2.0

1.6

3.79

3.83

g/l

0.09

303

Benign neoplasm of urinary organs

582

1.58

3.98

2.0

2.7

3.54

3.81

g/l

1.43

429

Lichen simplex chronicus

365

1.73

3.98

2.8

2.7

4.18

3.70

g/l

1.82

271

Dislocation, sprain and strain of joints and ligaments at neck level

196

1461

1.35

3.97

2.3

3.79

3.80

g/l

0.05

143

1077

Acute suppurative otitis media

266

1928

1.29

3.97

2.8

1.9

3.67

3.79

g/l

0.78

196

1425

Acute laryngitis and tracheitis

119

800

1.47

3.97

1.6

1.9

4.08

3.75

g/l

1.22

581

Premature rupture of membranes

109

1179

0.68

3.96

1.9

1.8

3.47

3.65

g/l

0.83

887

Exposure to other and unspecified animate mechanical forces

212

1.97

3.96

3.0

1.7

3.43

3.89

g/l

2.23

163

Drug-induced hypoglycaemia without coma

158

2.15

3.96

1.3

2.8

4.19

3.72

g/l

0.87

118

Hypertensive encephalopathy

3.34

3.96

2.5

2.4

3.71

3.72

g/l

—

Infective dermatitis

190

1413

1.36

3.95

1.8

2.4

4.09

3.78

g/l

1.85

114

1027

Cholangitis (primary sclerosing, PSC)

106

711

1.51

3.95

1.9

2.4

4.09

3.76

g/l

1.24

507

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

206

1552

1.34

3.92

2.5

1.4

3.63

3.85

g/l

1.34

135

1107

Other specified disorders of kidney and ureter

367

1.73

3.91

2.3

2.8

3.74

3.76

g/l

0.02

272

Exclusion endpoint for clefts

119

2.31

3.91

1.6

1.9

3.74

3.73

g/l

0.01

Benign neoplasm: Other and unspecified parts of small intestine

215

1.98

3.89

1.6

2.1

3.40

3.73

g/l

0.69

160

UC patients in KELA-register (code 208), prior to 1994

538

1.59

3.88

2.5

3.87

3.83

g/l

0.10

394

Noninflammatory disorders of female genital tract

639

2720

1.19

3.88

2.1

2.0

3.63

3.75

g/l

1.43

452

1969

Retinal breaks without detachment

285

2248

1.28

3.87

2.4

3.67

3.79

g/l

0.75

195

1614

Spinal osteochondrosis

2.55

3.86

1.4

2.0

3.48

3.66

g/l

0.39

Brachial plexus disorders

122

844

1.46

3.86

2.4

2.2

3.38

3.81

g/l

3.96

623

Parapsoriasis

194

2.01

3.85

1.7

2.4

3.82

3.75

g/l

0.08

146

Nystagmus and other irregular eye movements

114

2.35

3.84

1.7

2.2

3.49

3.74

g/l

0.54

Encephalopathy

102

2.46

3.84

1.8

2.5

3.80

3.76

g/l

0.03

Asthma mixed form (mode), excluding more controls

491

1.61

3.83

1.9

1.6

3.70

3.93

g/l

0.54

340

Corneal scars and opacities

280

1.83

3.83

1.7

2.6

3.57

3.77

g/l

0.74

203

Benign neoplasm of eye and adnexa

166

1216

1.38

3.83

1.7

1.4

3.73

3.85

g/l

0.55

119

842

Use of antiglaucoma preparations and miotics

165

1209

1.38

3.82

2.2

2.4

4.22

3.76

g/l

1.25

113

840

Benign neoplasm: Cerebral meninges

154

1115

1.40

3.82

2.0

1.4

3.46

3.82

g/l

3.77

109

783

Benign neoplasm of middle ear and respiratory system

131

922

1.44

3.81

2.5

1.4

3.57

3.90

g/l

2.64

101

659

Lung cancer and mesothelioma

344

2370

1.25

3.81

2.1

1.9

4.08

3.77

g/l

1.70

265

1647

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

134

949

1.43

3.78

2.0

2.5

3.84

3.80

g/l

0.15

688

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

137

881

1.42

3.78

1.4

1.6

3.53

3.77

g/l

1.57

105

653

Ill-defined and unknown causes of mortality

958

0.60

3.77

2.0

2.4

3.72

3.78

g/l

0.09

666

Lactose intolerance, other/unspecified

245

1.87

3.75

1.4

1.7

4.01

3.77

g/l

0.34

184

Ulcerative enterocolitis

289

1.80

3.74

1.8

2.3

4.04

3.75

g/l

0.94

204

Diffuse brain injury

296

1.78

3.74

2.5

1.9

4.21

3.90

g/l

0.75

216

Disseminated intravascular coagulation [defibrination syndrome]

3.73

3.74

1.7

1.6

3.50

3.62

g/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

316

2513

1.26

3.74

2.2

2.0

3.60

3.67

g/l

0.42

239

1825

Other specified and unspecified disorders of choroid

3.69

3.72

1.2

2.3

3.68

3.82

g/l

—

Dissection of aorta

396

1.68

3.71

1.6

2.7

3.76

3.78

g/l

0.04

287

Emotional disorders and disorders of social functioning with onset specific to childhood

159

2.06

3.69

1.1

1.4

3.59

3.70

g/l

0.20

127

Perichondritis of external ear

212

1.95

3.67

2.6

2.3

3.72

3.71

g/l

0.02

154

Congenital malformations of trachea and bronchus

2.45

3.67

2.7

1.9

3.50

3.66

g/l

0.27

Status post-ami

1072

0.66

3.66

1.5

2.3

3.67

3.80

g/l

0.46

726

Subacute thyroiditis

398

1.66

3.63

2.7

2.2

3.56

3.75

g/l

0.74

281

Other and unspecified trigeminal disorders

137

2.18

3.61

1.4

2.0

4.19

3.71

g/l

0.31

Alzheimer’s disease, wide definition

345

3537

0.81

3.61

1.8

2.2

3.90

3.76

g/l

0.58

215

2398

Other and unspecified mononeuropathies of upper limb

285

1.79

3.61

1.4

2.1

3.82

3.85

g/l

0.06

209

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

361

1.70

3.61

2.2

1.4

4.03

3.89

g/l

0.24

258

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

212

1.91

3.60

3.6

2.1

3.69

3.67

g/l

0.03

152

Thyrotoxicosis with diffuse goitre

206

1573

1.32

3.59

2.1

2.2

3.84

3.79

g/l

0.12

163

1136

Other disorders of central nervous system

105

2.36

3.59

1.2

1.8

3.40

3.76

g/l

0.74

Other secondary gonarthrosis

654

1.51

3.58

2.4

2.9

4.23

3.75

g/l

1.71

481

Cysts of oral region, not elsewhere classified

438

1.62

3.58

2.4

2.1

3.81

3.86

g/l

0.11

319

Sixth [abducent] nerve palsy

385

1.67

3.57

2.5

2.6

4.93

3.75

g/l

0.99

274

Benign neoplasm: Prostate

2.67

3.57

2.5

1.3

3.83

3.94

g/l

—

Injury of muscle and tendon at hip and thigh level

151

1103

1.38

3.56

2.1

2.3

3.51

3.83

g/l

2.55

109

809

Burns and corrosions

195

1480

1.33

3.56

1.9

2.2

3.95

3.84

g/l

0.43

137

1092

Viral encephalitis, not elsewhere classified/unspecified

207

1.93

3.56

3.5

2.4

4.27

3.76

g/l

0.32

151

Other neurotic disorders

574

1.54

3.55

1.5

2.5

3.77

3.82

g/l

0.14

417

Degenerative diseases of the nervous system

526

4665

0.84

3.54

1.8

2.2

3.91

3.78

g/l

0.77

323

3192

Achilles tendinitis

161

1189

1.37

3.54

2.5

2.1

3.83

3.88

g/l

0.12

116

888

Melanoma in situ of other and unspecified parts of face

167

2.07

3.52

2.3

2.5

3.50

3.63

g/l

0.32

120

Chronic myeloid leukaemia [CML], BCR/ABL-positive

113

2.32

3.52

1.5

2.7

3.61

3.79

g/l

0.28

Arthropathy in ulcerative colitis

119

2.26

3.51

1.6

1.8

3.87

3.81

g/l

0.06

Orchitis and epididymitis

154

1132

1.37

3.50

1.9

2.2

3.83

3.97

g/l

0.68

106

820

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

118

830

1.44

3.50

3.2

1.4

3.95

3.84

g/l

0.15

590

Chronic iridocyclitis

544

1.55

3.49

2.1

2.4

4.07

3.75

g/l

0.92

394

Tongue abnormality

112

781

1.46

3.49

2.5

3.70

3.74

g/l

0.07

570

Sleep disorders, other/unspecified

251

1.82

3.49

1.4

1.8

3.55

3.83

g/l

1.09

192

Injury of nerves at lower leg level

2.43

3.48

1.2

1.9

3.31

4.04

g/l

2.17

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

575

2933

1.18

3.48

2.0

1.4

4.01

3.99

g/l

0.07

403

2127

Otorrhagia

2.64

3.48

2.4

2.5

3.88

3.75

g/l

0.11

Benign neoplasm: Kidney

411

1.64

3.48

2.1

2.6

3.36

3.67

g/l

1.87

298

Postzoster neuralgia

160

2.07

3.48

3.4

2.1

3.40

3.67

g/l

0.67

110

Complications of other internal prosthetic devices, implants and grafts

466

1.60

3.47

1.9

2.3

3.77

3.73

g/l

0.09

339

Complications of genitourinary prosthetic devices, implants and grafts

267

1.80

3.46

1.8

1.9

4.00

3.76

g/l

0.62

194

Unspecified event, undetermined intent

223

1.88

3.46

2.4

2.7

3.40

3.75

g/l

1.32

169

Other disorders of pigmentation

506

1.57

3.45

2.9

2.1

3.64

3.74

g/l

0.29

373

Malnutrition

210

1.91

3.42

1.6

2.2

3.33

3.70

g/l

0.82

145

Ectropion of eyelid

548

1.55

3.41

1.5

2.4

3.94

3.91

g/l

0.06

361

Oesophageal obstruction

437

1.61

3.40

2.8

2.9

3.88

3.82

g/l

0.13

325

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

239

1.83

3.39

2.0

3.67

3.78

g/l

0.36

178

Other blood glucose lowering drugs, excl. Insulins

323

2629

1.24

3.39

1.7

2.3

4.08

3.76

g/l

3.65

223

1875

Type 1 diabetes, strict definition, subgroup 1

380

1.64

3.38

1.4

1.5

3.37

3.82

g/l

2.24

286

Atopic conjunctivitis

359

1.67

3.37

1.4

1.9

3.75

g/l

0.01

259

Fasciculation

115

2.25

3.36

1.6

1.9

3.36

3.88

g/l

1.18

Focal epilepsy, strict definition

317

2575

1.24

3.36

2.1

2.2

3.68

3.81

g/l

0.67

210

1830

Secondary parkinsonism, excluding more controls

233

1.84

3.34

2.7

2.2

3.96

3.73

g/l

0.23

167

Benign neoplasm: Anus and anal canal

323

1.71

3.34

2.8

1.5

3.63

3.88

g/l

0.92

229

Left hemicolectomy

301

1.74

3.33

2.5

2.6

4.70

3.73

g/l

2.44

222

Other, unspecified and serous retinal detachments

354

1.67

3.33

1.9

2.6

3.87

3.76

g/l

0.32

263

Spontaneous rupture of synovium and tendon

137

998

1.39

3.32

1.8

2.2

3.69

3.83

g/l

0.55

714

Other ill-defined and unspecified causes of mortality

839

0.60

3.32

1.5

2.4

3.79

3.81

g/l

0.01

583

Organic, including symptomatic, mental disorders

1036

6666

1.13

3.32

2.0

2.3

3.85

3.81

g/l

0.37

660

4699

Herpesviral keratitis and keratoconjunctivitis

487

1.57

3.32

2.9

2.4

3.72

3.80

g/l

0.17

361

Muscle strain

248

1.80

3.31

2.3

2.2

5.64

3.88

g/l

0.57

179

Congenital malformations of the musculoskeletal system, not elsewhere classified

2.35

3.31

1.4

2.0

3.60

3.66

g/l

0.09

2.48

3.30

1.8

1.9

3.34

3.94

g/l

1.20

Use of rivastigmine

171

2240

0.75

3.30

1.9

2.3

3.78

3.75

g/l

0.05

120

1501

Benign neoplasm: Skin of eyelid, including canthus

278

2234

1.26

3.29

3.1

2.3

3.63

3.79

g/l

1.39

198

1591

Nasal polyp

336

2754

1.23

3.29

2.8

2.3

4.24

3.87

g/l

0.92

245

1989

Scabies

370

1.64

3.27

2.0

1.9

3.68

3.84

g/l

0.49

277

Hyperfunction of pituitary gland

401

1.62

3.27

2.9

1.9

3.75

g/l

0.00

299

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

335

2748

1.23

3.26

2.3

1.4

3.75

3.85

g/l

0.75

225

1911

Personal history of malignant neoplasm

426

1.60

3.26

4.2

1.9

3.67

3.73

g/l

0.16

322

Focal brain injury

675

1.47

3.24

2.0

2.2

3.87

3.86

g/l

0.02

478

Alzheimer’s disease (Early onset), excluding more controls

461

0.48

3.23

1.0

2.1

4.24

3.77

g/l

0.92

323

Central retinal artery occlusion

282

1.75

3.20

3.7

2.4

3.99

3.67

g/l

1.02

204

Gluteal tendinitis

381

1.63

3.19

2.0

2.1

3.68

3.75

g/l

0.18

279

Corns and callosities

115

820

1.42

3.19

2.0

2.3

3.49

3.80

g/l

2.07

588

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

198

1531

1.30

3.18

1.9

2.1

3.67

3.69

g/l

0.09

144

1100

Contact with sharp object, undetermined intent

172

1.96

3.18

2.0

3.64

3.91

g/l

0.58

125

Allergic contact dermatitis due to drugs in contact with skin

245

1.80

3.17

1.5

2.0

4.30

3.74

g/l

1.65

181

Paralytic strabismus

124

897

1.40

3.17

2.0

2.4

4.20

3.80

g/l

0.61

657

Autonomic disorders

223

1.84

3.16

2.1

2.3

4.00

3.77

g/l

0.33

166

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

173

1.96

3.16

1.5

1.3

3.49

3.88

g/l

1.34

118

Malignant neoplasm of other connective and soft tissue

283

1.74

3.16

3.4

2.6

4.32

3.69

g/l

0.50

202

Viral meningitis

297

1.71

3.16

1.9

2.0

3.63

3.79

g/l

0.39

222

Hydrocele

210

1641

1.29

3.15

2.5

2.4

3.68

3.98

g/l

2.08

151

1182

Congenital malformations of the respiratory system

152

2.02

3.15

2.3

2.1

3.78

3.72

g/l

0.09

111

Disturbance of activity and attention

414

1.58

3.15

1.4

3.45

3.81

g/l

1.99

308

Benign neoplasm: Skin of ear and external auricular canal

510

1.54

3.15

2.5

4.36

3.81

g/l

0.57

374

Arterial embolism and thrombosis of lower extremity artery

454

1.57

3.14

1.5

2.7

3.81

3.76

g/l

0.13

330

Corneal ulcer

269

2166

1.25

3.12

2.2

3.84

3.80

g/l

0.18

200

1564

Crohn's disease of large intestine

486

1.54

3.11

1.6

2.3

4.08

3.73

g/l

1.41

359

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

119

2.17

3.11

2.7

2.3

3.25

3.78

g/l

1.74

Meralgia paraesthetica

345

1.65

3.11

1.5

2.3

4.10

3.84

g/l

0.49

249

Single delivery by forceps and vacuum extractor

665

0.66

3.10

1.3

1.6

3.72

3.70

g/l

0.04

516

Focal epilepsy

336

2771

1.22

3.10

2.1

2.2

3.71

3.82

g/l

0.58

220

1973

Other disorders of binocular movement

174

1.93

3.08

1.7

1.8

3.59

3.76

g/l

0.31

128

Pre-eclampsia or eclampsia

268

2160

1.25

3.08

2.3

2.1

3.64

3.68

g/l

0.21

183

1577

Benign neoplasm: Lip

218

1.83

3.07

3.4

1.4

3.87

3.93

g/l

0.07

155

Abnormal blood-pressure reading, without diagnosis

448

1.56

3.07

2.3

2.4

3.89

3.82

g/l

0.15

316

Septal defects

516

1.51

3.06

1.7

2.3

3.61

3.78

g/l

0.87

382

Other and unspecified mononeuropathies, also in other diseases

331

1.66

3.06

1.8

2.2

3.66

3.77

g/l

0.30

236

Other diseases of spinal cord

308

1.69

3.06

3.4

2.7

3.64

3.72

g/l

0.16

228

Injury of intra-abdominal organs

218

1.82

3.05

3.0

2.3

3.77

3.90

g/l

0.27

161

Redundant prepuce, phimosis and paraphimosis

292

2367

1.23

3.05

2.0

2.3

4.08

3.99

g/l

0.43

210

1723

Sequelae of injuries of neck and trunk

293

1.70

3.05

2.5

2.7

4.04

3.85

g/l

0.44

217

Assault by bodily force

553

1.50

3.03

1.6

2.1

3.93

3.87

g/l

0.14

411

Emotional disorders starting during childhood or adolescence

152

1.97

3.03

1.1

1.4

3.51

3.70

g/l

0.35

122

Injury of muscle and tendon at lower leg level

244

1952

1.26

3.03

2.5

2.3

3.71

3.88

g/l

0.98

181

1418

Sensorineural hearing loss

1510

9654

1.10

3.03

2.4

2.3

3.66

3.87

g/l

4.99

922

7004

Hyperkinetic disorders

450

1.54

3.02

1.4

1.5

3.49

3.80

g/l

1.67

339

Other acute disseminated demyelination

2.47

3.01

1.4

2.6

3.31

3.79

g/l

0.83

Polyp of the female genital tract

510

2531

1.18

3.01

1.8

2.1

3.72

3.77

g/l

0.34

368

1824

Complications of labour and delivery

731

4642

0.88

3.01

2.4

2.2

3.73

3.72

g/l

0.09

528

3346

Ingrowing nail

507

1.52

2.99

1.7

2.4

4.07

3.71

g/l

0.72

374

Other mental disorders due to brain damage and dysfunction and to physical disease

210

1655

1.28

2.99

2.6

2.3

3.88

3.77

g/l

0.39

131

1183

Episcleritis

532

1.50

2.98

1.4

2.1

3.98

3.77

g/l

0.56

387

Other inflammation of vagina/vulva

257

1.73

2.96

1.2

2.1

3.65

3.76

g/l

0.33

200

Schizophrenia

139

1849

0.75

2.95

2.4

2.2

3.65

3.85

g/l

0.74

1356

Benign neoplasm: Appendix

122

2.13

2.95

1.4

1.3

4.18

3.95

g/l

0.26

Convergent concomitant strabismus

468

1.53

2.94

2.2

2.0

3.83

3.78

g/l

0.06

345

Laparoscopic right hemicolectomy

107

767

1.42

2.94

2.1

2.7

3.71

3.78

g/l

0.26

555

Benign neoplasm: Tongue

289

1.69

2.93

3.9

1.3

3.81

3.86

g/l

0.10

208

Other disorders of the genitourinary system

230

1837

1.26

2.93

2.1

2.3

3.72

3.75

g/l

0.14

168

1303

Atrophic disorders of skin

221

1756

1.27

2.92

2.0

2.1

3.75

3.77

g/l

0.06

165

1240

Atrial septal defect

302

1.67

2.91

2.0

3.80

3.76

g/l

0.09

230

Asthma mixed form (mode)

526

1.50

2.91

1.9

1.7

3.70

3.90

g/l

0.45

366

Contusion of toe(s) without damage to nail

178

1.89

2.90

1.2

2.4

3.44

3.69

g/l

0.99

140

Injury of nerves and spinal cord at neck level

245

1.75

2.89

2.7

2.9

3.83

3.76

g/l

0.15

186

Haemangioma, any site

133

989

1.36

2.89

2.6

2.4

3.51

3.78

g/l

1.96

718

Burns and corrosions of external body surface, specified by site

150

1135

1.33

2.88

2.1

2.3

4.04

3.82

g/l

0.74

102

843

Other and unspecified disorders of autonomic nervous system

3.24

2.88

1.3

3.4

3.58

3.62

g/l

—

Haemorrhagic disorder due to circulating anticoagulants

144

2.01

2.88

1.9

2.1

4.41

3.71

g/l

1.56

107

Benign neoplasm of breast

198

1557

1.28

2.87

2.2

3.64

3.71

g/l

0.38

136

1104

Flat foot [pes planus] (acquired)

135

1007

1.35

2.86

1.8

2.5

3.89

3.64

g/l

0.79

713

Injury of other and unspecified intrathoracic organs

103

736

1.42

2.86

1.7

2.3

3.71

3.83

g/l

0.46

534

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

5.74

2.86

9.3

1.0

3.30

4.14

g/l

—

Haemangioma and lymphangioma, any site

140

1051

1.35

2.86

2.9

2.4

3.50

3.79

g/l

2.16

763

Myopia

144

1084

1.34

2.85

1.9

2.2

3.90

3.83

g/l

0.15

105

789

Malignant melanoma

270

2203

1.24

2.84

2.1

2.4

3.57

3.83

g/l

3.00

197

1564

Migraine, single triptan purchase ok & required. ICD-code if available is included

1157

7085

1.11

2.83

2.1

2.2

3.67

3.80

g/l

2.31

851

5119

Triptan medication for migraine, single purchase ok

1157

7085

1.11

2.83

2.1

2.2

3.67

3.80

g/l

2.31

851

5119

Benign neoplasm of other and unspecified intrathoracic organs

131

2.06

2.83

2.4

2.1

3.53

3.76

g/l

0.51

Other and unspecified diseases of spleen

3.02

2.82

4.1

2.9

2.88

3.87

g/l

—

Carcinoma in situ of rectum

2.30

2.81

1.5

1.2

3.95

3.86

g/l

0.09

Strabismus

383

3225

1.19

2.81

2.2

3.81

3.80

g/l

0.02

268

2305

Aortic valve malfunction, age under 60 years

138

1037

1.34

2.80

1.8

2.3

4.15

3.85

g/l

1.24

106

768

Single spontaneous delivery

537

3306

0.86

2.80

2.5

2.0

3.65

3.71

g/l

0.50

389

2359

Epiphora

263

1.71

2.79

2.6

2.3

3.61

3.76

g/l

0.39

185

Abnormality of red blood cells

2.64

2.78

2.1

1.2

3.31

3.65

g/l

—

Palindromic rheumatism

2.21

2.76

1.3

1.6

3.59

g/l

0.01

Benign neoplasm: Other parts of oropharynx

2.31

2.76

3.1

1.2

4.15

4.00

g/l

0.09

Left ventricular outflow tract obstruction (LVOTO), broad definition

144

1092

1.33

2.75

1.8

2.3

4.14

3.86

g/l

1.14

111

811

Pre-eclampsia or poor fetal growth

330

2744

1.20

2.75

2.3

2.0

3.57

3.67

g/l

0.85

229

2018

Abdominal aortic aneurysm (AAA)

198

1554

1.28

2.74

1.9

2.3

3.77

3.82

g/l

0.19

140

1048

Pigmented purpuric dermatosis

119

2.10

2.74

2.5

2.8

4.01

3.62

g/l

0.76

Blindness, monocular

2.25

2.73

4.8

2.0

4.18

3.71

g/l

—

Medical abortion

1006

4914

1.12

2.72

1.8

2.3

3.73

3.71

g/l

0.18

735

3438

Atlantoaxial subluxation

2.43

2.72

1.3

1.7

3.86

3.65

g/l

0.18

Delivery

543

3310

0.86

2.70

2.4

2.0

3.66

3.71

g/l

0.39

394

2362

Other abnormal findings in urine

176

1.87

2.70

5.7

2.3

4.04

3.77

g/l

0.62

122

Prolonged pregnancy

883

0.67

2.69

1.5

1.7

3.49

3.65

g/l

0.69

661

Benign neoplasm: Prostate

2.29

2.66

2.5

2.9

3.83

3.68

g/l

—

Other arterial embolism and thrombosis

353

1.59

2.64

1.3

2.5

3.65

3.76

g/l

0.23

251

Trigeminal neuralgia

672

1.42

2.63

2.6

2.3

3.90

3.81

g/l

0.20

484

Use of galantamine

1063

0.69

2.62

1.2

2.3

3.86

3.78

g/l

0.30

719

Benign neoplasm: Liver/bile ducts

207

1.77

2.61

2.5

1.3

3.89

3.85

g/l

0.05

151

Moderate visual impairment, binocular

346

1.59

2.61

1.7

1.9

3.59

3.71

g/l

0.27

242

Behavioural disorders, excluding more controls

2.27

2.61

1.3

2.5

3.77

3.90

g/l

0.13

Delivery, wide proxy

451

2794

0.85

2.61

2.3

2.0

3.72

3.71

g/l

0.04

321

1969

Malignant neoplasm of parotid gland

101

2.17

2.61

1.2

1.9

3.21

3.84

g/l

1.73

Other and unspecified mononeuropathies of lower limb

299

1.63

2.61

1.7

2.1

3.51

3.76

g/l

1.11

209

Granulomatous disorders of skin and subcutaneous tissue

245

1.70

2.60

3.0

1.9

3.61

3.78

g/l

0.41

188

Other meningitis

149

1.92

2.60

2.1

3.77

3.71

g/l

0.07

111

Senility

2.34

2.59

1.6

1.5

3.62

3.84

g/l

—

Unspecified threat to breathing

2.29

2.58

2.3

2.0

3.23

3.81

g/l

2.07

Hypertrophy of tongue papillae

129

2.00

2.56

1.7

2.0

3.70

3.78

g/l

0.14

Chronic hepatitis NAS

136

1.96

2.56

1.4

2.1

4.02

3.77

g/l

0.51

105

Other puerperal infections

427

1.51

2.54

1.2

1.6

3.50

3.70

g/l

0.97

320

Peroneal tendinitis

122

2.01

2.54

2.2

1.9

3.52

3.74

g/l

0.53

Pulmonary eosinophilia, not elsewhere classified

144

1.93

2.52

1.2

2.0

3.77

3.80

g/l

0.06

103

Benign neoplasm of meninges

177

1399

1.28

2.52

1.9

2.4

3.49

3.75

g/l

2.37

123

987

Contact with heat and hot substances

494

1.47

2.52

1.8

2.3

4.03

3.82

g/l

0.70

369

Crohn disease (strict definition, require KELA)

552

1.44

2.51

1.7

2.1

3.86

3.78

g/l

0.19

408

Hyperprolactinaemia

255

1.67

2.51

3.3

1.7

3.73

3.85

g/l

0.27

187

319

1.60

2.50

2.1

2.7

3.98

3.71

g/l

0.66

217

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

109

1457

0.74

2.49

2.8

2.3

3.77

3.81

g/l

0.10

1040

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

124

936

1.34

2.49

2.8

1.4

3.71

3.82

g/l

0.41

658

Focal epilepsy, mode (most common among epilepsy diagnosis)

289

2408

1.21

2.49

2.2

3.72

3.81

g/l

0.38

185

1705

Intentional self-harm by unspecified means

2.43

2.49

1.2

1.7

4.01

3.91

g/l

—

Myocardial infarction, with ST-elevation

336

2841

1.19

2.48

1.7

2.2

3.83

3.84

g/l

0.09

244

1988

Lateral epicondylitis

183

1454

1.27

2.47

1.8

2.2

3.93

3.85

g/l

0.21

120

1059

Alzheimer’s disease (Late onset)

322

3267

0.84

2.47

1.8

2.2

3.88

3.76

g/l

0.43

197

2214

Congenital malformations of heart and great arteries

162

1228

1.29

2.46

2.0

2.3

3.61

3.83

g/l

1.67

116

907

Chronic Coagulation defects

219

1.72

2.45

2.8

1.7

3.36

3.82

g/l

1.72

161

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

580

0.60

2.43

2.1

1.4

4.53

3.84

g/l

0.56

408

Melanocytic naevi of upper limb, including shoulder

212

1.73

2.43

2.0

1.3

3.55

3.90

g/l

1.06

154

Pre-eclampsia

237

1941

1.23

2.43

2.5

2.1

3.65

3.67

g/l

0.10

157

1418

Varicella [chickenpox]

352

1.55

2.42

5.4

1.9

4.26

3.89

g/l

0.36

261

Campylobacter enteritis

266

1.64

2.42

2.0

2.4

3.60

3.76

g/l

0.37

194

Colorectal cancer, excluding all cancers (controls excluding all cancers)

477

4015

1.15

2.42

2.2

1.4

3.76

3.85

g/l

0.96

324

2828

Manic episode

258

1.65

2.41

1.9

2.2

3.75

3.76

g/l

0.02

189

Benign neoplasm of bone and articular cartilage

106

785

1.36

2.41

1.5

1.3

3.71

3.82

g/l

0.32

563

Later onset COPD

602

4177

1.14

2.40

1.6

2.3

3.90

3.82

g/l

0.69

447

2857

Appendectomy

1013

8873

1.10

2.40

2.2

3.74

3.82

g/l

0.76

750

6378

Pedestrian injured in transport accident

104

770

1.36

2.39

1.5

2.3

3.79

3.76

g/l

0.07

564

Optic neuritis

378

1.53

2.38

1.5

2.2

3.47

3.75

g/l

1.12

279

Otitis media, unspecified

114

786

1.34

2.37

2.8

2.1

3.51

3.76

g/l

1.56

577

Crohn disease (strict definition, require KELA, min 2 HDR)

542

1.43

2.37

1.8

2.1

3.88

3.77

g/l

0.27

403

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

436

1.49

2.36

2.8

1.4

3.43

3.90

g/l

2.70

318

Inflammatory disorders of male genital organs, not elsewhere classified

133

1.93

2.35

1.1

3.0

4.41

3.85

g/l

0.46

Maternal care for known or suspected fetal abnormality and damage

131

891

1.31

2.35

1.7

3.54

3.64

g/l

0.53

113

668

Burn and corrosion of wrist and hand

307

1.58

2.35

1.6

2.1

3.83

g/l

0.01

227

Anorexia (incl.atypical)

427

1.49

2.35

3.1

1.7

3.44

3.78

g/l

1.62

320

Other factor of the environment

119

1.98

2.35

3.8

1.4

3.53

3.79

g/l

0.44

Polypectomy (DHB20)

112

844

1.34

2.31

2.5

2.4

3.98

3.87

g/l

0.40

632

Adenocarcinoma and papilloma adenocarcinoma of rectum

105

1393

0.75

2.31

2.9

2.3

3.76

3.81

g/l

0.13

996

Malignant neoplasm of rectum

106

1404

0.75

2.30

2.5

2.4

3.64

3.81

g/l

0.74

997

Melanoma in situ of trunk

149

1.87

2.30

2.8

1.3

3.62

3.93

g/l

0.56

102

Open wound of wrist and hand

648

5715

1.13

2.30

2.3

2.2

3.78

3.86

g/l

0.64

479

4128

Medial epicondylitis

357

1.53

2.30

1.4

2.0

3.58

3.84

g/l

0.90

250

Benign neoplasm: Connective and other soft tissue, unspecified

106

2.03

2.29

1.4

1.5

3.33

3.92

g/l

1.32

Amputation of ankle bones

255

1.64

2.29

2.0

2.7

4.02

3.71

g/l

0.62

182

Impotence

657

1.39

2.29

1.9

2.3

3.72

4.01

g/l

1.43

472

Postpartum haemorrhage

156

1716

0.79

2.28

1.9

2.0

3.68

3.65

g/l

0.08

105

1294

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

708

1.37

2.28

3.0

1.4

3.81

3.80

g/l

0.02

503

Acute lymphadenitis

530

1.43

2.28

2.5

2.3

3.52

3.77

g/l

1.04

390

All dysplastic lesions of the cervix uteri

251

2078

1.21

2.27

2.3

2.0

3.65

g/l

0.02

189

1520

Conduct disorder

2.04

2.27

1.3

2.0

3.77

3.81

g/l

0.04

Benign neoplasm: other/unspecified salivary gland

319

1.56

2.26

1.6

1.4

3.98

3.87

g/l

0.13

232

Suppurative and unspecified otitis media

422

3240

1.16

2.26

2.5

2.0

3.68

3.79

g/l

0.99

309

2360

Glaucoma

1101

8854

1.10

2.26

2.2

2.3

3.81

g/l

0.01

721

6259

Scar conditions and fibrosis of skin

375

1.51

2.25

2.0

3.96

3.72

g/l

0.55

274

Disorders of porphyrin and bilirubin metabolism

100

2.05

2.24

3.6

1.9

3.34

3.79

g/l

1.62

Contracture of joint

114

1.97

2.24

1.3

1.7

4.13

3.65

g/l

0.79

Benign neoplasm: Anus and anal canal

360

1.53

2.24

2.8

2.5

3.63

3.78

g/l

0.43

258

Dental caries 2, only avohilmo

1133

8193

1.09

2.22

2.5

2.2

3.76

3.81

g/l

0.45

855

5906

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

600

1.39

2.22

1.7

2.1

3.86

3.83

g/l

0.07

445

Melanocytic naevi of scalp and neck

195

1.72

2.22

2.5

1.4

3.54

3.90

g/l

1.10

145

Contusion of ankle

320

1.55

2.21

1.6

2.1

3.81

3.77

g/l

0.09

238

Burns and corrosions of multiple and unspecified body regions

203

1.70

2.21

1.9

2.2

4.09

3.72

g/l

0.99

152

Other specified disorders of external ear

460

1.46

2.20

1.9

2.6

3.87

3.89

g/l

0.03

342

Undefined dementia

137

1604

0.78

2.20

1.6

2.1

3.84

3.77

g/l

0.19

1062

Hordeolum and other deep inflammation of eyelid

552

1.41

2.18

2.7

2.6

3.62

3.86

g/l

0.95

410

Thyroiditis, unspecified

167

1.78

2.15

1.2

1.6

3.63

3.80

g/l

0.37

126

Other proliferative retinopathy

2.82

2.15

1.2

2.6

3.88

3.43

g/l

—

Contact with and exposure to communicable diseases

312

2644

1.18

2.15

2.2

2.0

3.77

3.74

g/l

0.07

149

1982

Orthopaedic devices associated with adverse incidents

221

1.67

2.15

1.1

2.4

3.86

3.68

g/l

0.17

156

Pedestrian injured in collision with pedal cycle

339

1.53

2.15

1.7

2.4

3.81

3.70

g/l

0.19

244

Dental pulpitis 3

281

1.49

2.15

1.1

1.2

3.64

3.57

g/l

0.17

225

Desensitization to allergens

330

1.53

2.14

1.5

1.7

4.01

3.84

g/l

0.36

249

Ulcer of vagina/vulva

228

1.65

2.14

2.2

3.95

3.60

g/l

1.12

176

Retinal haemorrhage

300

1.56

2.13

4.6

2.7

4.32

3.65

g/l

0.62

220

Benign lipomatous neoplasm of other sites/unspecified

142

1119

1.28

2.13

3.0

1.4

3.51

3.84

g/l

2.24

777

Benign neoplasm of male genital organs

229

1.65

2.12

2.0

1.4

3.45

3.97

g/l

1.86

166

Melanocytic naevi of upper limb, including shoulder

221

1.66

2.12

2.0

2.5

3.55

3.74

g/l

0.46

165

Graves ophthalmopathy, strict

229

1.65

2.12

1.2

1.8

4.33

3.79

g/l

0.30

173

conjunctival haemorrhage

129

1006

1.30

2.11

2.6

2.3

3.62

3.80

g/l

1.06

724

Benign neoplasm: Ill-defined sites within the digestive system

2.27

2.10

1.1

4.02

3.96

g/l

—

Other lesions of median nerve

325

1.53

2.10

1.2

2.2

3.51

3.77

g/l

0.99

226

Other bacterial agents as the cause of diseases classified to other chapters

103

2.00

2.10

4.7

2.3

4.47

3.67

g/l

0.51

Prepatellar bursitis

481

1.43

2.09

1.8

2.1

3.78

3.90

g/l

0.35

343

Oral lichen ruber planus, including avohilmo

737

1.35

2.09

2.4

2.5

3.66

3.74

g/l

0.26

521

HSIL lesion of the cervix uteri, vagina or vulva

200

1639

1.23

2.09

2.1

2.0

3.72

3.67

g/l

0.20

150

1182

Use of disulfiram, acamprosate or naltrexone

119

919

1.30

2.08

1.6

2.3

3.91

3.87

g/l

0.13

679

Vascular dementia (subcortical)

408

1.47

2.08

2.2

3.87

3.69

g/l

0.52

282

Sudden idiopathic hearing loss

171

1382

1.25

2.07

2.1

2.2

3.80

3.84

g/l

0.07

113

1024

Hyperosmolality and hypernatraemia

147

1.81

2.07

1.9

2.1

3.71

3.74

g/l

0.04

108

Benign neoplasm: Appendix

140

1.84

2.07

1.4

1.9

4.19

3.83

g/l

0.45

Other disorders of choroid

162

1.77

2.06

1.7

3.2

3.69

3.75

g/l

0.09

116

Recurrent dislocation of patella

269

1.57

2.06

1.5

1.8

3.85

3.58

g/l

0.72

186

Systemic sclerosis,strict definition

2.02

2.05

1.2

1.7

3.13

3.77

g/l

1.98

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

319

1.53

2.05

3.1

1.4

4.23

3.88

g/l

0.92

220

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

559

1.39

2.04

3.1

1.4

3.63

3.86

g/l

0.89

385

Asymptomatic human immunodeficiency virus [HIV] infection status

2.71

2.04

1.1

2.2

3.81

3.90

g/l

—

Other facial nerve disorders

279

1.56

2.03

2.3

2.2

3.52

3.72

g/l

0.54

201

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

118

1.89

2.03

2.8

1.9

3.15

3.87

g/l

2.48

Complications peculiar to reattachment and amputation

2.22

2.03

1.6

2.6

3.87

3.62

g/l

—

Malignant neoplasm of digestive organs

605

6639

0.89

2.02

2.0

2.3

3.80

3.83

g/l

0.21

419

4638

Varicose veins of other sites

741

1.33

2.01

2.5

3.98

3.78

g/l

0.45

543

Behavioural disorders

2.02

2.01

1.3

2.1

3.77

3.84

g/l

0.07

Paralytic ileus

452

1.44

2.01

3.5

2.4

4.08

3.97

g/l

0.16

329

Benign neoplasm of eye and adnexa

166

1343

1.25

2.01

1.7

2.4

3.73

3.79

g/l

0.22

119

962

Endometriosis of pelvic peritoneum

189

1527

1.23

2.01

1.4

2.1

3.54

3.77

g/l

1.34

126

1114

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

120

932

1.30

2.01

2.5

2.4

3.52

3.83

g/l

1.85

655

Benign neoplasm: Skin of lip

141

1.82

2.01

2.0

1.3

3.92

g/l

0.00

Schizophrenia or delusion, excluding more controls

395

3417

1.15

2.00

1.9

2.2

3.78

3.82

g/l

0.24

272

2472

Melanocytic naevi of lip

2.14

2.00

1.3

1.2

3.38

3.88

g/l

—

Conductive hearing loss, unspecified

127

996

1.29

2.00

2.0

2.3

3.83

3.80

g/l

0.05

738

Sequelae of injuries of head

528

1.40

1.99

2.8

2.4

3.87

3.85

g/l

0.06

388

Right hemicolectomy

107

822

1.32

1.99

3.0

2.5

3.79

3.85

g/l

0.15

595

Crohn disease (strict definition, all UC cases excluded)

444

1.43

1.99

1.6

2.2

3.82

g/l

0.00

328

Vascular dementia (mixed)

187

1.70

1.98

2.5

2.1

3.91

3.71

g/l

0.36

129

Other acquired deformities of musculoskeletal system and connective tissue

529

1.40

1.98

2.4

2.3

3.77

3.75

g/l

0.04

384

Other specified/unspecified dorsopathies

362

1.48

1.98

4.2

2.1

3.81

3.77

g/l

0.06

266

Disorder of the sleep-wake schedule

134

1.82

1.98

1.1

1.9

4.30

3.83

g/l

0.74

101

Meningitis

512

1.40

1.97

2.9

2.4

3.51

3.73

g/l

0.80

380

Juvenile osteochondrosis

233

1.60

1.97

1.3

2.1

4.00

3.84

g/l

0.35

178

Effects of other external causes

202

1.65

1.97

1.6

2.3

3.45

3.81

g/l

1.22

146

Oral lichen ruber planus

290

1.55

1.97

2.4

2.3

3.65

3.75

g/l

0.27

213

Unspecified dementia

137

1549

0.79

1.96

1.6

2.2

3.84

3.74

g/l

0.29

1058

Parkinson's disease, including avohilmo

295

2526

1.18

1.96

1.9

2.3

3.68

3.83

g/l

1.01

205

1769

Acute alcohol intoxication, ICD10

284

2422

1.18

1.96

1.3

2.3

4.04

3.84

g/l

1.50

218

1762

Malignant neoplasm of ovary

606

0.65

1.96

2.2

3.48

3.71

g/l

0.67

437

Other drug-induced secondary parkinsonism

106

1.95

1.96

1.9

2.1

3.66

3.71

g/l

—

Diseases of appendix

1223

10323

1.08

1.95

2.4

2.2

3.72

3.85

g/l

1.95

895

7431

Other and unspecified injuries of wrist and hand

330

1.50

1.95

1.1

1.9

3.69

3.80

g/l

0.22

251

Volvulus

282

1.55

1.95

1.7

2.2

3.76

3.75

g/l

0.01

210

Other and unspecified acute skin changes due to ultraviolet radiation

315

1.52

1.94

1.9

2.4

3.85

3.75

g/l

0.19

225

Other strabismus

279

2371

1.18

1.94

2.2

3.75

3.78

g/l

0.08

203

1722

Meningococcal infection

2.30

1.94

4.2

2.5

4.07

3.64

g/l

—

Iliotibial band syndrome

2.00

1.93

2.4

1.7

3.22

3.74

g/l

1.52

Contusion of other and unspecified parts of foot

372

1.46

1.92

2.3

2.2

3.51

3.69

g/l

0.52

274

Respiratory tuberculosis, confirmed

220

1.62

1.91

1.7

2.5

3.59

3.83

g/l

0.34

155

Dislocation of lens

166

1.72

1.91

2.8

2.7

3.34

3.61

g/l

0.74

125

Open wound of shoulder and upper arm

181

1.69

1.91

1.6

2.1

3.58

3.81

g/l

0.29

128

Other acute skin changes due to ultraviolet radiation

415

1.44

1.91

1.7

2.2

3.87

3.77

g/l

0.24

305

Hereditary ataxia

136

1.81

1.91

1.3

2.4

3.78

3.76

g/l

0.02

103

Lifestyle-related condition

114

1.89

1.91

4.0

1.4

3.39

3.79

g/l

0.73

Retrobulbar neuritis in diseases classified elsewhere

3.30

1.91

5.4

1.0

3.69

3.85

g/l

—

Acute appendicitis

1121

9778

1.08

1.90

2.4

2.2

3.73

3.85

g/l

1.60

826

7062

Disorders of eyelid in diseases classified elsewhere

349

1.48

1.90

1.1

2.5

3.85

3.86

g/l

0.03

259

Osteomyelitis of vertebra

2.64

1.89

5.8

1.2

3.94

3.63

g/l

—

Other and unspecified injuries of ankle and foot

333

1.49

1.88

1.3

2.1

3.58

3.71

g/l

0.42

249

Other infective (teno)synovitis

2.61

1.88

1.2

3.28

3.42

g/l

—

Carcinoma in situ of rectum

108

1.92

1.87

1.6

1.7

3.95

3.77

g/l

0.19

Surgical ablation of atrial fibrillation

2.22

1.87

1.1

1.4

4.37

3.71

g/l

—

Mental and behavioural disorders due to tobacco

123

970

1.28

1.87

1.7

2.5

3.91

3.78

g/l

0.26

719

HSIL lesion of the cervix uteri

172

1407

1.23

1.87

1.9

2.0

3.73

3.67

g/l

0.20

130

1025

Other disorders of conjunctiva

241

2039

1.19

1.86

2.8

2.3

3.70

3.79

g/l

0.35

165

1427

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

575

0.65

1.85

1.9

2.1

3.72

3.70

g/l

0.04

425

Acute appendicitis, no complications

829

7560

1.10

1.85

2.5

2.2

3.74

3.85

g/l

0.97

605

5512

Flatulence and related conditions

108

1.90

1.85

1.5

2.3

3.46

3.69

g/l

0.38

Burn and corrosion of head and neck

175

1.68

1.85

4.7

2.5

4.00

3.79

g/l

0.29

123

Malignant neoplasm of breast, HER-negative

261

3051

0.85

1.85

1.9

2.3

3.75

3.72

g/l

0.10

185

2118

Other sexually transmitted chlamydial diseases

301

1.50

1.85

1.4

1.3

3.75

3.90

g/l

0.51

218

Infectious mononucleosis

484

1.39

1.84

2.1

1.5

3.70

3.84

g/l

0.35

363

Benign neoplasm: Liver

183

1.66

1.84

2.7

1.3

3.74

3.84

g/l

0.17

131

Certain zoonotic bacterial diseases

191

1.65

1.84

2.5

2.3

3.26

3.74

g/l

1.42

140

Chronic inflammatory disorders of orbit

3.20

1.84

2.0

1.2

3.77

4.03

g/l

—

Lagophthalmos

138

1.78

1.83

2.2

2.0

3.66

3.80

g/l

0.17

Cerebral amyloid angiopathy

2.47

1.83

5.8

2.1

2.98

3.75

g/l

—

Nonspecific lymphadenitis

588

1.35

1.83

1.7

2.1

3.65

3.74

g/l

0.24

427

Benign neoplasm of middle ear and respiratory system

131

1045

1.26

1.83

2.5

2.4

3.57

3.85

g/l

1.96

101

760

Other diseases of gallbladder

572

1.36

1.82

2.5

3.83

3.73

g/l

0.25

412

Rheumatic valve diseases

279

1.53

1.82

1.5

1.9

4.07

3.72

g/l

1.02

191

Embedded teeth, including avohilmo

579

1.35

1.82

2.8

1.8

3.92

3.80

g/l

0.25

437

Benign neoplasm: Choroid

711

1.32

1.81

1.6

1.4

3.67

3.85

g/l

0.56

498

Other diseases of appendix

131

1.80

1.81

1.9

2.0

4.00

3.72

g/l

0.74

Liposarcoma, excluding all cancers (controls excluding all cancers)

109

1.89

1.81

2.3

1.3

3.21

3.95

g/l

2.44

Use of glatiramer acetate

116

1.84

1.80

1.6

1.8

3.40

3.89

g/l

1.48

Acquired absence of limb

102

1.92

1.80

1.7

2.0

4.44

3.80

g/l

0.57

Pyoderma

200

1.63

1.80

2.0

2.3

4.21

3.79

g/l

0.78

144

Benign neoplasm: Ill-defined sites within the digestive system

2.11

1.80

1.1

2.2

4.03

3.76

g/l

—

Ménière disease

163

1335

1.23

1.80

1.7

2.5

3.87

3.78

g/l

0.28

109

953

Injuries involving multiple body regions

345

1.47

1.80

2.4

3.94

3.77

g/l

0.37

253

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

109

852

1.29

1.79

2.8

1.4

3.76

3.80

g/l

0.10

597

Embolic stroke with flimmer

321

1.49

1.79

2.4

1.8

3.54

3.75

g/l

0.50

221

Benign neoplasm: Liver/bile ducts

232

1.58

1.78

2.5

2.0

3.89

3.83

g/l

0.10

167

Pathological resorption of teeth

272

1.53

1.78

1.1

1.9

3.91

3.89

g/l

0.02

199

Benign neoplasm: Tongue

330

1.48

1.78

3.9

2.4

3.81

3.83

g/l

0.03

238

Dystonia

635

1.34

1.77

1.2

2.4

3.39

3.75

g/l

1.99

464

Benign neoplasm: Lip

257

1.54

1.77

3.4

2.3

3.87

3.71

g/l

0.25

191

Perforation of tympanic membrane

149

1212

1.24

1.75

2.2

2.3

3.66

3.80

g/l

0.68

872

Foreign body in ear

155

1.70

1.75

1.8

2.5

3.63

3.72

g/l

0.11

118

Other diseases of peritoneum

542

1.36

1.75

1.6

2.4

3.79

3.73

g/l

0.11

395

Preparation and fitting of bite rail to mouth

174

1438

1.22

1.74

2.8

2.4

3.90

3.80

g/l

0.16

127

1056

Pregnancy, childbirth and the puerperium

406

2410

0.88

1.74

1.8

2.1

3.74

3.70

g/l

0.19

294

1660

Other predominantly sexually transmitted diseases, not elsewhere classified

172

1419

1.22

1.74

1.9

2.0

3.43

3.79

g/l

3.85

127

1029

Lung diseases due to external agents

239

2035

1.18

1.73

2.6

2.2

3.73

3.79

g/l

0.29

154

1420

Alcohol withdrawal state with delirium

109

857

1.28

1.73

1.3

2.3

4.09

3.89

g/l

0.79

638

Smoking dependency

123

981

1.26

1.73

1.7

2.5

3.91

3.79

g/l

0.25

726

Benign neoplasm: Larynx

340

1.46

1.73

2.7

1.4

3.57

3.95

g/l

1.39

250

Benign neoplasm: Skin of scalp and neck

242

1.55

1.73

3.3

1.4

3.83

3.91

g/l

0.14

179

Disorders of tooth development and eruption

266

1.51

1.73

2.7

1.7

3.90

3.89

g/l

0.01

195

Other bursitis of knee

118

1.81

1.73

2.0

2.4

4.05

3.75

g/l

0.56

Malignant neoplasm of small intestine

259

1.53

1.72

2.6

4.06

3.74

g/l

0.45

189

Disorders of lacrimal system and orbit in diseases classified elsewhere

259

1.53

1.71

1.2

1.9

4.30

3.76

g/l

0.32

193

Ulcerative rectosigmoiditis

109

858

1.28

1.71

2.0

2.3

3.95

3.79

g/l

0.47

633

Dislocation, sprain and strain of joints and ligaments of thorax

308

1.48

1.70

1.2

2.3

3.70

3.79

g/l

0.19

224

Other degenerative diseases of the basal ganglia

196

1.62

1.70

2.2

2.8

3.79

3.81

g/l

0.02

136

Other and unspecified abdominal hernia

502

1.37

1.70

1.3

2.1

4.07

3.77

g/l

1.21

370

Burn and corrosion of ankle and foot

134

1.75

1.69

1.3

2.2

4.30

3.73

g/l

1.08

Sexual dysfunction

119

1.79

1.68

2.7

2.2

3.76

3.88

g/l

0.16

Adult respiratory distress syndrome

142

1.73

1.68

4.2

2.1

3.55

3.72

g/l

0.25

101

Appendicitis, broad definition

1203

10255

1.07

1.67

2.5

2.2

3.72

3.85

g/l

2.01

880

7386

Benign neoplasm: other/unspecified salivary gland

343

1.45

1.67

1.6

2.5

3.98

3.78

g/l

0.28

249

Melanocytic naevi of scalp and neck

212

1.58

1.67

2.5

3.54

3.78

g/l

0.67

156

Other disorders of bone density and structure

228

1.55

1.67

1.6

2.2

3.56

3.74

g/l

0.38

167

Endometriosis of ovary

226

1917

1.18

1.66

1.7

2.1

3.58

3.78

g/l

1.22

150

1394

Benign leiomyoma with endometriosis

234

1997

1.18

1.66

2.1

1.5

3.59

3.75

g/l

1.35

159

1385

Congenital malformations of genital organs

689

1.30

1.66

1.6

1.9

3.63

3.68

g/l

0.16

515

Benign neoplasm: Skin of other and unspecified parts of face

183

1530

1.20

1.66

3.5

2.3

3.76

3.78

g/l

0.09

100

1096

Graves ophthalmopathy

261

1.52

1.66

1.2

1.9

4.30

3.77

g/l

0.31

199

Maze procedure for atrial fibrillation

2.16

1.65

1.3

1.7

4.23

3.75

g/l

0.52

Benign neoplasm: Cerebral meninges

154

1268

1.22

1.64

2.0

2.4

3.46

3.74

g/l

2.43

109

901

Anankastic personality disorder

302

1.47

1.64

2.1

2.4

3.73

g/l

0.01

234

Disorders of iron metabolism

143

1.71

1.64

1.3

2.0

4.41

3.87

g/l

0.70

111

Granuloma annulare

143

1.71

1.64

2.1

1.8

3.74

3.80

g/l

0.09

105

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

206

1743

1.19

1.63

2.5

2.3

3.63

3.79

g/l

0.81

135

1273

Benign neoplasm of male genital organs

246

1.53

1.63

2.0

2.7

3.45

3.76

g/l

0.89

172

Other peripheral vertigo

151

1242

1.23

1.63

1.8

2.5

3.62

3.78

g/l

0.97

100

898

Dacryoadenitis

2.00

1.62

1.7

1.2

3.75

3.77

g/l

—

Tonsillectomy and adenotomy

545

4207

0.90

1.62

1.8

2.0

3.58

3.79

g/l

3.59

377

3129

Nonsuppurative otitis media

244

1806

1.17

1.62

1.9

2.0

3.72

3.79

g/l

0.33

175

1301

Diseases of middle ear and mastoid

797

5998

1.09

1.61

2.4

2.1

3.73

3.79

g/l

0.46

571

4316

Erythema intertrigo

247

1.52

1.60

2.1

3.0

4.11

3.66

g/l

1.35

180

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

1.89

1.59

6.4

1.3

3.46

4.03

g/l

1.51

Any dementia

656

5063

0.91

1.58

1.9

2.2

3.86

3.79

g/l

0.40

396

3490

Other renal tubulo-interstitial diseases

207

1.57

1.58

1.9

4.05

3.61

g/l

0.94

154

Tooth eruption problems

101

787

1.27

1.58

2.4

1.7

3.92

3.73

g/l

0.54

590

malignant neoplasm of female genital organs

185

2192

0.84

1.58

1.7

2.2

3.80

3.71

g/l

0.33

135

1519

Tularaemia

137

1.71

1.58

3.0

2.1

3.17

3.74

g/l

1.41

102

Carcinoma in situ of oral cavity, oesophagus and stomach

2.11

1.58

1.0

1.3

4.17

3.86

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

673

1.30

1.58

2.2

2.3

3.70

3.74

g/l

0.12

478

Pneumonitis due to solids and liquids

131

1066

1.24

1.57

1.7

2.2

3.73

3.82

g/l

0.34

753

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

322

1.45

1.57

1.6

2.3

3.47

3.76

g/l

1.03

247

Respiratory tuberculosis, bacteriologically and histologically confirmed

232

1.53

1.57

1.7

2.5

3.59

3.80

g/l

0.29

164

Abnormal findings in secretions and smears from cervix uteri vagina vulva

587

4184

1.10

1.57

2.2

2.1

3.56

3.73

g/l

2.74

435

3011

Vascular dementia

157

1258

1.21

1.56

2.3

2.1

3.68

3.75

g/l

0.29

852

Acute nasopharyngitis (common cold)

151

1239

1.22

1.56

1.8

2.0

3.93

3.92

g/l

0.02

111

906

Pedal cyclist injured in noncollision transport accidents

147

1211

1.22

1.56

1.7

2.3

3.76

3.81

g/l

0.22

102

892

Benign neoplasm of brain and other parts of central nervous system

719

1.29

1.56

2.1

1.4

3.62

3.88

g/l

1.19

508

Occupational exposure to risk-factors

384

0.62

1.56

4.4

2.6

3.72

3.75

g/l

—

282

Amblyopia ex anopsia

339

1.43

1.56

1.3

2.1

3.65

3.75

g/l

0.17

248

Malignant neoplasm, without specification of site

391

1.40

1.54

3.0

2.4

3.52

3.75

g/l

0.63

269

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

2.71

1.54

1.9

1.4

3.97

3.85

g/l

—

Aphakia

161

1.64

1.54

2.1

2.4

3.92

3.68

g/l

0.46

124

Leiomyoma of uterus

995

5249

1.08

1.54

2.2

3.71

3.73

g/l

0.17

685

3727

Use of levodopa decarboxylase inhibitor

244

2108

1.17

1.53

2.0

2.3

3.66

3.81

g/l

0.81

171

1475

Melanoma in situ of trunk

170

1.63

1.53

2.8

2.9

3.62

3.73

g/l

0.16

123

Colorectal adenocarcinoma

280

3203

0.87

1.53

2.3

3.74

3.82

g/l

0.46

183

2238

Dysplasia of cervi uteri

275

1847

1.15

1.52

2.2

2.0

3.67

3.77

g/l

0.53

200

1340

Outcome of delivery

141

713

1.23

1.52

1.7

1.8

3.59

3.73

g/l

0.61

106

554

Other female pelvic inflammatory diseases

230

1978

1.17

1.51

1.7

2.3

3.69

3.71

g/l

0.07

143

1403

Pilonidal cyst

695

1.29

1.51

1.9

2.1

4.07

3.91

g/l

0.47

523

Pityriasis lichenoides chronica

2.32

1.50

2.5

2.9

3.70

3.87

g/l

—

Brain meningioma, excluding all cancers (controls excluding all cancers)

627

1.30

1.50

2.1

1.4

3.49

3.81

g/l

1.47

428

Cerebral aneurysm, nonruptured

132

1082

1.23

1.50

1.8

2.4

3.74

3.79

g/l

0.18

103

777

Alzheimer’s disease (Atypical or mixed), excluding more controls

909

0.77

1.49

2.1

2.2

3.74

3.82

g/l

0.20

616

Other and unspecified disease of Bartholin gland

343

1.42

1.49

1.3

2.4

3.60

3.72

g/l

0.41

262

Maternal care for other known or suspected fetal problems

129

1013

0.81

1.49

1.5

1.8

3.50

3.61

g/l

0.47

766

Other vitreous opacities

463

1.35

1.48

3.3

2.8

4.48

3.71

g/l

0.95

329

Dental caries 1 and operation codes, only avohilmo

471

2125

1.12

1.47

2.6

2.8

3.85

3.74

g/l

0.65

353

1391

Unspecified mental disorder

583

5315

1.10

1.47

1.9

2.2

3.79

3.83

g/l

0.29

407

3838

Nephropathy induced by other drugs, medicaments and biological substances

3.31

1.47

1.8

1.3

4.28

3.69

g/l

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

157

1312

1.20

1.46

3.0

1.4

3.77

3.85

g/l

0.28

109

929

Benign neoplasm: Other parts of oropharynx

110

1.77

1.46

3.1

1.8

4.15

3.83

g/l

0.23

Complications following infusion, transfusion and therapeutic injection

156

1.63

1.46

1.4

2.4

4.19

3.86

g/l

0.93

114

Other and unspecified injuries of thorax

164

1.61

1.45

1.7

2.2

3.96

3.83

g/l

0.22

114

Hypertrophic disorders of skin

507

1.33

1.45

2.6

2.2

3.87

3.73

g/l

0.33

376

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

482

1.34

1.45

2.8

2.5

3.43

3.79

g/l

1.80

351

Melanocytic naevi of lip

1.86

1.44

1.3

2.0

3.38

3.82

g/l

—

Other noninflammatory disorders of vagina

105

844

1.25

1.43

2.7

2.0

3.70

3.79

g/l

0.25

605

Vertigo of central origin

189

1.56

1.43

1.6

2.5

3.49

3.67

g/l

0.20

133

Combined immunodeficiencies

126

1.70

1.43

3.1

1.9

3.24

3.82

g/l

1.40

Malignant neoplasm of mesothelium and soft tissue

553

1.32

1.43

2.8

4.13

3.81

g/l

0.34

404

Benign neoplasm: Connective and other soft tissue, unspecified

126

1.70

1.43

1.4

1.9

3.33

3.75

g/l

0.85

Nontoxic single thyroid nodule

112

908

1.24

1.42

2.4

2.3

3.64

3.76

g/l

0.35

653

Hypertrophic scar

457

1.34

1.42

2.7

2.0

3.89

3.75

g/l

0.35

343

Peptic ulcer

111

1.75

1.42

2.7

1.7

3.71

3.58

g/l

0.18

Procedures for purposes other than remedying health state

246

1.48

1.42

2.3

1.5

3.35

3.76

g/l

2.00

187

Benign neoplasm of other and unspecified female genital organs

552

0.70

1.42

2.1

2.3

3.68

3.72

g/l

0.06

395

Other disorders of prostate

441

1.35

1.41

2.7

2.5

3.85

4.00

g/l

0.38

318

Benign lipomatous neoplasm

483

4377

1.11

1.41

2.5

2.3

3.63

3.80

g/l

1.95

311

3126

Graves disease, strict definition

123

1008

1.23

1.41

2.5

2.2

3.70

3.74

g/l

0.15

728

Bitten or struck by other mammals

127

1044

1.22

1.41

2.6

2.4

3.35

3.79

g/l

5.18

106

757

L01XE Protein kinase inhibitors

776

1.26

1.40

3.0

2.6

3.79

3.83

g/l

0.07

573

Dislocation, sprain and strain of joints and ligaments of knee

868

7490

1.08

1.40

1.9

2.3

3.80

3.85

g/l

0.40

619

5451

Hereditary corneal dystrophies

408

1.37

1.39

1.4

2.7

3.69

3.78

g/l

0.26

296

Respiratory conditions due to other external agents

256

1.47

1.39

6.5

1.9

3.75

3.66

g/l

0.14

187

Contact with other hot metals

127

1.68

1.38

1.0

2.0

4.03

3.76

g/l

0.49

Congenital deformities of feet

182

1.55

1.38

1.5

1.8

4.50

3.75

g/l

1.34

139

Peritonsillar abscess

258

2255

1.15

1.38

2.7

2.1

3.92

3.85

g/l

0.22

194

1643

TMD related pain

289

1.43

1.38

1.8

2.2

4.04

3.71

g/l

0.73

224

Degeneration of nervous system due to alcohol

265

1.46

1.37

1.3

2.8

4.15

3.86

g/l

0.61

190

Other disorders of breast

169

1432

1.19

1.37

2.1

2.2

3.47

3.72

g/l

1.93

119

1021

Contraceptive management

422

3294

0.90

1.37

2.2

2.1

3.98

3.83

g/l

0.36

306

2451

Examination and encounter for administrative purposes

400

1.36

2.9

2.4

3.74

3.89

g/l

0.40

300

Glaucoma secondary to other eye disorders

496

1.32

1.36

2.4

2.6

3.82

3.73

g/l

0.26

353

Use of rotigotine

136

1.66

1.36

1.9

1.6

3.54

3.75

g/l

0.41

102

Cauda equina syndrome

128

1.67

1.35

2.1

1.7

3.17

3.74

g/l

1.53

Macular cyst

342

1.40

1.35

1.7

2.9

3.73

3.72

g/l

0.01

262

Benign neoplasm: Brain, supratentorial

128

1.66

1.35

1.3

1.4

3.72

3.97

g/l

0.50

Neovascular glaucoma

497

1.32

1.34

2.4

3.82

3.76

g/l

0.15

355

Maternal care related to the fetus and amniotic cavity and possible delivery problems

411

2689

0.90

1.33

2.4

2.0

3.78

3.71

g/l

0.28

293

1987

Postpartum hemorraghe, all women as controls

156

1837

0.84

1.33

1.9

3.68

3.64

g/l

0.11

105

1374

Tuberculosis, IBD comorbidity

126

1043

1.22

1.33

2.3

2.2

3.78

3.80

g/l

0.04

732

Postpartum hemorraghe, parous women as controls

156

1616

0.84

1.33

1.9

2.0

3.68

3.65

g/l

0.08

105

1190

Obstructed labour due to malposition and malpresentation of fetus

148

1656

0.84

1.33

1.5

1.9

3.93

3.66

g/l

0.61

118

1250

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

650

3904

1.09

1.33

2.0

1.4

3.79

3.73

g/l

0.55

464

2747

Antepartum haemorrhage, not elsewhere classified

567

1.29

1.33

2.2

1.8

3.98

3.68

g/l

0.29

423

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

650

3904

1.09

1.33

2.0

1.4

3.79

3.73

g/l

0.55

463

2747

Degeneration of the brain due to alcohol

267

1.44

1.32

1.3

2.8

4.15

3.86

g/l

0.60

191

Anuria and oliguria

1.94

1.31

1.3

2.2

3.65

3.59

g/l

—

Presbyopia

658

1.27

1.30

1.4

2.2

3.64

3.82

g/l

0.64

479

Erectile dysfunction

149

1257

1.20

1.30

2.4

3.74

3.93

g/l

0.87

112

883

Glaucoma-related operations

794

1.25

1.29

2.7

2.5

4.20

3.76

g/l

0.58

567

Parkinson's disease, strict definition

256

2253

1.14

1.28

1.9

2.3

3.69

3.81

g/l

0.62

178

1579

Benign mammary dysplasia

225

1962

1.15

1.28

2.5

2.2

3.52

3.74

g/l

2.36

154

1385

Alopecia areata

235

1.46

1.28

1.8

1.9

3.67

3.74

g/l

0.12

180

Dementia

750

5574

0.93

1.26

1.9

2.3

3.88

3.81

g/l

0.45

460

3891

Benign neoplasm: Liver

203

1.50

1.26

2.7

1.9

3.74

3.84

g/l

0.16

145

Sequelae of injuries of upper limb

132

1104

1.20

1.26

2.5

2.4

3.92

3.80

g/l

0.23

811

Carcinoma in situ of skin, other sites/unspecified

139

1.62

1.26

3.5

1.2

4.15

3.80

g/l

0.30

Benign neoplasm: Skin of lip

163

1.56

1.25

2.0

1.9

3.92

3.79

g/l

0.14

118

Osteomalacia

1.80

1.25

8.1

2.3

3.58

3.75

g/l

—

Infective bursitis

321

1.39

1.25

1.7

2.2

3.73

3.95

g/l

0.59

230

Injury of nerves at shoulder and upper arm level

108

1.70

1.24

3.6

2.9

5.54

3.83

g/l

0.60

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

112

924

1.22

1.24

2.0

1.4

3.56

3.83

g/l

1.22

656

Postmenopausal atrophic vaginitis

422

2297

1.11

1.24

2.3

2.2

3.65

3.78

g/l

1.14

309

1650

Other rupture of muscle

2.01

1.24

1.0

1.8

4.17

3.77

g/l

—

Injury of muscle and tendon at shoulder and upper arm level

614

5667

1.09

1.24

2.2

2.3

3.85

3.87

g/l

0.09

432

4081

Specific development disorders of scholastic skills

161

1.54

1.23

1.3

1.6

3.65

3.71

g/l

0.06

128

Tuberculosis, wide

130

1090

1.20

1.23

2.3

2.4

3.78

3.80

g/l

0.04

766

Dental pulpitis 3, only avohilmo

264

1.36

1.22

1.1

3.57

g/l

0.01

209

Inflammation of lacrimal passages (acute and unspecified)

172

1.53

1.22

2.9

1.8

3.49

3.78

g/l

0.45

122

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

790

1.24

1.22

2.0

1.4

3.64

3.88

g/l

1.05

558

Peripheral retinal degeneration

357

1.36

1.22

3.2

2.6

3.82

3.73

g/l

0.10

267

Loose body in joint

238

1.44

1.22

2.0

2.4

3.70

3.67

g/l

0.05

169

Acute alcohol intoxication

396

3588

1.11

1.21

1.4

2.3

3.96

3.85

g/l

0.73

295

2579

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

401

1.34

1.20

1.9

1.5

3.83

3.88

g/l

0.07

279

Gilbert syndrome

1.92

1.20

4.8

1.9

3.19

3.73

g/l

—

Other benign neoplasms of connective and other soft tissue

132

1111

1.19

2.6

1.4

3.59

3.84

g/l

1.46

784

Hypersomnia

133

1.60

1.19

1.3

2.2

4.64

3.71

g/l

1.34

Carcinoma in situ of oral cavity, oesophagus and stomach

1.87

1.18

1.0

2.2

4.17

3.76

g/l

—

Frostbite with tissue necrosis

0.00

1.18

0.0

2.1

—

3.60

—

Benign neoplasm: Skin of scalp and neck

265

1.41

1.18

3.3

2.7

3.83

3.74

g/l

0.18

199

Parkinson's disease

273

2429

1.13

1.18

1.9

2.3

3.68

3.83

g/l

0.96

190

1707

Fistulae involving female genital tract

182

1.51

1.18

2.0

2.2

4.23

3.85

g/l

0.42

131

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

1069

0.81

1.17

2.1

1.4

3.70

3.86

g/l

0.54

750

Secondary parkinsonism+Parkinsonism in other disease

326

1.37

1.16

2.6

2.5

3.94

3.76

g/l

0.19

238

Chalazion

156

1336

1.17

1.16

2.9

2.4

3.73

3.85

g/l

0.54

105

964

Foreign body in alimentary tract

607

1.26

1.15

1.4

2.5

3.96

3.82

g/l

0.48

444

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

769

1.23

1.15

2.2

1.4

4.03

3.86

g/l

0.55

548

Foreign body or object entering through skin

607

1.26

1.15

2.9

2.3

4.05

3.85

g/l

0.31

453

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

733

1.24

1.15

1.2

1.4

3.55

3.88

g/l

1.92

519

Other fall from one level to another

303

2715

1.12

1.14

2.2

3.63

3.86

g/l

2.53

208

1972

Viral haemorrhagic fevers, not elsewhere classified/unspecified

955

0.80

1.14

3.0

2.3

3.50

3.82

g/l

1.79

705

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

135

1.59

1.14

3.0

1.3

4.21

3.86

g/l

0.71

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

477

3547

1.09

1.13

2.0

1.4

3.80

3.74

g/l

0.36

336

2477

Other maternal disorders predominantly related to pregnancy

627

4255

0.92

1.13

2.1

2.2

3.69

3.71

g/l

0.16

440

3115

Other intracranial haemorrhages

397

1.32

1.13

1.7

2.3

4.10

3.84

g/l

0.51

275

Congenital malformations of ovaries, fallopian tubes and broad ligaments

440

1.30

1.13

1.7

3.60

3.71

g/l

0.26

327

1.82

1.13

1.6

3.0

3.64

3.67

g/l

—

Benign neoplasm: Bone and articular cartilage, unspecified

1.82

1.13

2.3

1.2

4.81

3.88

g/l

—

Striae atrophicae

1.73

1.13

1.7

2.3

3.87

3.72

g/l

0.22

Traumatic amputation of wrist and hand

515

0.73

1.11

1.3

2.6

3.78

3.85

g/l

0.13

374

Acute otitis externa, noninfective

168

1.51

1.11

1.2

2.2

3.84

3.77

g/l

0.10

126

Ovarian dysfunction

432

1.30

1.11

1.4

1.7

3.61

3.70

g/l

0.20

333

Other acquired deformities of ankle and foot

1.76

1.11

1.4

1.9

4.08

3.51

g/l

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

104

1.66

1.10

1.3

2.2

4.40

3.73

g/l

—

Oligomenorrhoea

294

1.37

1.10

1.6

2.2

4.09

3.81

g/l

0.43

213

Other disorders of Eustachian tube

303

1.37

1.10

1.5

2.2

3.49

3.80

g/l

0.74

224

Foreign body entering into or through eye or natural orifice

104

864

1.21

1.10

2.6

2.3

3.88

3.84

g/l

0.09

642

Residual foreign body in soft tissue

451

1.29

1.10

2.0

3.74

3.88

g/l

0.24

322

Right side

1.76

1.08

1.3

1.8

—

3.67

—

Other injuries of upper limb, level unspecified

1.68

1.08

2.1

2.2

3.56

3.87

g/l

0.51

Benign neoplasm: Spinal cord

137

1.56

1.07

1.1

1.3

3.24

3.85

g/l

2.36

100

Maternal care for cervical incompetence

419

0.71

1.07

7.1

2.4

3.63

3.78

g/l

0.30

314

Other diseases of biliary tract

135

1153

1.18

1.07

2.3

2.4

3.73

3.77

g/l

0.19

100

815

Benign neoplasm: Conjunctiva

331

1.34

1.06

1.3

3.93

3.91

g/l

0.04

236

Rheumatic fever incl heart disease

401

1.31

1.06

1.5

2.4

3.98

3.72

g/l

0.69

287

Spinal enthesopathy

339

1.34

1.06

2.8

1.9

4.14

3.73

g/l

0.68

215

Oral leukoplakia

212

1.44

1.06

1.2

2.1

3.90

3.82

g/l

0.16

156

Other and unspecified nail disorders

212

1.43

1.05

2.2

2.3

3.48

3.79

g/l

0.64

161

Persistent delusional disorders

923

0.81

1.05

2.2

2.4

3.85

3.78

g/l

0.11

661

Neuralgic amyotrophy

2.37

1.05

7.0

3.0

2.92

3.88

g/l

—

Other haemoglobinopathies

2.37

1.05

1.8

1.1

4.14

3.52

g/l

—

Pregnancy with abortive outcome

1008

4971

1.06

1.05

1.8

2.3

3.71

g/l

0.04

731

3472

Contusion of toe(s) with damage to nail

1.66

1.05

1.6

3.80

3.90

g/l

—

Benign neoplasm: Bone and articular cartilage, unspecified

1.77

1.04

2.3

1.7

4.81

3.82

g/l

—

Chondromalacia

315

1.35

1.04

1.4

2.1

3.95

3.81

g/l

0.33

238

Benign neoplasm of other and unspecified sites

341

1.33

1.04

2.7

1.4

3.52

3.87

g/l

1.23

251

2.33

1.04

3.0

2.8

5.02

4.23

g/l

—

Corneal degeneration

171

1.49

1.04

1.2

2.0

3.99

3.75

g/l

0.85

123

Malignant neoplasm of oesophagus

311

0.67

1.04

1.4

2.7

4.09

3.84

g/l

0.64

218

Serous carcinoma of ovary

462

0.73

1.04

2.5

2.4

3.53

3.75

g/l

0.51

342

Medicines for HER+ breast cancer

492

5187

0.92

1.03

2.0

2.3

3.79

3.73

g/l

0.41

348

3643

Contact with blunt object, undetermined intent

1.93

1.03

1.5

2.9

3.66

3.60

g/l

—

Universal erythroderma, KELA reimbursement

155

1.51

1.03

1.3

2.3

3.91

g/l

0.00

111

Measles

1.71

1.02

1.0

1.4

3.98

3.81

g/l

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

102

1214

0.84

1.02

3.2

2.3

3.55

3.85

g/l

2.05

891

Lesion of radial nerve

386

1.31

1.02

2.1

2.2

4.00

3.78

g/l

0.40

278

Effects of foreign body entering through natural orifice

339

3081

1.10

1.02

2.2

2.3

3.78

3.89

g/l

0.70

243

2241

Acquired absence of organs, not elsewhere classified

131

1.55

1.01

4.2

2.3

3.42

3.85

g/l

0.63

100

Superficial injury of neck

147

1.51

1.01

1.3

1.7

3.51

3.78

g/l

0.60

106

Car occupant injured in other and unspecified transport accidents

229

2038

1.13

1.01

2.0

2.2

3.83

g/l

0.00

158

1472

Alzheimer’s disease (Late onset), excluding more controls

273

1633

1.12

1.01

1.9

2.2

3.98

3.79

g/l

0.63

164

1139

Varus deformity, not elsewhere classified

115

1.59

1.01

1.4

2.1

3.16

3.54

g/l

—

Tetraplegia

1.75

1.01

1.8

1.7

4.28

3.87

g/l

—

Other benign neoplasm of uterus: Corpus uteri

1.75

1.01

4.8

1.2

3.08

3.98

g/l

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

718

1.22

1.00

2.2

3.70

3.73

g/l

0.07

532

Transient global amnesia

118

1383

0.85

1.00

2.4

3.39

3.79

g/l

3.99

1004

Inguinal hernia, bilateral

176

1543

1.15

1.00

2.5

2.2

3.79

3.88

g/l

0.38

129

1105

Benign neoplasm of bone and articular cartilage

106

893

1.19

0.99

1.5

2.3

3.71

3.77

g/l

0.16

646

Pedal cyclist injured in transport accident

296

2676

1.11

0.99

2.0

2.2

3.76

3.82

g/l

0.30

201

1952

Separation of retinal layers (serosa)

432

1.28

0.99

1.8

2.4

3.88

3.79

g/l

0.18

322

Dermatitis herpetiformis

198

1.43

0.99

3.4

2.2

3.75

3.77

g/l

0.03

144

Malignant neoplasm of breast, HER-positive

472

5033

0.92

0.99

2.0

2.3

3.79

3.73

g/l

0.38

332

3531

Reiter disease

1.78

0.98

5.1

1.9

4.31

3.74

g/l

1.01

Alzheimer’s disease, wide definition, excluding more controls

284

1739

1.11

0.98

1.9

2.2

4.00

3.81

g/l

0.68

177

1212

Unspecified jaundice

603

1.24

0.98

1.6

2.3

4.14

3.84

g/l

0.71

448

Vasomotor rhinitis (mode)

104

877

1.19

0.97

2.1

2.6

3.94

3.77

g/l

0.46

631

Other problems related to primary support group, including family circumstances

809

1.20

0.97

1.9

2.0

3.63

3.73

g/l

0.32

590

Aneurysms, operations, SAH

261

2349

1.12

0.97

1.9

2.2

3.81

3.78

g/l

0.13

193

1659

Acute epiglottitis

133

1.52

0.95

3.9

1.9

4.85

3.79

g/l

0.43

Struck by thrown, projected or falling objec

435

1.27

0.95

1.2

2.5

3.79

3.83

g/l

0.09

321

Other specified and unspecified disorders of eyelid

150

1.49

0.94

1.5

2.6

3.78

3.76

g/l

0.03

107

Myocardial infarction, unclassifiable

363

3531

0.91

0.94

1.8

2.2

3.69

3.83

g/l

1.42

256

2424

Benign neoplasm: Peripheral nerves and autonomic nervous system

150

1.49

0.94

3.9

1.4

3.78

3.96

g/l

0.34

107

Convalescence

570

1.24

0.94

2.1

3.73

3.79

g/l

0.13

429

Laparoscopic left hemicolectomy

209

1.41

0.94

2.6

2.4

3.76

3.77

g/l

0.03

149

Changes in corneal membranes

2.22

0.93

1.5

2.5

3.52

3.60

g/l

—

Benign neoplasm: Choroid

781

1.20

0.93

1.6

2.5

3.67

3.79

g/l

0.31

563

Dronedarone medication

357

1.30

0.93

2.0

2.5

3.66

3.87

g/l

0.52

258

Acute drug-induced interstitial lung disorder

1.63

0.93

9.7

1.9

3.72

3.82

g/l

0.09

Tuberculosis of other organs, strict

331

1.31

0.92

2.8

2.5

4.00

3.80

g/l

0.28

237

Amputation of thigh

366

1.30

0.92

1.3

2.3

4.34

3.80

g/l

1.38

252

Exposure to unspecified smoke, fire and flames

1.65

0.92

1.0

2.2

3.43

4.00

g/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

117

1360

0.86

0.92

2.7

1.4

3.75

3.85

g/l

0.33

955

FESS (DNB20)

129

1489

0.86

0.91

2.4

2.3

3.74

3.83

g/l

0.34

1089

Secondary parkinsonism

323

1.31

0.91

2.7

2.5

3.96

3.73

g/l

0.23

234

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

785

0.81

0.91

2.9

1.4

3.46

3.77

g/l

1.49

535

Other benign neoplasm of uterus: Other parts/unspecified

592

1.23

0.90

2.7

1.5

3.76

3.77

g/l

0.03

392

Benign neoplasm: Lower jaw bone

1.96

0.90

1.7

1.1

3.70

3.73

g/l

—

Hypermetropia

673

1.21

0.90

2.5

2.2

3.69

3.76

g/l

0.24

493

malignant neoplasm of male genital organs

794

4756

1.06

0.90

2.1

2.4

4.03

3.92

g/l

0.67

539

3410

Inguinal or femoral hernia, bilateral

178

1576

1.13

0.90

2.5

2.2

3.77

3.88

g/l

0.51

131

1130

Pterygium

377

1.29

0.89

2.1

2.6

3.57

3.86

g/l

0.64

269

Achalasia of cardia

194

1.41

0.89

2.2

3.0

3.75

3.61

g/l

0.25

147

Use of rasagiline

342

1.30

0.89

1.5

2.8

3.33

3.73

g/l

2.35

249

Embedded and impacted teeth

193

1457

1.13

0.89

2.0

1.9

3.73

3.76

g/l

0.09

124

1095

Benign neoplasm: Tonsil

111

1.55

0.89

2.5

1.2

5.13

3.88

g/l

—

Benign neoplasm: Long bones of lower limb

254

1.35

0.89

1.3

3.56

3.90

g/l

0.62

190

Benign neoplasm: Spinal cord

144

1.48

0.88

1.1

2.3

3.24

3.64

g/l

1.40

107

TMD related operations

204

1822

1.12

0.88

2.8

2.3

3.86

3.81

g/l

0.09

149

1338

Benign neoplasm of brain and other parts of central nervous system

776

1.19

0.88

2.1

2.5

3.62

3.80

g/l

0.68

567

Contact with other hot fluids

237

1.36

0.88

1.4

2.3

3.93

3.79

g/l

0.21

181

Lichen sclerosus et atrophicus

145

1268

1.15

0.88

2.1

2.0

3.69

3.77

g/l

0.41

105

887

All dysplastic lesions of the vagina

246

1.35

0.88

2.8

1.9

3.61

3.75

g/l

0.31

192

All dysplastic lesions of the vulva

458

1.25

0.88

1.3

2.3

3.44

3.68

g/l

0.77

339

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

448

0.75

0.88

2.5

1.4

3.53

3.74

g/l

0.49

308

Presbycusis

256

2306

1.11

0.88

2.5

2.2

3.72

3.80

g/l

0.31

171

1642

Other congenital malformations of circulatory system

255

1.35

0.87

1.7

2.6

4.04

3.74

g/l

0.61

187

Disturbances of smell and taste

486

1.24

0.87

2.8

2.9

3.83

3.76

g/l

0.11

355

Benign neoplasm: Skin of trunk

432

1.26

0.87

3.0

1.4

3.56

3.85

g/l

1.00

317

Urethritis and urethral syndrome

204

1.39

0.86

1.2

2.2

3.63

3.70

g/l

0.09

152

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

179

1.42

0.86

2.1

1.7

3.38

3.67

g/l

0.32

125

Malignant melanoma of skin

183

1629

1.13

0.86

2.0

2.4

3.57

3.80

g/l

1.94

131

1165

Other and unspecified degenerative diseases of nervous system

300

1.31

0.86

1.6

2.4

4.13

3.70

g/l

0.61

215

Endometriosis ASRM stages 1,2

195

1741

1.12

0.86

1.4

2.0

3.53

3.69

g/l

0.83

129

1264

Dementia in other diseases classified elsewhere

615

1.21

0.85

1.7

2.5

3.99

3.85

g/l

0.20

441

Bacterial meningitis

371

1.28

0.85

3.7

2.5

3.57

3.74

g/l

0.43

273

Blood alcohol or alcohol intoxication level

196

1.39

0.85

1.4

2.1

3.58

3.86

g/l

0.46

144

Benign neoplasm: Short bones of upper limb

129

1.49

0.84

1.4

3.48

3.94

g/l

0.68

LeFortI or BSSRO operation

320

0.71

0.84

1.0

1.7

3.79

3.80

g/l

0.00

244

Malignant neoplasm of prostate

786

4694

1.06

0.83

2.1

2.4

4.03

3.92

g/l

0.66

531

3364

Hypertrichosis

121

1.50

0.83

1.2

1.9

3.76

3.72

g/l

—

Benign lipomatous neoplasm of other sites/unspecified

142

1248

1.14

0.82

3.0

2.4

3.51

3.81

g/l

1.83

897

Benign neoplasm: Vulva

260

0.68

0.82

2.3

2.2

3.82

3.69

g/l

0.20

195

Melanocytic naevi of other and unspecified parts of face

571

1.21

0.82

2.8

1.4

3.52

3.81

g/l

1.19

411

Pregnancy hypertension

464

3895

1.08

0.82

2.3

2.1

3.67

3.70

g/l

0.22

333

2834

Motorcycle rider injured in noncollision transport accidents

223

1.35

0.82

1.8

1.7

3.58

3.86

g/l

0.58

169

Benign neoplasm of other and unspecified female genital organs

499

0.78

0.82

2.1

1.3

3.68

3.77

g/l

0.16

346

Endometriosis diagnosis and infertility diagnosis occurring together

101

865

1.17

0.82

1.6

2.1

3.61

3.74

g/l

0.37

633

L02BG Aromatase inhibitors

403

4342

0.93

0.82

2.2

2.3

3.83

3.74

g/l

0.66

288

3059

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

122

1.50

0.81

1.3

1.2

3.29

3.91

g/l

3.06

Abnormalities of forces of labour

829

1.17

0.81

1.4

2.0

3.99

3.67

g/l

1.42

628

LSIL lesion of the vulva

285

1.31

0.81

1.3

2.0

3.37

3.71

g/l

0.93

217

Deep bite

107

806

1.16

0.80

2.0

2.3

3.57

3.75

g/l

0.87

601

Other benign neoplasms of uterus

748

1.18

0.80

3.0

1.4

3.66

3.76

g/l

0.29

503

Mandibular retrognathia AND surgery (BSSRO)

200

0.65

0.80

1.0

1.7

4.00

3.86

g/l

—

153

Colorectal cancer

357

3859

0.92

0.80

2.3

2.2

3.76

3.82

g/l

0.38

243

2707

Contact with machinery

123

1407

0.87

0.80

2.2

2.3

3.73

3.91

g/l

0.76

1037

Other benign neoplasm of uterus: Corpus uteri

1.62

0.79

4.8

2.1

3.08

3.75

g/l

—

Acute inflammation of orbit

1.69

0.79

10.6

1.2

4.00

3.92

g/l

—

Right ventricular outflow tract obstruction

1.83

0.79

1.0

1.9

3.03

3.77

g/l

—

Benign neoplasm: Larynx

393

1.26

0.79

2.7

2.4

3.57

3.87

g/l

0.97

292

Migraine without aura, drug-induced

1.55

0.79

5.7

2.3

3.70

3.75

g/l

—

Discharge from other and unspecified firearms

0.00

0.79

0.0

2.4

—

3.85

—

Respiratory tuberculosis, clinically confirmed

165

1.41

0.79

1.2

2.6

3.64

3.78

g/l

0.17

118

Other obstetric trauma

339

0.73

0.79

1.9

2.1

3.89

3.65

g/l

0.25

260

Schizoaffective disorder

730

1.18

0.79

1.8

2.3

3.71

3.75

g/l

0.10

534

Injury of muscle and tendon at forearm level

182

1.39

0.79

1.5

2.0

4.19

3.91

g/l

0.47

134

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

114

1308

0.87

0.78

2.7

1.4

3.73

3.84

g/l

0.41

915

Carcinoma in situ of skin, other sites/unspecified

157

1.43

0.78

3.5

2.1

4.15

3.67

g/l

0.45

106

Gonococcal infection

331

1.28

0.78

2.2

1.8

3.81

3.75

g/l

0.13

247

LSIL lesion of the cervix uteri, vagina or vulva

137

1206

1.14

0.78

2.6

2.1

3.43

3.72

g/l

2.39

107

872

Correction of physiology of bite - demanding therapy visit

639

0.81

0.78

4.3

2.3

3.72

3.71

g/l

0.02

475

Benign neoplasm of ovary

237

2156

1.10

0.77

2.3

1.4

3.80

3.75

g/l

0.26

176

1500

Occlusion and stenosis of arteries, not leading to stroke

149

1.43

0.76

3.7

2.2

3.79

3.78

g/l

0.01

106

Other contact dermatitis

102

881

1.16

0.76

1.7

2.4

3.96

3.77

g/l

0.41

638

Pleural plaque

178

1597

1.12

0.76

2.3

2.2

4.00

3.84

g/l

0.39

124

1097

Fall on and from ladder

114

994

1.15

0.76

3.8

2.5

3.69

3.88

g/l

0.86

739

Crystalline deposits in vitreous body

116

1.49

0.76

3.7

2.7

5.47

3.62

g/l

—

Evidence of alcohol involvement determined by blood alcohol level

124

1.47

0.76

1.6

1.7

3.45

3.76

g/l

0.58

Macular hole

818

1.17

0.76

1.9

2.6

4.03

3.73

g/l

0.76

585

Diseases of thymus

2.14

0.76

2.4

3.0

3.28

3.43

g/l

—

Brain meningioma

661

1.19

0.75

2.2

2.5

3.49

3.74

g/l

0.99

478

Superficial injuries involving multiple body regions

236

1.32

0.75

3.1

2.4

3.90

3.67

g/l

0.34

176

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

359

3332

1.08

0.74

3.2

1.4

3.87

g/l

0.01

252

2364

Maternal care for known or suspected malpresentation of fetus

101

870

0.86

0.74

1.9

1.7

3.52

3.64

g/l

0.50

651

Caught, crushed, jammed or pinched in or between objects

424

1.23

0.73

1.3

2.2

3.79

3.82

g/l

0.04

313

Childhood allergy (age < 16)

400

1.22

0.73

1.1

1.2

3.53

3.66

g/l

0.37

314

Defect, injury or illness of neck

1.82

0.73

1.1

1.3

4.37

3.69

g/l

—

Burn and corrosion of trunk

281

1.29

0.73

1.3

2.5

3.89

3.75

g/l

0.32

212

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

405

3167

1.07

0.73

2.2

1.5

4.03

3.88

g/l

0.72

311

2232

Hypertrophy of breast in women and men

238

2173

1.10

0.72

1.9

2.3

3.74

3.76

g/l

0.08

169

1565

Placenta praevia

265

0.71

0.72

1.1

1.8

3.46

3.74

g/l

0.68

199

Tuberculosis of other organs

282

1.29

0.72

2.7

2.4

4.09

3.78

g/l

0.38

199

Malignant neoplasm of bladder

121

1065

1.14

0.72

2.0

2.4

4.04

3.82

g/l

0.64

747

Maternal care for known or suspected abnormality of pelvic organs

185

1416

0.90

0.72

2.6

2.0

3.76

3.67

g/l

0.23

141

1055

Brain glioblastoma and astrocytoma

182

0.65

0.72

1.2

3.1

3.44

3.72

g/l

—

134

Chorioretinal inflammation

300

1.28

0.71

1.5

2.3

3.52

3.74

g/l

0.62

220

Carcinoma in situ of middle ear and respiratory system

1.58

0.71

1.9

1.3

3.41

3.79

g/l

—

Dental caries 3 and operation codes, only avohilmo

520

2453

1.07

0.71

2.4

2.7

3.83

3.77

g/l

0.33

394

1640

Correction of physiology of bite - very demanding therapy visit

247

1.30

0.71

1.6

1.8

3.67

3.83

g/l

0.48

191

Uterine polyps

129

1141

1.13

0.71

2.0

2.2

3.72

3.78

g/l

0.21

823

Labour and delivery complicated by fetal stress [distress]

138

1038

0.89

0.71

1.6

1.7

3.53

3.58

g/l

0.25

107

789

Calcaneal spur

118

1.46

0.70

1.2

1.7

3.97

3.82

g/l

—

Benign neoplasm: Respiratory system, unspecified

1.91

0.70

1.0

1.1

4.02

4.33

g/l

—

Mixed conductive and sensorineural hearing loss

199

1807

1.11

0.70

2.6

2.2

3.64

3.85

g/l

1.25

124

1312

Carcinoma in situ of breast, intraductal

111

974

1.14

0.69

1.8

1.4

3.71

3.77

g/l

0.15

682

Carcinoma in situ of other and unspecified sites

428

1.22

0.69

3.2

1.4

3.86

3.89

g/l

0.04

318

Use of interferon beta-1a

178

1.36

0.69

1.3

1.8

3.47

3.87

g/l

0.73

140

Papillary adenocarcinoma of thyroid gland

602

1.19

0.69

2.0

2.5

4.00

3.74

g/l

0.71

434

Divergent concomitant strabismus

788

1.16

0.68

1.8

2.2

3.60

3.81

g/l

1.11

564

Inflammatory disorders of breast

538

1.19

0.68

1.5

2.3

4.09

3.76

g/l

0.88

394

Abnormal findings on antenatal screening of mother

375

0.77

0.68

1.0

1.5

4.24

3.64

g/l

1.25

273

Radial styloid tenosynovitis [de Quervain]

520

1.20

0.68

2.2

2.1

3.55

3.82

g/l

1.21

375

Frontotemporal dementia

1.58

0.67

2.4

2.1

4.86

3.75

g/l

—

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

1.54

0.67

1.2

1.3

3.63

3.95

g/l

—

Congenital malformations of the nervous system

136

1.41

0.67

1.2

2.1

3.51

3.68

g/l

0.21

105

Arthropathy in Crohn disease

1.53

0.67

1.1

2.2

3.25

3.72

g/l

—

conjunctival degenerations and deposits

241

1.30

0.67

3.9

2.0

4.19

3.74

g/l

1.26

178

Dislocation, sprain and strain of joints and ligaments of head

330

1.25

0.66

1.3

1.9

3.68

3.75

g/l

0.11

243

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

527

0.81

0.66

2.6

2.5

3.84

3.77

g/l

0.11

386

Melanocytic naevi, other sites/unspecified

772

1.16

0.66

1.9

1.3

4.16

3.86

g/l

0.24

562

Dementia, including avohilmo

825

5953

0.95

0.66

1.9

2.3

3.86

3.81

g/l

0.25

511

4158

Alzheimer disease, excluding more controls

308

1906

1.08

0.65

2.1

2.2

3.96

3.84

g/l

0.39

182

1337

Communicating hydrocephalus

251

1.29

0.65

1.6

2.7

3.74

3.70

g/l

0.06

183

Normal-pressure hydrocephalus

741

0.84

0.64

2.5

3.91

3.78

g/l

0.34

523

Adenocarcinoma and papillary adenocarcinoma of stomach

359

0.77

0.64

1.2

2.5

3.45

3.81

g/l

0.99

256

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

179

1626

1.10

0.64

2.3

1.4

3.73

3.84

g/l

0.62

117

1113

Carcinoma in situ, bladder

387

1.22

0.64

3.4

1.4

3.93

3.90

g/l

0.04

285

Inflammatory diseases of prostate (prostatitis)

195

1779

1.10

0.64

2.1

2.5

3.88

3.99

g/l

0.52

130

1300

Carcinoma in situ of larynx

1.73

0.63

2.4

2.9

3.70

3.51

g/l

—

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

424

0.80

0.62

3.4

2.3

3.60

3.73

g/l

0.27

299

Benign neoplasm: Respiratory system, unspecified

1.71

0.62

1.0

1.3

4.02

3.89

g/l

—

Benign neoplasm: Male genital organ, other/unspecified

0.00

0.62

0.0

1.1

—

3.51

—

Female genital prolapse

455

2472

1.06

0.62

2.3

2.1

3.71

3.77

g/l

0.29

306

1777

Long labour

182

1745

0.91

0.62

2.3

2.0

3.57

3.64

g/l

0.39

139

1312

Benign neoplasm: Conjunctiva

361

1.23

0.62

1.3

2.8

3.93

3.76

g/l

0.49

271

Drowning to ice

0.00

0.62

0.0

1.2

—

3.91

—

Traumatic amputation of hip and thigh

0.00

0.62

0.0

2.0

—

3.51

—

Other disorders of male genital organs

352

1.23

0.61

1.7

2.5

3.76

4.01

g/l

0.56

250

Vascular dementia (undefined)

503

1.19

0.61

2.2

3.45

3.76

g/l

0.84

342

Ototoxic hearing loss

0.00

0.61

0.0

3.2

—

3.82

—

Congenital malformations of lung

0.00

0.61

0.0

1.1

—

4.19

—

Injury of nerves at wrist and hand level

371

1.22

0.61

2.4

2.6

3.65

3.82

g/l

0.35

270

Hypospadias

0.00

0.60

0.0

2.6

—

3.45

—

Family history of malignant neoplasm

1068

0.88

0.60

2.9

2.0

3.58

3.76

g/l

0.80

781

Vertical strabismus

335

1.23

0.60

1.9

2.5

3.60

3.76

g/l

0.20

245

Use of dimethyl fumarate

1.55

0.60

1.0

2.3

3.29

3.69

g/l

—

Other congenital malformations of the digestive system

342

1.23

0.60

1.5

2.5

3.63

3.69

g/l

0.11

253

Benign neoplasm of other and unspecified sites

372

1.22

0.60

2.7

2.2

3.52

3.69

g/l

0.48

273

Vitiligo

1.46

0.59

1.4

1.7

4.28

3.65

g/l

—

Beningn neoplasm: Meninges, unspecified

175

1.33

0.59

1.6

1.4

3.29

3.87

g/l

1.59

122

Abscess of Bartholin gland

219

1.29

0.59

3.5

2.2

3.65

3.75

g/l

0.18

175

Injury of blood vessels at hip and thigh level

1.76

0.59

2.3

1.9

4.78

3.94

g/l

—

Vestibular neuronitis

130

1169

1.12

0.58

2.1

2.4

3.78

3.80

g/l

0.05

842

Twin gestation

622

1.16

0.58

1.2

1.9

3.55

3.69

g/l

0.63

464

Small plaque parapsoriasis

1.71

0.58

1.7

2.2

4.42

3.91

g/l

—

Benign neoplasm: Brain, supratentorial

158

1.34

0.58

1.3

2.8

3.72

3.76

g/l

0.05

117

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

428

1.19

0.58

2.7

1.9

3.64

3.77

g/l

0.35

296

Other and unspecified water transport accidents

1.70

0.57

1.0

1.2

3.78

3.68

g/l

—

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

247

1.27

0.57

1.7

1.4

3.85

3.97

g/l

0.25

175

Spermatocele

118

1058

1.12

0.56

2.6

2.3

3.87

3.95

g/l

0.13

768

Other specified and unspecified disorders of lens

133

1.38

0.56

1.7

2.5

3.90

3.54

g/l

—

Acute and transient psychotic disorders

140

1267

1.11

0.56

2.0

2.3

3.76

3.82

g/l

0.18

920

Erosion and ectropion of cervix uteri

357

1.21

0.56

3.4

2.0

3.87

g/l

0.00

261

Infections of genitourinary tract in pregnancy

923

0.88

0.56

2.2

3.69

3.70

g/l

0.03

680

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

248

1.26

0.56

4.2

1.4

3.97

3.81

g/l

0.31

187

Unequal limb length (acquired)

1.63

0.56

1.2

2.2

4.85

3.43

g/l

—

Rubella [German measles]

330

1.22

0.55

2.3

1.9

4.65

3.94

g/l

2.01

243

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

240

1.26

0.54

4.0

1.3

3.01

3.78

g/l

2.52

167

Bilateral sagittal split ramus osteotomy operation

261

0.76

0.54

1.0

1.7

3.79

3.90

g/l

0.14

199

Toxic effect of carbon monoxide

170

0.70

0.54

1.2

2.0

3.36

3.85

g/l

—

121

Ethmoidectomy

141

1551

0.91

0.54

2.8

2.3

3.70

3.83

g/l

0.61

100

1132

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

432

1.19

0.54

1.3

2.2

3.53

3.94

g/l

1.86

310

Anisometropia and aniseikonia

322

1.22

0.54

2.9

2.5

3.47

3.84

g/l

1.13

236

Malignant neoplasm of brain

338

0.79

0.53

1.5

2.4

3.89

3.82

g/l

0.10

252

Disorders of puberty, all

1.54

0.53

1.2

1.9

4.12

3.47

g/l

—

Unspecified chronic bronchitis

461

1.18

0.52

1.9

2.8

3.65

3.91

g/l

0.81

319

Non-small cell lung cancer

241

2586

0.93

0.52

2.1

2.3

4.07

3.81

g/l

0.88

185

1809

Multiple gestation

638

1.15

0.52

1.2

1.9

3.57

3.68

g/l

0.45

478

Hirsutism in women

100

1.41

0.52

1.1

1.5

3.95

3.75

g/l

—

Open wound of thorax

135

1.34

0.51

2.2

2.1

4.04

3.81

g/l

0.22

Carcinoma in situ of middle ear and respiratory system

1.41

0.51

1.9

3.0

3.41

3.77

g/l

—

Single delivery by caesarean section

138

879

0.91

0.51

2.0

1.6

4.12

3.68

g/l

1.18

100

695

Embolic stroke

630

1.15

0.51

2.0

2.5

3.69

3.86

g/l

0.50

430

Malignant neoplasm of corpus uteri

107

1189

0.90

0.51

1.5

2.2

4.01

3.73

g/l

0.96

824

Crushing injury of wrist and hand

162

1.31

0.50

1.6

2.6

4.28

3.86

g/l

0.25

122

Hydrocephalus

1062

0.89

0.50

2.2

2.5

3.72

3.80

g/l

0.22

761

Benign neoplasm: Peripheral nerves and autonomic nervous system

171

1.30

0.50

3.9

2.2

3.78

3.80

g/l

0.03

120

Other obstructed labour

734

0.87

0.50

1.9

2.2

3.83

3.70

g/l

0.34

547

Impacted teeth

116

974

1.11

0.50

1.5

1.7

3.61

3.73

g/l

0.42

734

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

234

1.25

0.50

2.8

1.3

4.39

4.00

g/l

0.50

165

Congenital malformations of uterus and cervix

127

1.35

0.50

1.2

2.0

3.34

3.71

g/l

0.71

104

Carcinoma in situ of cervix uteri

613

1.14

0.49

2.3

1.3

3.38

3.74

g/l

1.71

445

Car occupant injured in noncollision transport accident

298

1.21

0.49

3.7

2.4

4.03

3.76

g/l

0.58

221

Venous complications and haemorrhoids in the puerperium

107

0.65

0.49

1.3

1.6

3.90

3.91

g/l

—

Maltreatment syndromes

353

1.19

0.49

2.1

1.8

3.59

3.87

g/l

0.82

263

Lesion of sciatic nerve

636

0.86

0.49

1.3

2.4

3.88

3.77

g/l

0.17

439

Oral leukoplakia, including avohilmo

326

1.20

0.49

1.3

2.0

3.97

3.75

g/l

0.46

243

Other abnormal products of conception

277

1729

1.07

0.49

1.8

2.0

3.67

3.70

g/l

0.19

215

1270

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

512

1.16

0.48

2.5

1.4

3.92

3.86

g/l

0.12

374

Complications predominantly related to the puerperium

264

2478

1.07

0.47

2.0

2.1

3.73

3.71

g/l

0.05

191

1801

Other appendicitis

107

967

1.11

0.47

2.9

2.4

3.62

3.82

g/l

0.89

705

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

536

4486

1.05

0.47

2.2

2.1

3.68

3.70

g/l

0.21

386

3254

Malignant neoplasm of endocrine gland

863

1.12

0.47

2.4

2.5

3.88

3.76

g/l

0.37

630

Benign neoplasm: Uterine tubes and ligaments

0.59

0.46

1.0

2.6

3.34

3.87

g/l

—

Injury of muscle and tendon at wrist and hand level

182

1687

1.08

0.46

1.9

2.3

3.84

3.86

g/l

0.08

127

1242

Distal bite

175

0.74

0.46

2.4

1.4

3.18

3.70

g/l

—

138

Other articular cartilage disorders

246

1.23

0.46

2.5

2.1

3.99

3.69

g/l

0.59

173

Dementia due to Parkinsons disease, excluding more controls

237

1.23

0.46

1.3

2.2

4.19

3.70

g/l

0.27

167

Other benign neoplasms of uterus

790

1.12

0.45

3.0

2.2

3.66

3.72

g/l

0.17

561

Open bite

283

1.20

0.45

1.1

1.5

3.80

3.79

g/l

0.03

219

Deep endometriosis

1084

0.90

0.45

1.5

2.2

3.56

3.72

g/l

0.60

782

Carcinoma in situ of larynx

1.67

0.44

2.4

1.1

3.70

3.90

g/l

—

Benign neoplasm: Short bones of upper limb

148

1.29

0.44

1.4

2.1

3.48

3.85

g/l

0.52

112

Female infertility, tubal origin

395

1.17

0.44

1.3

1.8

3.98

3.84

g/l

0.35

295

Other complications of labour and delivery, not elsewhere classified

545

0.86

0.43

1.3

1.5

3.50

3.66

g/l

0.40

419

Keratoconus

230

1.22

0.43

1.8

2.2

4.08

3.87

g/l

0.34

171

Disorders of globe

313

1.19

0.43

1.8

2.4

5.18

3.72

g/l

0.68

220

Gastrointestinal stromal tumor and sarcoma

140

1.30

0.43

1.3

2.3

3.29

3.75

g/l

2.05

Supervision of high-risk pregnancy

170

952

1.08

0.42

1.7

1.8

3.53

3.74

g/l

1.40

121

736

Maternal care for known or suspected disproportion

276

1.20

0.42

1.4

2.1

3.81

3.72

g/l

0.21

203

Benign neoplasm: Male genital organ, other/unspecified

0.00

0.42

0.0

1.3

—

3.57

—

Sequelae of inflammatory diseases of the central nervous system

1.54

0.42

1.8

4.0

3.46

3.63

g/l

—

Intentional self-harm by other and unspecified firearm discharge

0.00

0.42

0.0

1.3

—

3.05

—

Convergence insufficiency and excess

1.36

0.42

1.4

1.8

3.52

3.79

g/l

—

Benign neoplasm: Vulva

228

0.78

0.42

2.3

1.3

3.82

3.76

g/l

0.08

170

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

241

2138

1.06

0.41

2.1

1.4

4.07

3.86

g/l

0.64

185

1480

conjunctival scars

0.00

0.41

0.0

1.9

—

4.33

—

Other inherited muscular atrophy

0.00

0.41

0.0

3.0

—

3.72

—

Benign neoplasm: Tonsil

132

1.30

0.41

2.5

2.0

5.13

3.81

g/l

—

Non-allergic asthma

116

1063

1.09

0.40

2.1

2.5

3.84

3.78

g/l

0.14

750

Benign neoplasm: Long bones of lower limb

287

1.19

0.40

1.3

2.0

3.56

3.77

g/l

0.34

215

Generalized epilepsy, strict definition

168

1.26

0.40

1.4

2.1

3.79

3.75

g/l

0.06

130

Female infertility

333

1953

1.05

0.40

1.9

2.1

3.70

3.76

g/l

0.34

242

1438

Toxic effects of substances chiefly nonmedicinal as to source

110

1201

0.91

0.40

1.7

2.4

3.70

3.83

g/l

0.48

880

Multiple delivery

835

0.90

0.40

2.1

1.9

3.71

3.66

g/l

0.17

632

Obstructed labour due to maternal pelvic abnormality

166

1781

0.93

0.40

2.3

2.2

3.68

3.76

g/l

0.37

111

1276

Other and unspecified spinal muscular atrophies

106

1.34

0.40

2.0

2.4

3.73

3.71

g/l

—

Symptoms and signs involving appearance and behaviour

1.42

0.39

1.0

2.2

3.72

3.77

g/l

—

Other and unspecified injuries of shoulder and upper arm

288

1.19

0.39

1.4

2.3

3.69

3.80

g/l

0.15

207

Benign neoplasm: Rectum/anal canal icd-9

115

1.32

0.39

1.1

1.3

3.47

3.84

g/l

—

Other benign neoplasm of uterus: Other parts/unspecified

646

1.12

0.39

2.7

2.2

3.76

3.71

g/l

0.13

452

Heterophoria

769

1.11

0.39

3.0

2.3

3.79

3.80

g/l

0.01

562

Malignant neoplasm of head and neck

124

1143

1.09

0.39

2.3

2.4

3.66

3.86

g/l

0.82

830

Phakomatoses, not elsewhere classified

1.39

0.39

2.4

2.1

3.45

3.72

g/l

—

Problems related to social environment

269

0.81

0.38

3.2

1.8

3.21

3.75

g/l

1.27

198

Sequelae of tuberculosis

252

1.20

0.38

3.8

2.2

4.01

3.69

g/l

0.50

179

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

297

3000

0.95

0.38

1.9

1.4

3.75

3.74

g/l

0.04

209

2088

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

112

1030

1.09

0.38

2.0

2.5

3.56

3.81

g/l

1.05

741

Pedal cyclist injured in other and unspecified transport accidents

133

1232

1.08

0.37

2.2

2.3

3.65

3.81

g/l

0.67

908

Mumps

268

0.82

0.37

1.4

2.2

4.01

3.86

g/l

0.14

195

Wilms' tumor, excluding all cancers (controls excluding all cancers)

1.41

0.37

1.0

1.2

3.26

3.78

g/l

—

Urticaria due to cold and heat

1.31

0.37

1.7

1.6

4.30

3.84

g/l

—

Oral lichen ruber planus wide, hypothyreosis or thyroxin

696

1.11

0.37

2.0

2.6

3.46

3.73

g/l

1.50

496

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

253

1.19

0.37

1.6

2.2

4.30

3.82

g/l

0.17

187

Generalized epilepsy

346

1.16

0.37

1.7

2.3

3.99

3.70

g/l

0.61

259

Frontotemporal dementia, wide, incl. Pick's disease

1.35

0.36

2.4

2.0

4.86

3.81

g/l

—

Benign neoplasm: Uterine tubes and ligaments

0.65

0.36

1.0

1.3

3.34

4.01

g/l

—

Other deformity of hallux (acquired)

1.33

0.36

1.2

1.9

3.60

3.56

g/l

—

Mental retardation, excluding more controls

240

1.19

0.36

1.7

2.4

3.64

3.78

g/l

0.29

175

Malignant neoplasm of other endocrine glands and related structures, excluding all cancers (controls excluding all cancers)

1.41

0.35

3.7

1.1

3.15

3.93

g/l

—

Hypertrophy of breast

192

1808

1.06

0.35

1.4

2.2

3.76

3.73

g/l

0.12

136

1306

Haemorrhage in early pregnancy

294

2734

1.05

0.35

2.1

3.49

3.70

g/l

2.36

202

2005

Hypersensitivity pneumonitis due to organic dust

181

1.22

0.35

3.3

2.8

3.51

3.71

g/l

0.26

135

HSIL lesion of the vulva

181

1.22

0.35

1.4

2.2

3.54

3.72

g/l

0.34

141

Inflammation of lacrimal passages (chronic)

200

0.79

0.35

1.2

2.1

3.80

3.82

g/l

—

140

Pedal cyclist injured in collision with motor vehicle

287

0.83

0.35

1.3

2.2

4.40

3.88

g/l

0.47

217

Pedestrian injured in collision with car, pick-up truck or van

255

1.18

0.34

1.5

2.3

3.99

3.79

g/l

0.39

189

Use of ropinirole

481

1.13

0.34

2.3

2.9

3.68

3.85

g/l

0.42

352

Sequelae of infectious and parasitic diseases

882

1.09

0.34

2.9

2.1

3.83

3.86

g/l

0.08

632

Bruxism

154

1.24

0.34

1.2

2.0

3.49

3.75

g/l

0.50

117

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

145

1.25

0.34

1.4

1.6

3.75

3.90

g/l

0.07

106

Malignant neoplasm of heart, mediastinum and pleura, excluding all cancers (controls excluding all cancers)

200

1.21

0.34

1.3

1.4

3.48

3.98

g/l

1.41

136

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

191

1.21

0.34

2.5

1.3

3.77

3.79

g/l

0.03

133

Gender identity disorders

1.34

0.34

1.0

1.8

4.32

3.61

g/l

—

Other benign neoplasms of connective and other soft tissue

132

1230

1.08

0.34

2.6

2.4

3.59

3.81

g/l

1.17

887

Malignant neoplasm of oral cavity

406

1.14

0.33

2.3

2.8

3.91

3.85

g/l

0.09

294

Acute appendicitis, with complications

292

2788

1.05

0.33

2.4

2.2

3.70

3.84

g/l

1.19

221

1998

Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)

1.32

0.33

5.7

1.3

3.18

3.87

g/l

—

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

105

970

1.08

0.33

1.8

2.2

3.74

3.68

g/l

0.20

701

Impacted maxillary molar

228

1.19

0.33

2.1

1.7

3.88

3.71

g/l

0.17

178

Malignant neoplasm of stomach

692

1.10

0.33

1.2

2.4

3.55

3.86

g/l

1.58

490

Renal cell carcinoma of kidney

473

1.13

0.33

1.9

2.6

3.83

3.79

g/l

0.04

328

Failed induction of labour

285

0.84

0.32

1.3

1.6

3.66

3.63

g/l

0.06

221

Mesothelioma

165

0.78

0.32

1.1

2.7

3.66

g/l

—

120

Postpartum care and examination

559

0.91

0.32

1.6

3.38

3.72

g/l

1.81

437

Other melanin hyperpigmentation

276

1.17

0.32

3.0

2.2

3.57

3.75

g/l

0.33

195

Other and unspecified disorders of skin and subcutaneous tissue

790

1.09

0.32

1.7

2.4

3.71

3.81

g/l

0.21

571

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

841

0.91

0.31

3.1

2.4

3.86

3.82

g/l

0.09

617

Benign neoplasm: Skin of trunk

485

1.12

0.31

3.0

2.4

3.56

3.74

g/l

0.50

362

Persons encountering health services in circumstances related to reproduction

689

4803

0.97

0.31

2.1

2.2

3.90

3.84

g/l

0.20

515

3532

Malignant neoplasm of breast

750

5558

0.97

0.31

1.9

2.3

3.78

3.72

g/l

0.48

529

3895

Kyphosis

138

1.24

0.31

1.4

1.6

4.48

3.74

g/l

—

101

Schizotypal disorder

184

1.20

0.30

1.8

3.74

3.89

g/l

0.32

138

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

325

0.86

0.30

1.2

1.4

3.45

3.89

g/l

1.39

224

Endometriosis of rectovaginal septum and vagina

943

0.92

0.30

1.6

2.1

3.62

3.78

g/l

0.52

673

Foreign body in genitourinary tract

1.30

0.30

2.8

1.2

3.37

3.87

g/l

—

Benign neoplasm: Skin, unspecified

410

1.13

0.30

2.3

1.4

4.14

3.82

g/l

0.74

300

Beningn neoplasm: Meninges, unspecified

194

1.19

0.30

1.6

1.8

3.29

3.74

g/l

1.13

138

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

344

1.14

0.30

2.7

1.4

4.03

3.89

g/l

0.26

243

Cholesteatoma of middle ear

702

0.91

0.29

2.1

2.5

3.80

3.83

g/l

0.07

519

Postpartum haemorrhage due to retained placenta

796

0.92

0.29

2.0

1.8

3.68

3.70

g/l

0.04

568

Autoimmune thyroiditis

176

1.20

0.29

2.1

1.8

3.60

3.79

g/l

0.38

135

Poor fetal growth

699

1.09

0.28

1.7

1.8

3.29

3.67

g/l

2.83

512

Intrahepatic Cholestasis of Pregnancy (ICP)

460

1.11

0.28

2.7

1.9

3.64

3.70

g/l

0.14

341

LSIL lesion of the cervix uteri

864

1.08

0.27

3.3

2.1

3.44

3.70

g/l

1.61

634

Gestational diabetes (for exclusion)

264

1949

0.96

0.27

1.8

3.79

3.61

g/l

1.84

194

1459

Other corneal oedema

1.28

0.26

2.8

2.0

3.48

3.67

g/l

—

Benign leiomyoma with endometriosis

234

2241

1.05

0.26

2.1

2.2

3.59

3.72

g/l

0.92

159

1589

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.29

0.26

6.0

1.2

3.17

3.88

g/l

—

Malignant neoplasm of thyroid gland

818

1.08

0.26

2.4

2.5

3.91

3.76

g/l

0.44

598

Cyst of Bartholin Gland

357

1.12

0.26

2.5

2.1

4.07

3.72

g/l

0.18

276

ILD medications: acetylcysteine

1.29

0.26

1.6

1.3

3.07

3.83

g/l

—

Mesothelioma, excluding all cancers (controls excluding all cancers)

160

0.81

0.26

1.1

1.3

3.66

3.87

g/l

—

109

Female infertility, associated with anovulation

395

1.12

0.26

1.1

1.5

3.58

3.71

g/l

0.38

291

Excessive vomiting in pregnancy

654

1.09

0.26

2.3

2.2

3.56

3.71

g/l

0.42

486

Other and unspecified intracranial injuries

310

1.13

0.26

1.9

2.6

3.95

3.78

g/l

0.38

223

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

149

0.80

0.26

1.2

1.4

3.44

3.89

g/l

—

108

Oral lichen ruber planus, hypothyreosis or thyroxin

188

1.18

0.25

2.7

1.8

3.80

3.79

g/l

0.01

149

Foreign body in respiratory tract

540

1.10

0.25

2.6

2.4

4.06

3.76

g/l

0.53

394

Malignant neoplasm of breast, HER2-negative

733

5512

0.98

0.25

1.9

2.3

3.77

3.72

g/l

0.41

517

3861

Dependent personality disorder

207

1.16

0.25

1.9

2.0

3.76

3.82

g/l

0.11

157

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

540

1.09

0.25

1.6

1.9

3.73

3.70

g/l

0.08

396

Any dementia, excluding more controls

634

4510

0.97

0.25

2.0

2.3

3.86

3.79

g/l

0.37

385

3116

Melanocytic naevi of other and unspecified parts of face

637

1.09

0.25

2.8

2.4

3.52

3.72

g/l

0.68

465

Anomalies of dental arch relationship, including avohilmo

184

1576

1.05

0.25

1.9

2.3

3.71

3.80

g/l

0.48

117

1155

Motorcycle rider injured in other and unspecified transport accidents

424

0.89

0.25

1.3

2.0

3.98

3.88

g/l

0.18

318

Malignant neoplasm of oropharynx

191

0.83

0.25

6.4

2.0

3.13

3.80

g/l

—

137

Hepatocellular carcinoma

255

1.14

0.24

2.3

2.8

4.26

3.71

g/l

1.36

181

Other osteochondropathies

706

1.08

0.24

2.3

2.2

4.87

3.84

g/l

1.36

527

Gestational [pregnancy-induced] hypertension

240

2302

1.04

0.24

2.5

2.0

3.74

3.62

g/l

0.90

177

1674

Other noninflammatory disorders of cervix uteri

639

1.08

0.23

2.7

2.1

4.13

3.80

g/l

0.38

452

Early lumbar disc prolapse, operated

658

1.08

0.23

1.9

3.67

3.91

g/l

1.00

493

Ectopic pregnancy

172

1801

0.95

0.23

1.5

2.4

3.65

3.76

g/l

0.51

134

1293

Benign neoplasm: Cranial nerves

313

1.12

0.23

3.1

1.3

3.52

3.86

g/l

1.09

228

Respiratory tuberculosis

785

1.07

0.23

2.1

2.5

3.70

3.85

g/l

0.41

551

Respiratory tuberculosis, confirmed and not-confirmed

785

1.07

0.23

2.1

2.5

3.70

3.85

g/l

0.41

551

Female infertility, cervigal, vaginal, other or unspecified origin

295

1906

1.04

0.23

2.0

3.70

3.76

g/l

0.33

215

1405

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.29

0.23

1.8

1.2

3.96

3.90

g/l

—

Bicuspidal aortic valve syndrome

342

1.11

0.23

2.0

2.3

3.61

3.86

g/l

0.68

252

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

1.26

0.23

6.0

1.7

3.17

3.67

g/l

—

Toxic effect of ethanol

342

1.11

0.23

1.2

2.2

3.36

3.79

g/l

1.29

255

Malignant neoplasm of other and unspecified urinary organs

1.26

0.23

1.0

1.3

4.44

4.03

g/l

—

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

285

1.13

0.23

3.2

1.3

4.21

3.95

g/l

0.32

205

Congenital malformations of spine and bony thorax

1.26

0.22

1.0

2.1

3.68

3.82

g/l

—

Habitual aborter

0.77

0.22

4.7

2.1

3.60

3.78

g/l

—

Benign neoplasm: Pelvic bones, sacrum and coccyx

1.23

0.22

1.8

2.8

3.96

3.91

g/l

—

Benign neoplasm of thyroid gland

399

0.90

0.22

2.4

2.2

3.82

3.71

g/l

0.15

295

Calculus of urinary tract in diseases classified elsewhere

0.00

0.22

0.0

1.1

—

4.35

—

Antenatal screening

187

1008

1.05

0.22

1.9

1.8

3.92

3.73

g/l

0.56

151

776

Malignant neoplasm of placenta, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

3.50

—

L02BB Anti-androgens

138

1448

0.95

0.21

1.8

2.4

4.27

3.87

g/l

0.77

1006

Disorder of amino-acid metabolism, other/unspecified

0.00

0.21

0.0

2.0

—

3.39

—

Use of selegiline

633

1.08

0.21

2.2

2.4

3.61

3.85

g/l

0.91

461

Use of levodopa decarbox-comt-inhibitor

440

1.10

0.21

1.1

2.9

3.47

3.79

g/l

1.28

319

Malignant neoplasm of eye, brain and central nervous system

471

0.91

0.21

1.5

2.4

3.81

3.76

g/l

0.10

345

Hyperalimentation, other specified

0.00

0.21

0.0

1.3

—

3.70

—

Diseases caused by chlamydiae

1.24

0.21

1.5

2.0

3.70

3.78

g/l

—

Wilms' tumor

1.26

0.21

1.0

1.3

3.26

3.77

g/l

—

Non-small cell lung cancer, adenocarcinoma

934

0.94

0.20

1.8

2.6

3.79

3.81

g/l

0.06

687

Non-small cell lung cancer, adenocarcinoma, helper endpoint

934

0.94

0.20

1.8

2.6

3.79

3.81

g/l

0.06

687

Dyshidrosis [pompholyx]

123

0.81

0.20

4.0

2.0

3.78

3.77

g/l

—

Male infertility

303

0.89

0.20

1.6

2.1

4.02

3.97

g/l

0.06

222

Calculus of lower urinary tract

732

1.07

0.20

1.9

2.5

4.06

3.89

g/l

0.42

531

Intermittent heterotropia

423

1.09

0.19

2.1

2.0

3.46

3.83

g/l

1.25

311

Infections of breast associated with childbirth

241

1.12

0.19

1.1

1.6

3.34

3.79

g/l

0.84

189

Malignant neoplasm of tonsil

175

0.85

0.19

5.1

1.8

3.13

3.80

g/l

—

128

Malignant neoplasm of liver and intrahepatic bile ducts

424

1.09

0.19

2.0

2.6

4.10

3.86

g/l

0.58

304

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

156

1.16

0.19

1.7

1.4

3.26

3.80

g/l

1.37

119

Other congenital malformations of face and neck

232

1.12

0.18

2.9

1.9

3.77

3.71

g/l

0.07

178

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

833

1.06

0.18

1.8

1.4

3.79

3.82

g/l

0.09

597

Left side

1.20

0.18

1.0

2.1

—

3.76

—

647

1.06

0.17

2.1

2.2

3.63

3.82

g/l

0.59

425

Benign neoplasm: Rectum/anal canal icd-9

129

1.17

0.17

1.1

1.8

3.47

3.64

g/l

—

Circumscribed brain atrophy

257

0.89

0.17

1.7

2.9

4.16

3.68

g/l

0.38

179

Malignant neoplasm of heart, mediastinum and pleura

148

1.15

0.17

1.1

2.8

3.23

3.69

g/l

1.29

106

Dislocation, sprain and strain of joints and ligaments of elbow

543

1.07

0.17

1.8

3.65

3.76

g/l

0.36

400

Other diseases caused by chlamydiae

101

1.19

0.16

1.4

1.9

3.50

3.83

g/l

—

Colon adenocarcinoma

179

1852

0.97

0.16

2.3

2.4

3.73

3.81

g/l

0.41

117

1311

Glaucoma, exfoliation

184

1779

1.04

0.16

2.2

2.3

3.93

3.74

g/l

0.34

121

1215

Congenital malformations of aortic and mitral valves

379

1.08

0.16

2.0

2.3

3.61

3.86

g/l

0.76

278

Labour and delivery complicated by umbilical cord complications

422

0.92

0.16

2.9

2.1

3.88

3.69

g/l

0.40

327

Benign neoplasm: Skin of lower limb, including hip

283

1.10

0.16

1.7

1.3

3.81

3.83

g/l

0.02

203

Eustachian salpingitis and obstruction

603

1.06

0.16

2.1

2.0

3.62

3.81

g/l

0.73

439

Follow-up care involving plastic surgery

399

1.08

0.16

1.6

1.8

3.53

3.69

g/l

0.37

300

Other and unspecified injuries of abdomen, lower back and pelvis

130

1.16

0.15

2.2

4.14

3.70

g/l

—

Crowding of teeth, including avohilmo

356

0.93

0.15

3.6

1.8

3.47

3.77

g/l

0.68

278

Contact with lifting and transmission devices, not elsewhere classified

178

1.13

0.15

1.6

2.4

3.95

3.69

g/l

0.59

126

Carcinoma in situ of other and unspecified sites

488

1.07

0.15

3.2

2.6

3.86

g/l

0.01

350

Inflammatory disease of cervix uteri

830

0.95

0.15

1.4

2.2

3.90

3.73

g/l

0.37

601

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

757

6267

0.99

0.15

2.2

3.65

3.77

g/l

1.54

542

4514

Burn and corrosion of hip and lower limb, except ankle and foot

213

0.89

0.15

1.2

2.3

4.09

3.69

g/l

0.78

155

Fourth [trochlear] nerve palsy

244

0.90

0.15

1.5

2.6

3.71

3.76

g/l

0.06

176

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

461

0.93

0.15

2.6

1.4

3.84

3.87

g/l

0.05

329

Androgenic alopecia

1.09

0.15

1.1

2.0

3.80

3.82

g/l

—

Carcinoma in situ of cervix uteri

665

1.05

0.14

2.3

2.1

3.38

3.69

g/l

1.33

490

Early lumbar disc prolapse operation

777

0.95

0.14

1.9

1.8

3.69

3.84

g/l

0.52

579

Polycystic ovarian syndrome

266

1.09

0.14

1.2

1.6

3.64

3.80

g/l

0.35

204

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

165

1701

0.97

0.14

2.6

1.4

3.74

3.85

g/l

0.58

114

1184

Dementia due to Parkinson's disease

315

0.92

0.13

1.3

2.5

4.19

3.72

g/l

0.26

221

Melanocytic naevi, other sites/unspecified

853

1.04

0.13

1.9

2.5

4.16

3.84

g/l

0.27

633

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS